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Abstract 
 
Acute Pancreatitis (AP) is inflammatory disease characterised by the pathological activation 
of the digestive enzymes and extensive necrosis of the pancreases and surrounding tissue, 
which currently has no effective treatment. Pathological agents like the bile acid 
taurolithocholic acid-3-sulfate (TLC-S) have been shown to induce necrosis of pancreatic 
acinar cells by causing intracellular calcium (Ca2+) to reach cytotoxic concentrations. TLC-S 
acts on elements of the secondary Ca2+ messenger pathways normally used in physiological 
signalling to achieve these Ca2+ increases. 
Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most novel of these secondary 
Ca2+ messengers to be identified and several recent advancements have been made regarding 
its activity. This study has used these advancements to better characterise NAADP-induced 
Ca2+ release in PAC, and its role in both physiological and pathological Ca2+ signalling. 
NAADP-induced Ca2+ release was found to involve the activity of both Two-pore channel 
(TPC) and Ryanodine receptor (RyR) Ca2+ channels; with a varying involvement of the 2 
TPC and 3 RyR isoforms. The NAADP antagonist Ned-19 completely inhibited Ca2+ 
responses to a physiological concentration of the secretagogue cholecystokinin (CCK) and 
had a protective effect against a pathological concentration of CCK.  
The size of the Ca2+ response to TLC-S was significantly inhibited in the presence of Ned-19, 
and the antagonist significantly reduced the amount of necrosis induced. Another related bile 
acid, cholate, was found to have a similar necrotic effect to PAC as a result of pathological 
increases in cytosolic Ca2+. While neither Ned-19 or GSK-7975A (an inhibitor of store-
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operated Ca2+ entry) alone had a significant effect on cholate-induced necrosis, a combination 
of the two did have a protective effect.  
These findings suggest that Ned-19 may provide a potential therapeutic solution to AP, 
though it may need to be used in combination with inhibitors of other Ca2+ signalling to be 
effective.  
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Chapter 1: Introduction  
 
1.1 Calcium signalling 
1.1.1 Calcium as a signal 
The importance of calcium ions (Ca2+) on cellular processes was first identified in 1883 by 
Sydney Ringer during the development of his physiological saline solution (Ringer 1883). He 
observed that solutions made with tap water rather than distilled water allowed the continued 
beating of an isolated frog heart due to a contaminate he identified as lime (Ca2+). Since this 
initial discovery, Ca2+ has been shown to act as an intracellular signal in most cell types 
studied and play a role in a wide range of cellular processes (Berridge et al. 2000). 
Ca2+ can interact with many important biological molecules thanks to its physical properties 
(Jaiswal 2001) and proteins have evolved a specific structural domain, the EF hand, to do so 
(Schäfer and Heizmann 1996). Binding of Ca2+ to these domains can have a drastic effect on 
their activity (Ikura 1996); making Ca2+ a potent signal. Due to its ability to interact with 
biological molecules excessive Ca2+ is toxic to cells casing disruption of lipid membranes, 
aggregation of proteins and nucleic acids, and precipitation of phosphates. Because of this, all 
cellular life has evolved a system of pumps and exchangers to maintain Ca2+ homeostasis 
(Case et al. 2007). Eukaryotic cells maintain a resting cytosolic Ca2+ concentration ([Ca2+]c) 
around 100 nM compared to an extracellular concentration of 1 mM ([Ca2+]e). Eukaryotes 
make a greater use of Ca2+ signalling than prokaryotes, this is probably due to the presence of 
organelles in eukaryotic cells, which act as intracellular Ca2+ stores (Williams 1980). This 
creates three possible mechanisms for an increase in [Ca2+]c: entry of Ca2+ from the 
extracellular space, release from organelles or a coordination of the two (Chavis et al. 1996).             
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1.1.2 Calcium Homeostasis  
Homeostasis is a process by which various elements of a biological system act to maintain a 
state of equilibrium; one such example is the [Ca2+]c which is maintained by a series of ion 
channels, pumps and organelle stores, which together form the cell’s ‘Ca2+ signalling toolkit’ 
(Berridge et al. 2003). As Ca2+ itself is a potent signal, involved in a wide and diverse  range 
of cellular processes (Berridge et al. 2000), increases in [Ca2+]c occur often in cells and must 
rapidly be returned to resting levels (Fig. 1.1.2). 
The largest source of increases to [Ca2+]c is entry of Ca2+ from the extracellular space, with 
Ca2+ freely moving down a concentration gradient through the opening of channels in the 
plasma membrane (PM) (Clapham 2007). Cells can be divided into two types, excitable and 
non-excitable, based on whether or not they express voltage-gated channels in their plasma 
membranes, though both express ligand gated channels (Mahaut-Smith et al. 2016). Voltage-
gated channels are gated by the electrical potential across the plasma membrane, allowing 
rapid entry of Ca2+ in response to depolarisation of the membrane (Catterall 1995). As non-
excitable cells lack these types of channel, there are resistant to changes in membrane 
potential.  
While extracellular Ca2+ might be the largest pool from which [Ca2+]c increases can occur, it 
is not the sole source. The ability of physiological stimuli to induce [Ca2+]c increases in Ca2+ 
free extra cellular conditions (Chew 1986), shows the presence of a stored pool of Ca2+  
within cells that can readily be mobilized. 
The endoplasmic reticulum (ER), or the sarcoplasmic reticulum (SR) in myocytes, forms the 
largest Ca2+ store in most cells (Verkhratsky 2005), with a luminal free Ca2+ concentration 
([Ca2+]l) in the 100 µM range (Lam and Galione 2013). [Ca2+]l storage is facilitated by 
various Ca2+ binding proteins, e.g.  calsequeastrin and calreticulin (Milner et al. 1992), which  
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Fig. 1.1.2 The cell’s ‘Calcium Signalling Toolkit’ 
Stimuli at the cell’s plasma membrane can induce elevations in cytoplasmic calcium either by 
the influx of extracellular calcium through the opening of plasma membrane channels, the 
release of calcium from organelle stores via the production of intracellular messengers or a 
combination of the two. Such elevations can drive a range of calcium sensitive cellular 
processes. Cytoplasmic calcium is restored to resting levels by extrusion from the cell, uptake 
into organelle stores or binding by buffer proteins.  
 
 
 
Reproduced by permission from Macmillan Publishers Ltd: [Nature Reviews Molecular Cell Biology], (Berridge 
et al. 2000) copyright 2000. 
  
22 
 
prevent the toxic effects mentioned previously. Release of Ca2+ from the ER is tightly 
controlled by ligand gated ion channels, the activation of which results in a rapid increase in 
[Ca2+]c (Streb et al. 1983).  Maintenance of [Ca2+]l is achieved by the sarco/endoplasmic 
reticulum Ca2+ ATPase (SERCA) (Periasamy and Kalyanasundaram 2007), which actively 
pumps Ca2+ from the cytoplasm into the ER lumen. This action reduces the [Ca2+]c and 
increases the [Ca2+]l after efflux of Ca2+ into the cytosol, aiding in cellular Ca2+ homeostasis. 
Myocytes show coupling of voltage gated channels in the plasma membrane to channels in 
their SR, allowing for a depolarization in the plasma membrane to trigger a release of Ca2+ 
from the SR (Dulhunty et al. 2017). 
Mitochondria also play an important role in Ca2+ homeostasis, acting as buffers in response to 
elevations in [Ca2+]c (Williams et al. 2013). Such an elevation results in a rapid influx of Ca2+ 
into mitochondria via the mitochondrial Ca2+ uniporter (MCU) (Kirichok et al. 2004) which 
uses the negative charge of the inner mitochondrial membrane to facilitate uptake. This is 
followed by a slower release of Ca2+ back into the cytosol by mitochondrial Sodium (Na+) 
Ca2+ exchanger (NCLX). The rapid influx of Ca2+ into the mitochondria prevents a toxic level 
of [Ca2+]c being reached, while the slow extrusion creates a smaller increase in [Ca2+]c which 
is taken back up by the ER via SERCA pumps. Increases in mitochondrial Ca2+ also trigger 
the production of ATP (Tarasov et al. 2012), ensuring that there is a ready supply of the 
nucleotide for the Ca2+ ATPases that help restore resting [Ca2+]c by pumping Ca2+ across 
membranes against its concentration gradient. 
In recent years it has become apparent that the ER is not the only Ca2+ store in cells, with a 
range of acidic organelles combining to form a pool of mobilizable Ca2+ (Patel and Docampo 
2010). Of these organelles lysosomes have received the largest amount of interest, due to the 
disruption of lysosomes by glycyl-L-phenylalanine-naphthylamide (GPN) blocking aspects of 
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Ca2+ release (Churchill et al. 2002). Other organelles have also been shown to release Ca2+, 
e.g. the nucleus (Gerasimenko et al. 2003) or the Golgi body (Yang et al. 2015); though due 
to the amount of Ca2+ contained within these organelles there is only small localised elevation 
in [Ca2+]c, which is probably linked to the organelle’s function, e.g. gene transcription 
(Brailoiu et al. 2006). 
In addition to buffering by mitochondria and uptake back into stores, elevations in [Ca2+]c are 
returned to resting levels by extrusion of Ca2+ across the plasma membrane into the 
extracellular space. This is performed actively by the plasma membrane Ca2+ ATPase 
(PMCA) (Carafoli 1991) and in excitable cells by secondary active transport via Na+ Ca2+ 
exchangers (NCX) (Dipolo and Beaugé 2006).     
Together this community of stores, buffers and pumps create a dynamic system; where by a 
rapid elevation in [Ca2+]c can occur in response to stimuli, allowing the activation of Ca2+ 
binding proteins and a physiological response. This elevation in [Ca2+]c is then returned to 
basal levels before a cytotoxic level of [Ca2+]c is reached and allows for repeat stimulation of 
cells to occur.  
 
1.1.3 Secondary messengers 
Various extracellular messengers (e.g. Thrombin (Sacks et al. 2008), insulin (Contreras-
Ferrat et al. 2010) or ghrelin (Camiña et al. 2003)) have been found to be capable of inducing 
increases in the [Ca2+]c by inducing the release of Ca2+ from intracellular organelle Ca2+ 
stores. As these extracellular messengers act on receptors located on the plasma membrane of 
cells there is a need for the creation of a second messenger within the cell to convey the 
extracellular messenger’s signal to the organelle stores. Currently three such intracellular 
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secondary Ca2+ messengers have been identified: Inositol Trisphosphate (IP3), cyclic ADP-
Ribose (cADPR) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) (Berridge et 
al. 2003). 
 
1.1.3.1 IP3-induced calcium release 
IP3 was the first of these messengers identified by Berridge et al. in 1983. Using the salivary 
glands from blowfly he showed that there was an increase in IP3 in response to 5-
hydroxytryptamine (Berridge et al. 1983), which was known to induce fluid secretion via an 
increase in [Ca2+]c (Prince et al. 1972). Its Ca2+ mobilizing activity was then confirmed in 
pancreatic acinar cells (PAC), where micromolar concentrations were shown to induce a rise 
in intracellular Ca2+ from a non-mitochondria store (Streb et al. 1983). Since this initial 
discovery IP3 has been shown to have activity in a range of different cell types including 
leukocytes (Burgess, McKinney, et al. 1984), hepatocytes (Burgess, Godfrey, et al. 1984) and 
β cells (Biden et al. 1984).  
Production of IP3 occurs via the hydrolysis of plasma membrane associated 
phosphatidylinositol 4,5-bisphosphate by phospholipase C (PLC) into IP3 and diacylglycerol 
(Berridge et al. 2000). There are multiple isoforms of PLC (Rhee 2001), which can be 
activated by various mechanisms in a stimuli specific manner (Berridge et al. 2003), allowing 
for an integration of stimuli or creating cell specificity for a signal. 
IP3 mobilizes Ca2+ from the ER (Delfert et al. 1986), as seen by its sensitivity to thapsigargin 
(Tg), which inhibits SERCA pump (Thastrup et al. 1990). IP3 induces Ca2+ release though its 
own receptor (IP3R) (Mourey et al. 1990), of which there are three isoforms that can form 
either homo or heterotetramers (Taylor et al. 1999). IP3R’s also show a sensitivity to 
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increases in [Ca2+]c, with uncaging of Ca2+ able to induce release of Ca2+ from the ER via 
IP3R’s (Wang et al. 2006). This phenomenon, named Ca2+-induced Ca2+ release (CICR), 
creates a form of positive feedback that amplifies the amount of Ca2+ released in response to 
a stimulus. While IP3 has been shown to bind directly to its receptor (Ferris et al. 1989; 
Mignery and Südhof 1990; Yoshikawa et al. 1999) it has been suggested that rather than 
directly gating the channel itself it promotes the binding of Ca2+ to the receptor, which in turn 
induces opening of the channel’s pore (Taylor et al. 2004). This would suggest that IP3’s 
mechanism of action is to reduce the requirement for CICR to occur.  
 
1.1.3.2 cADPR-induced calcium release 
Despite IP3’s Ca2+ mobilizing activity being demonstrated it was thought unlikely to be the 
sole secondary messenger used by cells due to the spatiotemporal calcium release exhibited 
in response to distinct or integrated stimuli. Lee et al. had previously reported that IP3 was 
able to mobilise Ca2+ from a non-mitochondrial store via a novel assay using sea urchin egg 
homogenate (Clapper and Lee 1985). Using this new assay they decided to test the effect of 
pyridine metabolite nucleotides, which were known to alter in concentration during 
fertilization (Schomer and Epel 1998) with NAD being rapidly phosphorylated, and the 
resulting NADP being reduced to NADPH. 
Lee’s group found that both NAD and NADP could mobilize Ca2+ from stores in the 
homogenate at physiological concentrations, after a short delay in the case of NAD but not 
NADP (Clapper et al. 1987). This delay in response to NAD could be abated by an alkaline 
pre-treatment prior to use on the homogenate. The same alkaline pre-treatment on NADP 
significantly reduced the concentration required to activate Ca2+ release; indicating that a 
modification to the nicotinamide of both dinucleotides is required for the activity observed 
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for both NAD and NADP. Not knowing what these modified forms of the dinucleotides were 
Lee named them E-NAD and A-NADP respectively, unknowingly having discovered both 
cADPR and NAADP. 
As well as discovering what would later be identified as the two secondary messengers, Lee’s 
paper also identified several of the characteristics of their signalling. First, both E-NAD and 
A-NADP acted on a store that was not the mitochondria, as previously suggested for the 
release of Ca2+ induced by pyridine nucletodies (Frei et al. 1985).  The second characteristic 
observed was that repeat applications of a single activator (either of these new messengers or 
IP3) showed desensitisation, with the Ca2+ response to subsequent applications being 
diminished compared to the initial release. However, application of a second different 
activator following treatment with one of the other two still produced a large response, 
implying that the three act independently of each other. Finally, separation of organelle stores 
by gradient centrifugation showed a partial separation of A-NADP’s activity from that of E-
NAD and IP3, with all three acting on non-mitochondrial stores. These observations, over 
time, would be confirmed and lay the foundation for the mechanism and kinetics of these 
secondary Ca2+ messengers. 
With the discovery that an active form of both NAD and NADP could induce release from 
Ca2+ stores Lee et al. then aimed to identify the molecular structure of these compounds. The 
first to be identified was E-NAD two years later through a combination of techniques, and 
found to be to be cADPR (Lee et al. 1989). The newly identified messenger was shown to 
mobilize Ca2+ in a receptor dependent manner; with its activity distinct from IP3’s, but from 
overlapping Ca2+ stores (Dargie et al. 1990). Pituitary cells were the first mammalian cell 
type shown to be sensitive to cADPR-induced Ca2+ release (Koshiyama et al. 1991); with a 
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diverse range since also found to be sensitive including T-lymphocytes (Bruzzone et al. 
2003), smooth muscle (Bai et al. 2005) and mesenchymal stem cells (Tao et al. 2011).  
cADPR acts on the same ER Tg-sensitive store as IP3, and (due to its sensitivity to 
micromolar concentrations of ryanodine) cADPR induced Ca2+ release was identified as 
occurring through ryanodine receptors (RyR) (Mészáros et al. 1993). These channels are 
closely related to IP3R in structure and activity (Taylor and Tovey 2010; Amador et al. 2013), 
indicating a shared evolutionary history between the activity of IP3 and cADPR. They are 
activated by Ca2+ binding to its large cytoplasmic domain (Hadad et al. 1994), with RyR1 
displaying a bell-shaped dependence towards Ca2+ (Meissner 1984). RyR form large multi-
proteins complexes both in the cytoplasm and ER lumen (Lanner et al. 2010), with many of 
them affecting their activity (Bers 2004). This includes calmodulin in the cytoplasm (Fruen et 
al. 2000) and calsequestrin in the lumen (Beard et al. 2004); as the activity of these proteins is 
also modulated by binding Ca2+ it adds extra complexity to how Ca2+ affects the gating of 
RyR. Several members of the FKBP family of proteins, which bind the immunosuppressant 
drug FK506 (Marks 1996), have been found to have a potent effect on RyR’s activity. 
FKBP12 and FKBP12.6 associate with RyR1 and RyR2 respectively (Jayaraman et al. 1992; 
Timerman et al. 1996), stabilizing the channel in its closed state and reducing its sensitivity to 
Ca2+ (Timerman et al. 1993; Xiao et al. 1997). When the respective protein dissociates from 
the channel it enters a state of subconductance, where it is sensitized to Ca2+ again (Brillantes 
et al. 1994). Similarly, FKBP12 has been found to modulate the activity of IP3R by affecting 
their interaction with various other proteins (MacMillan et al. 2005).  
Unlike IP3, which binds directly to its receptor (Ferris et al. 1989; Mignery and Südhof 1990; 
Yoshikawa et al. 1999); cADPR does not do so to RyR’s (Walseth et al. 1993); however it 
does still act on them by increasing their sensitivity to CICR (Galione et al. 1991), which they 
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are a major component of (Imagawa et al. 1987). Of the three RyR isoforms (Lanner et al. 
2010), cADPR has only been shown to affect the opening of the RyR2 and RyR3 isoforms 
(Lee 1997), with its activity dependent on the presence of calmodulin (Lee et al. 1994). The 
actual mechanism by which cADPR potentiates RyR sensitivity to CICR is unknown, with 
several suggested models. The most basic  model is that cADPR increases RyR’s sensitivity 
to the [Ca2+]c; alternatively it may sensitise RyR’s by increasing the [Ca2+]l (Lukyanenko et 
al. 2001); or it might bind to FKBP12.6, causing its dissociation from RyR’s (Tang et al. 
2002).   
 
1.1.3.3 NAADP-induced calcium release 
While E-NAD was quickly identified as cADPR (Lee et al. 1989); the other unknown Ca2+ 
releasing pyridine nucleotide (Clapper et al. 1987), A-NADP, proved harder to identify. Lee 
et al. found commercially available NADP displayed the ability to mobilize Ca2+ from sea 
urchin egg homogenate that had been desensitised to both high concentrations of IP3 and 
cADPR with no delay, implying that the active form of NADP was present in the commercial 
product. A combination of three different chromatographic and spectrographic techniques 
were used to isolated and identify A-NADP from NADP, using the alkaline-activation 
process used in the previous report to maximise the yield of A-NADP. These techniques 
indicated that the active compound was NAADP (Lee and Aarhus 1995), a compound with a 
high structural similarity to NADP that only differs in the substitution of a nicotinamide 
group with a nicotinic acid group. This relatively simple structural substitution was enough to 
provide Ca2+ mobilizing activity, as HPLC purified NADP (which lacks any NAADP 
contamination) had no activity when applied to sea urchin egg homogenate. Lee et al. 
suggested the presence of the contaminate NAADP in the commercially available NADP was 
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due to a simple deamination of some of the NADP, though questioned if this would be the 
reaction used in the NAADP synthesis pathway in vivo or if phosphorylation of NAAD was a 
more viable alternative.    
NAADP’s identity was confirmed by a second group (Chini et al. 1995), who also looked at 
its Ca2+ release properties in the sea urchin egg homogenate compared to the other two Ca2+ 
moralizing agents, IP3 and cADPR. As described in Lee’ original paper, repeat applications 
of NAADP were shown to be auto-desensitizing but have no effect on subsequent 
applications of cADPR or IP3. Additionally, while NAADP induced Ca2+ release could be 
blocked by TMB-8 (a non-specific [Ca2+]i release inhibitor (Chiou and Malagodi 1975)) its 
activity was insensitive to both heparin and ruthenium red (RR), inhibitors of IP3 and 
cADPR-induced release respectively (Taylor and Broad 1998). The group also found 
thionicotinamaide-NADP (thio-NADP) blocked NAADP induced release, but showed no 
effect on either IP3 or cADPR induced Ca2+ release. A lack of interaction between the binding 
of the three Ca2+ mobilizing agents to the sea urchin egg homogenate was also observed, as 
pre-incubation of any of the three did not diminish the subsequent binding of a radio-labelled 
form of either of the other two messengers.  
While the previous work into NAADP’s activity had all taken place using either homogenates 
of sea urchin eggs or microsomes isolated from them, Perez-Terzic et al. used intact eggs and 
microinjected to introduce the messenger into their cytosols (Perez-Terzic et al. 1995). In 
these experiments NAADP clearly showed the ability to increase [Ca2+]i upon its addition and 
showed the same lack of desensitisation to pre-application of either IP3 and cADPR observed 
in the homogenate. Co-application of heparin with NAADP showed no effect on NAADP’s 
activity like it did when co-applied with IP3; however pre-incubation with thio-NADP 
inhibited NAADP-induced increases of [Ca2+]i, but did not affect increases induced by the 
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other messengers. Interestingly the group found that microinjection of NAADP into eggs that 
were already fertilized showed a much diminished Ca2+ response compared to unfertilised 
cells, similar to how responses are reduced after subsequent applications of NAADP.  
While these experiments were far from conclusive they hinted at a possible role for NAADP 
in fertilisation, which would be the first cellular process linked to NAADP signalling. This 
function was given further weight upon the discovery that the level of NAADP present in 
sperm significantly increases when the sperm encounters egg jelly during the acrosome 
reaction (Churchill et al. 2003), allowing the sperm to deliver a bolus of NAADP into the 
cytosol of the egg when its membrane and that of the egg fuse. There has been some dispute 
as to the role of NAADP in fertilisation however; with some advocating that it is not a bolus 
of NAADP that sperm delivers but an isoform of Phospholipase C (Nomikos et al. 2012). In 
this model the PLCζ delivered by the sperm converts PIP2 in the egg’s membrane into IP3, 
which in turn generates the Ca2+ waves seen during fertilisation, implying that NAADP is not 
required for this cellular process. 
The first proof of NAADP being able to induce Ca2+ release in mammalian cells was 
observed using pancreatic acinar cells (PAC) (Cancela et al. 1999), the same cell model used 
to confirm the role of IP3 (Streb et al. 1983). This report found that nanomolar concentrations 
of NAADP induced Ca2+ in PAC but showed no effect at higher micromolar concentrations, 
suggesting the messenger causes rapid receptor desensitisation at these concentrations. While 
a desensitising concentration of NAADP had no effect on IP3 or cADPR induced Ca2+ spikes, 
inhibitors of the other messengers blocked responses to NAADP. This implied that the 
observable response to NAADP was distinct from the activity of IP3 and cADPR; but did 
require the involvement of their associated ion channels to increase its response by the 
process CICR, which both IP3R and RyR are known to be sensitive to (Santulli and Marks 
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2015). These results were replicated in the sea urchin egg model (Churchill and Galione 
2001) in accordance with the previous finding that, unlike IP3 and cADPR,  NAADP acted on 
a Ca2+ store that was Tg insensitive (Genazzani and Galione 1996). Together this lead to the 
creation of the ‘trigger hypothesis’ of NAADP activity; which suggests that NAADP is able 
to mobilise a small amount of Ca2+ from a store distinct from that which both IP3 and cADPR 
act on, this initial Ca2+ release then acts as a trigger to induce further Ca2+ release through 
IP3R and RyR via CICR, thus amplifying the size of the response to NAADP.  
Density centrifugation of sea urchin egg homogenates showed that NAADP’s activity was 
physically distinct from that of IP3 and cADPR, corresponding with its insensitivity to Tg. 
The fraction it showed activity in contained the egg’s reserve granules, a type of acidic 
organelle related to lysosomes in mammalian cells (Churchill et al. 2002). This corresponded 
with latter findings in several mammalian cell types; where NAADP’s activity is also Tg 
insensitive (Mitchell et al. 2003) , but can be disrupted by either Bafilomycin A1 (Brailoiu et 
al. 2005) (an inhibitor of the Vacuolar-type H+-ATPase (V-ATPase) used to fill acid 
organelles with Ca2+ (Gagliardi et al. 1999)) or GPN (Collins et al. 2011) (which causes the 
osmotic lysis of lysosomes (Berg et al. 1994)). These findings heavy imply that NAADP acts 
on lysosomes in mammalian cells, an argument strengthened by the lysosomal  location of 
several NAADP receptor candidates (Calcraft et al. 2009; Zhang et al. 2009). There is 
however evidence that addition to acidic stores NAADP can also mobilize some Ca2+ from 
the ER in some types of mammalian cells (Gerasimenko et al. 2003; Gerasimenko, 
Sherwood, et al. 2006; Steen et al. 2007) and in higher plants (Navazio et al. 2000). 
Since Streb et al.’s report, NAADP has been shown to have a signalling function in a diverse 
range of mammalian cells, e.g. sperm (Churchill et al. 2003),  neurones (Brailoiu et al. 2005), 
cardiac myocytes (Macgregor et al. 2007) and β cells (Mitchell et al. 2003); as well as in 
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higher plants (Navazio et al. 2000). While NAADP showed the ability to inhibit its own 
activity in both the sea urchin egg model and in mammalian cells, it showed a different 
mechanism of auto-inhibition in the two. Sea urchin eggs pre-incubated with a sub-activating 
concentration of NAADP show no response to subsequent applications of normally activating 
concentrations of NAADP (Aarhus et al. 1996). However in mammalian cells there is a bell-
shaped curve of NAADP induced Ca2+ release (Berg et al. 2000); with nanomolar 
concentrations showing a dose-depended response which then become inhibitory at 
micromolar concentration with 100 µM NAADP enough to completely inhibit NAADP 
induced release (Galione et al. 2011). While these patterns of auto-inhibition do differ they 
both suggest that NAADP acts on its receptor via two separate binding sites, an activating 
one and an inhibitory one, which have different affinities to NAADP. Evidence for this has 
been provided pharmacologically, using agents that affect NAADP’s activity and ability to 
bind to its receptor differently (Rosen et al. 2009). Such variance between invertebrate and 
mammalian signalling may indicate that there has been an evolution event that may have 
greatly reduced the affinity of the regulatory NAADP-binding site on the mammalian 
NAADP receptors. 
NAADP shows a high degree of structural similarity with NADP, which shows no Ca2+ 
mobilizing activity, with an amino group substituted for a hydroxyl group the only difference 
between the two compounds (Lee and Aarhus 1995). It is unsurprising therefore that the 
negative charge the hydroxyl group of the carboxylic acid residue provides, specifically at the 
3-position on the pyridine ring, has been found to be a key structural requirement for 
NAADP’s activity (Lee and Aarhus 1997). The 2’-phosphate attached to the ribose and the 
amino group at the 6-postion of the adenine ring have also been shown influence the 
messenger’s activity, but are less vital than 3-position of the carboxylic acid residue. The 
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mammalian cell line SKBR3 showed diminished sensitivity when modifications were made 
to the 4- and 5- position of nicotinic acid, whereas sea urchin eggs only show sensitivity to 
modifications at the 4- position (Ali et al. 2014).  
 
1.1.3.4 NAADP synthesis  
After discovering cADPR and its action mobilizing Ca2+ from internal stores Lee and his 
collaborators wanted to identify how this metabolite of NAD was synthesised in vitro.  All 
previously identified NADases cleaved NAD into nicotinamide and ADPR, meaning that 
either one of these previously identified enzymes had an alternative activity as a cyclase or a 
novel enzyme was involved. In a two part study, a novel NADase from the mollusc Aplysia 
californica was identified and purified (Hellmich and Strumwasser 1991; Lee and Aarhus 
1991). This enzyme was shown to both synthesis cADPR from NAD, and induce an increase 
in extracellular Ca2+ when microinjected into sea urchin eggs. The enzymes showed a high 
specificity for β-NAD as a substrate, lacking activity for a range of NAD analogues other 
than a limited activity for NADH. This also suggested that the reaction the enzyme catalysed 
was direct and not via an intermediate, e.g. ADP-ribose, as it displayed no activity for these 
compounds. To distinguish it from the NADases that had been previously characterised it was 
named ADP-ribosyl cyclase due to its unique cyclase activity. 
Using the protein sequence of the new identified enzyme a search of the GenBank library was 
conducted to identify any possible mammalian homologues (States et al. 1992). This 
sequence comparison identified CD38 as a candidate, which shares a 69% sequence 
homology with ADP-ribosyl cyclase. CD38 is a 46kDa type 2 plasmalemma glycoprotein, 
with its N-terminus forming a transmembrane domain and its C-terminus locating 
extracellularly. Previously it had been identified as a phenotype marker indicating different 
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subpopulations of human T and B lymphocytes, appearing on their surfaces during both the 
early and late, but lacking during the intermediate, stages of their maturation (Jackson and 
Bell 1990); as well as a cell marker for leukaemia (Deaglio et al. 2008). The two peptides 
differ in two key aspects: ADP-ribosyl cyclase lacks the transmembrane domain and the four 
glycosylation sites of CD38, which are likely due to the different cellular locations of the two 
proteins.  
Expression of the C-terminus of CD38, the region with a similar peptide sequence to ADP-
ribosyl cyclase, produces a peptide that experimentally can both catalyse the formation and 
hydrolysis of cADPR (Howard et al. 1993). Additionally glucose-induced insulin secretion 
by β cells (Takasawa et al. 1993), a process shown to involve cADPR, can be impaired using 
CD38 autoantibodies (Ikehata et al. 1998). Together these findings indicate that CD38 is the 
cyclase that catalyses the physiological production (and degradation) of cADPR in 
mammalian cells. 
The initial experiments that discovered the existence of both cADPR and NAADP showed 
that NAADP could be produced artificially by exposing NADP to an alkaline pre-treatment 
(Clapper et al. 1987). However, psychologically a different reaction involving the base 
exchange of NADP’s nicotinamide group and nicotinic acid (NA) occurs. Interestingly this 
reaction can be catalysed by either ADP-ribosyl cyclase or the C-terminus of CD38 (Aarhus 
et al. 1995); meaning these are multifunctional enzymes involved in the production of two 
independent secondary Ca2+ messengers (Fig. 1.1.3.4). This alternative enzymatic function 
requires a high concentration of NA and an acidic environment, which implies it does not 
occur under standard cytoplasmic conditions (Casey et al. 2010). It also suggests a common 
origin for both NAADP and cADPR, as they are both synthesised from nicotinic nucleotides 
by the same enzyme, possibly originating as a single pathway that diverged into two separate  
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Fig. 1.1.3.4 CD38 is an ectoenzyme that can synthesize both secondary calcium 
messengers cADPR and NAADP 
CD38 can synthesize either cADPR or NAADP from NAD or NADP and nicotinic acid 
depending on the reaction conditions; the enzyme can also hydrolyze cADPR into ADPR. 
 
 
Yongjuan Zhao, Richard Graeff and Hon Cheung Lee; Roles of cADPR and NAADP in pancreatic cells; Acta 
Biochim Biophys Sin (Shanghai); 2012; 44 (9): 719-729; by permission of Oxford University Press (Zhao et al. 
2012). 
  
36 
 
signalling pathways. 
Despite having been shown to be capable of catalysing the synthesis of both cADPR and 
NAADP, there is some controversy as to whether CD38 is the endogenous mammalian ADP-
ribosyl cyclase. This is due to cataylic domain of CD38 (Howard et al. 1993; Aarhus et al. 
1995) existing in the extracellular region of the protein. This creates a ‘topological paradox’ 
where the protein’s active site is physically isolated from both its substrates and/or the site of 
its product’s activity across a lipid membrane (De Flora et al. 1997). 
To try and solve the topological paradox several models have been suggested including a 
transport model and orientation model. The transport model was proposed for cADPR 
synthesis, it proposes that the NAD is transported out of the cell by connexin 43 and then the 
resultant cADPR produced is transported back into the cell by nucleoside transporters (Guida 
et al. 2002; Tao et al. 2011).  Alternatively it has been suggested that polymers of CD38 can 
form channels that allow NAD and cADPR to cross the membranes (Franco et al. 1998), 
however this is disputed (da Silva et al. 1998). Several cell lines have been shown to take-up 
both radiolabelled cADPR and NAADP (Billington et al. 2006); though due to the kinetics of 
cADPR and NAADP signalling, which are very rapid (especially in the case of NAADP), it is 
unlikely uptake is physiologically relevant. However, in the case of NAADP it would support 
the evidence that it can act on several cell types extracellularly (Moreschi et al. 2008; Djerada 
et al. 2013); which otherwise would require NAADP synthesised intracellularly to be 
excreted by cells.  
The orientation model suggests that a subset of CD38 (that normally exists in a type 2 
orientation with its C-terminus located in the lumen during synthesis and transport, or 
extracellularly at the plasmalemma) has its orientation rotated to type 3 with its C-terminus 
located in the cytosol. This would allow easy access for either NAD or NADP to CD38’s 
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cyclase active site and would be a better fit for the kinetics of the secondary messengers 
signalling. There are several studies supporting this model of CD38 activity (Adebanjo et al. 
1999; Khoo et al. 2000), one of which shows several mutations to the N-terminus CD38 can 
affect orientation and activity of CD38 (Zhao et al. 2015). These mutations all reduce the 
positive charge of the short native intracellular N-terminus region of CD38 either directly by 
increasing or decreasing the number of negative or positively charge residues respectively, or 
indirectly by introducing residues prone to phosphorylation; which, following the ‘positive-
inside rule’ (von Heijne 1989), would reverse the topology of the protein. This model is 
suitable for explaining cADPR synthesis but does not explain how the conditions for NAADP 
(low pH and high concentration of NA) would occur. 
A third model proposes that CD38 can ‘escape’ from the ER after synthesis via lipid droplets 
(Ploegh 2007), though this would share the same issues with the orientation model for 
NAADP signalling and lacks evidence supporting it.   
It is possible that synthesis of NAADP occurs in the lumen of one or more type of 
intracellular organelle that CD38 localises to (Yamada et al. 1997; Orciani et al. 2008). The 
conditions inside these lumens would be more conducive to the production of NAADP and 
create a physically distinct way in which it and cADPR are synthesised. However, like the 
transport model described above, the kinetics of transporting NADP into and NAADP out of 
the organelles raises doubt as to the viability of this model. 
As well as its cyclase active site being located extracellularly, another reason it is disputed 
that CD38 is the sole ADP-ribosyl cyclase in mammals is the effect observed when its gene is 
knocked out of cells or animals. In CD38 null mice a reduction in cADPR synthesis is 
observed in some cell types but not in others (Young et al. 2006) and in CD38 deficient 
myometrial cells there is no difference in NAADP levels compared to wildtype cells (Soares 
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et al. 2007). Due to the wide range of cellular process that cADPR and NAADP have been 
linked to it is unlikely that CD38 is the sole cyclase, otherwise CD38 null mice should not be 
viable.  
Some redundancy in ADP-ribosyl cyclase activity has been observed, with CD157 being 
shown to contain some activity (Yamamoto-Katayama et al. 2002). Like CD38 this protein is 
a cell surface antigen and acts as a mediator of neutrophil adhesion and migration (Funaro et 
al. 2004), as such the two proteins share around high degree of sequence homology (33%) 
(Ferrero et al. 1999) and a similar structure. The expression of CD157 is limited to a few 
types of tissue though (Ortolan et al. 2002) and by sharing a structure with CD38 it also 
shares the same topological paradox in its activity. There is also evidence in neurones from 
CD38 null mice that there is a separate intracellular ADP-ribosyl cyclase present (Ceni et al. 
2003); this may mean there is at least one more protein with the ability to 
synthesise cADPR and/or NAADP. 
 
1.1.3.5 NAADP receptors 
As NAADP Ca2+ mobilizing activity was found to be distinct from that of both IP3 and 
cADPR (Chini et al. 1995; Lee and Aarhus 1995), it was believed that it would act via a 
unique ‘NAADP receptor’. It was assumed that like IP3R (Mourey et al. 1990) this 
unidentified receptor would be a ligand-gated ion channel, which was responsible for both 
NAADP binding and channel activity. The search for such a receptor has yielded several 
possible candidates and proven controversial within the field. 
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1.1.3.5.1 Ryanodine receptors 
The initial candidate identified were the RyR family of channels, with NAADP most 
commonly being associated with the type 1 isoform. This link was established using both 
cardiac (Mojžišová et al. 2001) and skeletal myocytes (Hohenegger et al. 2002); the first 
study patched RyR2 from dog cardiac microsomes incorporated into lipid bilayers and 
observed NAADP increased their opening potential. The probability of an observed RyR2 
opening correlated in line with the concentration of NAADP over the range tested and could 
be blocked by several RyR inhibitors. The second study used preparations of heavy 
sarcoplasmic reticulum membranes from rabbit white skeletal muscle to produce vesicles 
containing purified RyR1 and used them to perform a series of florescent and 
electrophysiological assays. NAADP was observed to increase opening potential of the RyR1 
and could mobilised Ca2+ from these vesicles, but displayed the same sensitivity to the RyR 
inhibitors seen in the other study. [3H]ryanodine binding to purified RyR1 has also been 
shown to increase in the presence of NAADP, though this effect could be blocked by a 
NAADP antagonist (Dammermann et al. 2009). 
Activation of type 1 RyR by NAADP is attractive as it has been suggested that this isoform is 
insensitive to cADPR (Lee 1997), and therefore would mean that the isoform is still be 
regulated by a secondary messenger. As cADPR and NADDP display a probable shared 
evolutionary background (evident in their similar molecular precursors, NAD and NADP 
(Clapper et al. 1987), and single enzymatic catalyst (Aarhus et al. 1995)), it would be logical 
that they work on the same family of receptors and potentially could have evolved along with 
them. 
The suggestion of one or more isoforms of RyR acting as a NAADP sensitive ion channel has 
proven controversial ever since its proposal. RyR are located on the ER/SR of most cells and 
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not the acidic vesicles that NAADP has been shown to act upon (Churchill et al. 2002), their 
location on the ER/SR is also incompatible with the insensitivity that NAADP induced Ca2+ 
release shows to Tg (Mitchell et al. 2003). One study has claimed to show that both type 1 
and type 2 RyR have no sensitivity to NAADP (Copello et al. 2001); this study also claimed 
the same for cADPR however, against the general consensus of the field (Venturi et al. 2012), 
and so its validity is questionable. Other groups have also produced negative data for RyR’s 
when presenting alternative proteins as NAADP sensitive Ca2+ channels in order to validate 
their alternative (Pitt et al. 2010; Zhang et al. 2011).  
Despite this controversy there is growing evidence that NAADP can act via RyR in at least 
some cell types (Mitchell et al. 2003; Langhorst et al. 2004; Jiang et al. 2013), notably PAC 
(Gerasimenko et al. 2003; Gerasimenko, Sherwood, et al. 2006; Gerasimenko et al. 2015). In 
this type of secretory cell, in addition to their conventional ER location both RyR and IP3R 
are located in the membranes of acidic secretory granules. The first study that showed that 
NAADP can act upon RyR using this cell type observed that NAADP could mobilise a small 
observable amount of Ca2+ from the nuclear envelope (Gerasimenko et al. 2003), the lumen 
of which is continuous with that of that of the cell’s ER. It is possible that Ca2+ release from 
this store is used to drive the activity of transcription factors and therefore gene expression, 
which NAADP has shown to do in neurones (Brailoiu et al. 2005). NAADP induced Ca2+ 
release from the nuclear envelope was sensitive to Tg, unlike the acidic store it is classically 
associated with, and could be blocked by use of either of the RyR inhibitors ryanodine or RR. 
These factors heavily imply that, at least in the case of this intracellular store, NAADP 
mobilises Ca2+ through RyR. Interestingly a high auto-inhibitory concentration of NAADP 
did not prevent cADPR induced Ca2+ release from this store, this would indicate that either 
the two messengers act on RyR through different mechanisms or possibly in the isoform 
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dependent manner previously suggested.  In addition to the nuclear store NAADP has been 
show to mobilise Ca2+ from both acidic and ER stores via RyR’s under normal physiological 
conditions in this cell type (Gerasimenko, Sherwood, et al. 2006). A second cell type in 
which there is strong evidence for NAADP acting on RyR are T cells, whose activation 
requires transient intracellular Ca2+ signals. Knockout of RyRs from the Jurkat cells (an 
immortalized human T lymphocyte line) (Dammermann and Guse 2005) or RyR1 from 
primary murine T cells (Wolf et al. 2015) either abated or significantly reduced the NAADP-
induced Ca2+ signals observed.  
 
1.1.3.5.2 TRP-ML1 
Despite RyR being reported as acting as NAADP sensitive intracellular ion channels, the 
scepticism of some in the field meant that the search for the ‘true NAADP receptor’ 
continued. This lead to the identification of a second potential candidate, nonspecific cation 
channel transient receptor potential mucolipin 1 (TRP-ML1). TRP-ML1 is a nonspecific 
cation channel located on lysosomal and late endosomal membranes (Waller-Evans and 
Lloyd-Evans 2015); mutation to which can cause the lysosomal storage disease, 
mucolipidosis IV (Sun et al. 2000). 
Zhang et al. demonstrated its candidacy in a series of papers (Zhang and Li 2007; Zhang et al. 
2009; Zhang et al. 2011) using a range of different cell types and several different techniques. 
The first paper (Zhang and Li 2007) used lysosomes and ER microsomes isolated from the 
livers of male Sprague Dawley rats and reconstituted into lipid bilayers for patch clamp 
analysis. The lysosome bilayers could be activated by NAADP in the cis solution but not the 
trans and showed the bell shaped dose response to NAADP that it is classically associated 
with. However, neither IP3 or a low concentration of ryanodine elicited a response and 
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blockers of both IP3R and RyR failed to inhibit a response to NAADP. Several voltage-gated 
calcium channel antagonists, e.g. nifedipine, which had previously been shown to block 
NAADP induced Ca2+ release in sea urchin eggs; were all capable of reducing the opening 
potential elicited by NAADP to varying degrees. Alternatively, the ER enriched bilayers 
showed an increase in opening potential when treated with cADPR, which could be blocked 
with a high concentration of ryanodine, but not when treated with NAADP. The group 
reported that a TRP-ML1 polyclonal antibody attenuated the response of the lysosome 
bilayers to NAADP in a concentration dependent manner, though no evidence was provided 
to support the specificity of the antibody used.  The second paper (Zhang et al. 2009) 
confirmed the findings of the first using lysosomes purified from coronary atrial myocytes, 
which showed the same pharmacological profile to the lysosome-lipid bilayers used in the 
previous report (unresponsive to IP3 or cADPR, no effect on NAADP induced release by 
antagonist of the other messengers and blocked to a varying degree by a range of compounds 
previously shown to reduce NAADP-induced Ca2+ release or by a TRP-ML1 Ab in a dose 
dependent manner). The group’s final paper (Zhang et al. 2011) supporting TRP-ML1 as a 
NAADP sensitive lysosomal ion channel used human fibroblasts to observe the effect of 
knocking TRP-ML1 out of cells and then restoring its expression. NAADP induced Ca2+ 
release in wild type cells, but had no effect on TRP-ML1-/- cells; restoring the channel’s 
expression to knockout cells rescued NAADP’s effect. Interactions between lysosomes and 
endosomes were observed in WT cells which could be increased by the addition of NAADP, 
any increase induced by NAADP could be decreased below that of untreated cells by addition 
of either a Ca2+ chelator or NAADP antagonist. KO of TRP-ML1 significantly reduced these 
interactions compared to unstimulated WT cells, restoring the channel re-established 
NAADP’s ability to stimulate interactions between the organelles.7 A BODIPY-FL C5-
LacCer BSA complex was used to measure lipid trafficking, WT cells exposed treated with 
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the fluorescent lipid showed a small amount of colocalization with lysosomes. This 
colocalization was significantly increased by the addition of NAADP, whose effect could be 
reduced by a pre-treatment of its antagonists or bafilomycin A1. Hardly any colocalization 
was observed in TRP-ML1-/- cells even when treated with NAADP, however a significant 
increase occurred when the protein was reintroduced and treated with NAADP. 
Together these results gave a strong case for TRP-ML1’s candidacy as a NAADP sensitive 
ion channel, as well as providing further scepticism to RyR’s also being so. TRP-ML1’s 
lysosomal location, combined with the bell-shaped dose response to NAADP and it response 
to the various pharmacological agents tested makes it an appealing prospect. Additionally the 
group’s work shows a direct role for NAADP in endocytosis and lipid trafficking; this fits 
with another group’s observation that irregular Ca2+ handling by lysosomes occurs in 
Niemann-Pick disease type C1 (Lloyd-Evans et al. 2008 p.1), another lysosomal storage 
disease like mucolipidosis IV. 
However like with RyR there is evidence to the contrary, over expression of TRP-ML1 
neither increases the binding of radiolabelled NAADP in NRK cells (Pryor et al. 2006) or 
increases release in response to NAADP in SKBR3 cells (Yamaguchi et al. 2011). No 
significant difference was observed in the response of pancreatic acinar cells from           
TRP-ML1-/- mice compared to wild type cells to NAADP cells (Yamaguchi et al. 2011). 
There is evidence supporting TRP-ML1 having an alternative function to that of a NAADP 
sensitive ion channel. This includes it being a PI(3,5)P2 sensitive Ca2+ ion channel instead of 
a NAADP sensitive one (Dong et al. 2010 p.5) or a lysosomal Ca2+ leak channel (Lee et al. 
2015). Alternatively it has been suggested that instead of a Ca2+ channel it is a proton channel 
involved in the acidification of the lysosomal lumen (Soyombo et al. 2006), though this has 
been disputed (Kogot-Levin et al. 2009). There is also evidence for it being an iron channel 
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(Dong et al. 2008); however as the channel is an unselective cation channel (also known to be 
permeable to Na+ and K+ (Cheng et al. 2010)) it may be multifunctional with a varying ion 
permeability (dependent on the stimulus and/or the luminal and cytosolic conditions (Xu et 
al. 2007; Lee et al. 2015)). One possibility is that as TRP-ML1 easily forms complexes with 
other proteins (Miedel et al. 2006) it may act as a subunit of a NAADP receptor complex, 
even if this is just a scaffolding role rather than acting as an ion channel. This could explain 
some of the results that Zhang et al. produced, e.g. an antibody for TPR-ML1 could prevent it 
from associating with other proteins and therefore prevent formation of receptor complex. 
This is a possibility as it has been found that while TRP-ML1 and TPCs, the other family of 
lysosomal ion channels linked to NAADP induced Ca2+ release, do not affect each other’s 
activity they do associate with one another (Yamaguchi et al. 2011). 
As well as TRP-ML1; two other TRP proteins, both of the TRP melastatin (TRPM) sub 
family, have been reported as acting as being activated by NAADP. With TRPM2 reported as 
having NAADP-induced activity in T cells (Beck et al. 2006), neutrophils (Lange et al. 
2008), β cells (Lange et al. 2009) and HEK cells (Starkus et al. 2010); additionally NAADP 
has been reported to activate TRPM4 in HeLa cells (Ronco et al. 2015). Unlike TRP-ML1 
however, it has not been suggested that NAADP acts directly on TRPM2 or TRPM4; but 
instead may do so indirectly by its activity affecting the membrane potential of lysosomes or 
their luminal pH (Lu et al. 2013), which can affect TRPM channel opening (Starkus et al. 
2010). Another possibility is that NAADP could enhance the interaction between the TPRM 
channels and their endogenous ligands (Lange et al. 2008).  
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1.1.3.5.3 Two-pore channels 
Two-Pore Channels were identified as NAADP sensitive ion channels in reports by three 
independent research groups released within several months of each other in 2009 (E. 
Brailoiu et al. 2009; Calcraft et al. 2009; Zong et al. 2009). The family of ion channels was 
identified when looking for an evolutionary midpoint between the families of voltage-gated 
Ca2+ and Na+ channels comprised of four homologous six transmembrane domains and the 
single domain channels like voltage-activated K+. A channel was cloned from rat kidneys and 
named TPC1 based on its structure, but no function could be discerned when it was expressed 
in xenopus oocytes (Ishibashi et al. 2000). Homologues of this protein were found in multiple 
species of plant, with several paralogs found in some (Hashimoto et al. 2004; Kadota et al. 
2004; Kurusu et al. 2004); these channels were localised to the vacuole (an acidic organelle in 
plants related to the eukaryotic lysosome) and found to act as a Ca2+ dependent Ca2+ release 
channels required for several physiological processes in plants (Peiter et al. 2005). Due to the 
conflicting data surrounding RyR’s and TRPM-ML’s and their possible roles as NAADP 
sensitive channels, TPC’s made an enticing prospect as an alternative candidate as they had 
no know function in mammalian cells but had been shown to act as a Ca2+ channel in plants 
and were localised to plant vacuoles (an acidic organelle that is the functional equivalent of 
lysosomes in mammalian cells (Wink 1993)).  
Three members of the TPC family have been have been identified in animals, with equal 
evolutionary divergence (Calcraft et al. 2009). In primates the expression of TPC3 has been 
lost as the gene has been truncated, it is also not present in some species of rodent, including 
mice and rats, where the gene is completely deleted. As some species of rodent do express 
TPC3, e.g. rabbits and squirrels, and the difference in the type of mutation implies that the it 
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was lost independently in primates and the rodent species but was redundant in both (Zhu et 
al. 2010).  
Human TPC’s are widely expressed throughout the body; with both isoforms being found 
most types of tissue tested, though with a varied level of expression. Colocalization assays 
with cell markers showed TPC1 primary with the endosomal marker endo-GFP and to a 
much lesser degree the lysosomal marker LAMP-1 (E. Brailoiu et al. 2009). TPC2 however 
only colocalizes with the lysosomal marker; meaning both channels are found in the 
membranes of the acidic organelles of the endolysosomal system but to distinct components. 
When TPC3 from chickens was expressed in HEK cells it colocalized with TPC1, 
alternatively when rabbit TPC3 was expressed in these cells it colocalized with both TPC1 
and TPC2 (Ogunbayo et al. 2015). Such colocalization may indicate a possible redundancy of 
function between the proteins and explain why they are lacking in some species. TPC1 also 
has been found to have an splice variant that colocalizes with TPC2 rather than to endosomes 
(Ruas et al. 2014), though the physiological relevance of this variant has not been reported. 
NAADP has been heavily implicated in the release Ca2+ from lysosomes (Churchill et al. 
2002; Yamasaki et al. 2004), and because of TPC2’s location exclusively in the membranes 
of these organelles two of the three groups (Calcraft et al. 2009; Zong et al. 2009) decided to 
solely investigate the relationship between this channel and NAADP. Alternatively, the third 
group focused on NAADP’s relationship with TPC1 (E. Brailoiu et al. 2009). However, all 
three groups decided to use a genetic approach to maximise any effect observed.  
The two groups investigating TPC2 both decided to heterologously express the channel in 
HEK293 cells, which express it at low endogenous levels (Galione 2011). Together they 
found that by increasing the channel’s expression there was a corresponding increase in 
NAADP binding membranes from TPC2 over expressing cells compared to wildtype ones. 
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Additionally, there was an increase in the size of the NAADP-induced Ca2+ response, which 
varied directly in relation to the level of TPC2 expression. TPC2 overexpressing cells still 
showed the characteristic bell shaped dose response curve to NAADP and inhibition of 
signalling by pre-treatment with bafilomycin. Pre-treatment of TPC2 overexpressing cells 
with shRNA for TPC2 also inhibited the NAADP response. No response was observed when 
the overexpressing cells were treated with NADP, demonstrating the response is unique to 
NAADP. The two groups disagreed slightly over the effect of pre-treating cells with Tg, one 
group saw no effect while the other saw a significant reduction in the Ca2+ response to 
NAADP. It is possible that this difference is due to one group expressing human TPC2 and 
the other murine; both results however, do demonstrate that Ca2+ is being mobilized from a 
non-ER store in their TPC2 overexpressing cells. To confirm their results from cultured cells 
one of the groups decided to test a possible physiological role of TPC2 in primary cells by 
producing TPC2-/- mice and observing its effect on pancreatic β-cells. Previously it had been 
shown that NAADP-induced Ca2+ release in these cells triggers a Ca2+-activated cation 
current across the plasma membrane (Mitchell et al. 2003; Naylor et al. 2009); when the 
group looked for these cation currents in β-cells from TPC2-/- mice none could be measured 
in response to NAADP. 
The third group testing TPC1’s interaction with NAADP also chose to over express their 
target protein, however unlike the other groups they decided to use SKBR3 cells, which they 
had previously used to characterise NAADP effect on (Schrlau et al. 2008). Overexpression 
of TPC1 produced similar results to over expressing TPC2 (an increase in the response to 
NAADP which could be inhibited by pre-incubation with bafilomycin or reduced by pre-
incubation with either ryanodine or TPC1 shRNA). Targeted mutation of the predicted pore 
forming region of TPC1 to reduce its permeability of Ca2+ also reduced the size of the Ca2+ 
response to NAADP. However, the group expressing murine TPC2 also did express murine 
  
48 
 
TPC1 in their experiments and observed little to no effect of NAADP on it. It is possible that 
this is a result between differential channel activity between the two species or because a lack 
of coupling between TPC1 and the ER via CICR, producing only very small localised 
increases in [Ca2+]c compared to the much larger global responses elicited by the TPC2 
expressing cells (Zhu et al. 2010). 
Expression of TPC3 from the sea urchin Strongylocentrotus purpuratus (Sp) in mammalian 
cells has provided conflicting results. In SKBR3 cells a clear Ca2+ response to NAADP that 
was significantly larger than that in WT cells was observed in SpTPC3 transfected cells, 
though much smaller than that observed in cells transfected with either SpTPC1 or SpTPC2 
from the urchin (Brailoiu et al. 2010). When the three proteins were independently expressed 
in HEK293, both SpTPC1 or SpTPC2 expression resulted in a significant increase in 
NAADP-induced Ca2+ release, however SpTPC3 appeared to inhibit Ca2+ release to levels 
below that of the WT control (Ruas et al. 2010). The differences in results seen may be cell  
specific or due to the two groups who produced these reports using different constructs of the 
SpTPC3 gene. 
Despite this evidence indicating that TPC’s act as a NAADP sensitive Ca2+ channel, this 
function has been questioned (Wang et al. 2012; Cang et al. 2013). In the first of two studies 
by Ren’s & Xu’s groups vacuolin-1enlarged endolysosomes were patched and reported to 
have a PI(3,5)P2 induced Na+ current, but very limited permeability to Ca2+ and no sensitivity 
to NAADP (Wang et al. 2012). PI(3,5)P2 is a phosphoinositide specific to the membranes of 
endolysosomes (Di Paolo and De Camilli 2006), which has been linked to Ca2+ homeostasis 
of these organelles (Dong et al. 2010). The activity observed was specific to PI(3,5)P2 but not 
to a range of other phosphoinositides and was not present when enhanced endolysosomes 
from TPC double KO mice were patched. NAADP alone elicited no response and had no 
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effect on the response observed when used in combination with PI(3,5)P2 compared to using 
the lipid alone. While permeability to Ca2+ was observed for hTPC2 it was significantly low 
to that of Na+ and Li+. The Ren group’s second study reported that the Na+ mobilizing 
activity of TPC’s were sensitive to inhibition by ATP via a mTOR dependent process, and 
forms complexes with the kinase (Cang et al. 2013). TPC’s association with mTOR gave 
them the ability to sense nutrient depletion. This fits with previous findings that mTOR 
translocates off lysosomal membranes upon nutrient depletion (Sancak et al. 2010; Korolchuk 
et al. 2011), which would remove its kinase activity from TPC’s and therefore their inhibition 
by ATP.  
A key argument presented by Ren & Xu groups against NAADP acting on TPC’s was the 
finding that the response to the secondary messenger was not diminished in Tpc1-/-/Tpc2-/- β 
cells (Wang et al. 2012). These findings however have been challenged, as it was observed 
that the knockout cells used to show this apparent lack of TPC sensitivity to NAADP could 
still express approximately 91% of the protein’s structure and still responded to NAADP 
(Ruas et al. 2015). As such, a new TPCN1/2-/- mouse was produced which demonstrated no 
expression of either TPC isoform. Cells from these new double knockout animals showed no 
response to NAADP, but were restored when wild type TPC’s were re-expressed in the 
TPCN1/2-/- cells. β cells from these knockout animals were found to be NAADP insensitive 
(Arredouani et al. 2015), contradicting Ren & Xu group’s findings (Fig. 1.1.3.5.3.1). TPC’s 
activity has been reported to be regulated by a range of factors; including [Mg2+]c, NAADP, 
PI(3,5)P2, its phosphorylation state, luminal pH, [Ca2+]l and membrane potential  (Pitt et al. 
2010; Rybalchenko et al. 2012; Jha et al. 2014). They have also been reported as being non- 
selective cation channels with a permeability order of H+ >> K+ > Na+ ≥ Ca2+ (Pitt et al. 
2014), but physiologically are likely to be selective for Ca2+ due to the concentration and  
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Fig. 1.1.3.5.3.1 TPC 1/2 double knockout mice are insensitive to NAADP  
(A) Representative traces of single cell fura-2 recordings of mouse embryonic fibroblasts 
(MEF) isolated from wild-type (WT), Tpcn1−/− (TPC1 KO), Tpcn2−/− (TPC2 KO), 
and Tpcn1/2−/− (DKO) animals with the addition of NAADP-AM or DMSO control and ATP 
positive control. (B) Mean calcium release over a 500 s period upon addition of NAADP-AM 
or DMSO control; n =384-621 cells; ***P < 0.001 relative to WT using the ANOVA–Tukey 
test. C Mean calcium response to a range of NAADP-AM concentrations in MEF isolated 
from WT and DKO cells; n = 41-105 cells. 
 
 
 
 
Adapted under the terms of the Creative Commons Attribution 4.0 License from M Ruas et al.; EMBO J; 2015 
(Ruas et al. 2015). 
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electrophysiological gradients across lysosomal membranes. Together this evidence has 
resulted in Ren’s group findings that TPC channels are PI(3,5)P2 and ATP sensitive, can be 
regulated by mTOR and are Na+ permeable being accepted within the field (Jha et al. 2014); 
but their assertion that TPC’s are NAADP insensitive being rejected (Ruas et al. 2015).  
TPC proteins dimerize to form ion channels, and have been shown to form both homo and 
heterodimers (Rietdorf et al. 2011). TPCs have two domains, each comprised of 6 
transmembrane regions; the first 4 transmembrane regions of each of a TPC proteins 2 
domains are required for dimerization, while the 5th and 6th are responsible for the pore 
forming loop (Churamani et al. 2012). 
The crystal structure of TPC1 from the plant Arabidopsis thaliana has recently been resolved 
(Guo et al. 2016; Kintzer and Stroud 2016) (Fig. 1.1.3.5.3.2), supporting the predicted 
mammalian structure of TPC. This structure included an EF-hand domain close to the 
cytosolic C-terminus end of TPC1 with 2 EF-hand motifs, which suggests that Ca2+ binding 
to these motifs may induce a conformational change in the channel. As mammalian TPC1 
had previously been reported to be voltage sensitive (Rybalchenko et al. 2012), it was not 
surprising that the structure contained a voltage sensing domain in the loop between the 1 st 
and 2nd transmembrane regions of each domain; with the channel’s voltage sensing ability 
conferred by the second of the two domains. While the structure of TPC1’s ion selectivity 
filter is similar to the related Nav and Cav channels, it lacks the specific anionic residue 
known to confer selectivity for either Na+ or Ca2+ (Payandeh et al. 2011; Tang et al. 2014); 
this matched the predicted in silico model (Rahman et al. 2014) and supports the lack of TPC 
cation specificity (Pitt et al. 2014). In accordance with previous reports of its activity (Cang 
et al. 2013; Jha et al. 2014), the protein’s structure showed multiple possible phosphorylation 
sites. Interestingly, while Arabidopsis thaliana TPC1 (AtTPC1) has been reported as being  
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Fig. 1.1.3.5.3.2 X-ray crystallography structure of Arabidopsis thaliana TPC1 
(A) Topological diagram of a single Arabidopsis thaliana TPC1 protein. (B) Side view of an 
Arabidopsis thaliana TPC1 channel dimer. The 6-TM I, 6-TM II, and EF hands from one 
subunit are shown in green, red and orange, respectively; with the other subunit’s 
symmetrical domains shown in lime green, purple and light orange, respectively. The 
cytosolic EF-hand domains with bound Ca2+ (cyan sphere) in EF1 are boxed and the two 
luminal Ba2+ (blue spheres labelled 1 and 2) binding sites are circled.  
 
 
 
 
 
Adapted by permission from Macmillan Publishers Ltd: [Nature] (Guo et al. 2016), copyright 2016. 
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insensitive to both NAADP and PI(3,5)P2  (Boccaccio et al. 2014) its structure did show a 
binding site for trans-Ned19, a NAADP specific antagonist that shares a high 3D electrostatic 
homology to NAADP (Naylor et al. 2009). Ned-19 was found to bind both the pore domains 
and voltage sensitive domains, allosterically blocking channel activation. It has also been 
found that the C-terminal end of AtTPC1 contains a helix forming motif that is required for 
both the dimerization of TPC proteins and their channel activity (Larisch et al. 2016). The 
lumenal N-terminal end of both human isoforms of TPC have been found to contain three 
glycosylation sites (Hooper et al. 2011), site directed mutations that prevent glycosylation 
enhanced the size of the response to NAADP. 
While it was expected that the ‘NAADP-receptor’ would contain both NAADP-binding and 
channel activity, this has been found to not be the case for TPC channels. Studies in both sea 
urchin eggs and mammalian cells using radiolabelled photoprobe 5-azido-NAADP ([32P-
5N3]NAADP) (which has a high affinity for the NAADP receptor and cross links to in under 
UV light) found no change in probe binding when TPC’s were either over expressed or 
knocked out (Lin-Moshier et al. 2012; Ruas et al. 2015). Western blotting with antibodies for 
the various TPC isoforms performed using both sea urchin egg homogenate and mammalian 
cell preparations did not show antibody binding to the same band as the probe, but 
immunoprecipitation of TPC’s did show some co-precipitation with the probe (Walseth et al. 
2012). Using radiolabelled NAADP to identify the size of NAADP binding proteins, several 
different weight bands were labelled in sea urchin egg homogenate (Walseth et al. 2012);  
with the strongest binding at both 40 and 45 kDa. However in mammalian cells, NAADP was 
found to bind to a range of low weight peptides both of the S100 cytoplasmic and the P100 
membrane fraction, consistently labelling a 22/23kDa (Lin-Moshier et al. 2012; Walseth et al. 
2012). The difference in the size between the urchin and mammalian proteins may be related 
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to the different profiles of activation described previously between the species (Aarhus et al. 
1996; Berg et al. 2000) 
These finding prove that NAADP does not act directly on TPC channels, but instead 
associates with TPC via one or more separate binding proteins. The discovery of NAADP 
binding proteins opens a range of possibilities: are there multiple binding proteins that affect 
NAADP’s activity on a cell specific basis? Will different NAADP-binding proteins associate 
with different ion channels, meaning there is no single ‘NAADP receptor’? Is the two binding 
site model of NAADP activity still relevant, and if so are the two sites on the same binding 
protein? 
NAADP binding proteins are not the only proteins that have been found to associate with 
TPC channels, and are likely to form signalling complexes in the membranes of their 
associated organelles. Both human TPC isoforms have been found to associate with another 
‘NAADP receptor’ candidate, TRP-ML1; though neither isoform of TPC channel was found 
to affect TRP-ML1’s activity and vice versa (Yamaguchi et al. 2011). Based on its ability to 
locate to lysosomal membranes and its effect on TPC channels it is likely mTOR can 
associate with any complex TPC’s form (Cang et al. 2013). Yeast two hybrid assays have 
identified the anti-apoptotic protein Hax-1 (Sharp et al. 2002) as binding to the cytoplasmic 
region of TPC2 (Lam et al. 2013). A ‘One-Strep’ pull down method has also been used to 
identify proteins that associate with TPC’s, creating a TPC ‘interactome’ (Lin-Moshier et al. 
2014). This technique identified 40 different proteins that have been reported to have a range 
of different functions including Ca2+ homeostasis, membrane trafficking/organisation and 
autophagy regulation. The Rab GTPase Rab7 was found to associate with the N-terminus of 
TPC2, but not TPC1; together Rab7 and TPC2 were found to cause the proliferation of 
endolysosomal structures. This association appears to be dependent on the lysosomal pH, as 
  
55 
 
over expression of TPC2 increases their pH and shows a reduced association with Rab7 (Lu 
et al. 2013). 
While TPC’s activity has been shown to be independent of RyR (Brailoiu et al. 2010; 
Ogunbayo et al. 2011), there is conflicting evidence where TPC can directly couple to IP3R 
or RyR and may do so in a cell specific manner (Davis et al. 2012; Jiang et al. 2013). 
Despite some reports to the contrary (Wang et al. 2012; Cang et al. 2013), it is now 
commonly accepted that the TPC family of proteins form NAADP sensitive ion channels, 
with their sensitivity to NAADP conferred via one or more separate NAADP-binding 
proteins. TPC’s have been shown to have a physiological role in a range of different cell 
types, including: megakaryoblasts (López et al. 2012), neuronal precursor cells (Zhang et al. 
2013), gastric smooth muscle (Pereira et al. 2014), cardiac ventricular myocytes (Capel et al. 
2015) and β cells (Arredouani et al. 2015). While activity in such a wide range of different 
cells highlights the ubiquity of TPC activity, it raises the question of their physiological 
importance due to the viability of TPC1/2-/- mice (Ruas et al. 2015).  
 
1.1.3.5.4 P2Y11  
As a secondary messenger NAADP is classically associated as having an intracellular target 
(Galione et al. 2010), however there is some limited evidence that NAADP may also act 
extracellularly. Extracellular application of NAADP to 1321N1 human astrocytoma cells 
induced an increase in [Ca2+]i in a dose-dependent manner, via a combination of the entry of 
extracellular Ca2+ and the production of intracellular cAMP, IP3 and cADPR (Moreschi et al. 
2008). This response to extracellular NAADP was also observed in human granulocytes, 
where a similar effect had previously been seen in this cell type in response to NAD via a 
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P2Y11- dependent mechanism had previously been reported (Moreschi et al. 2006). Based on 
this the P2Y11 specific inhibitor NF157 (Ullmann et al. 2005), which had been shown to 
inhibit the effect of NAD on granulocytes, was tested against NAADP’s effect. NF157 had a 
similar inhibitory effect against the [Ca2+]i increases induced by extracellular NAADP; 
implying it also acted via the P2Y11 receptor, but as a more potent ligand.  
Extracellular NAADP was also found to have a protective effect against ischemia and 
reperfusion injury in Langendorff perfused rat hearts (Djerada et al. 2013). This 
cardioprotective effect was inhibited by NF157 and found to be due to the activation of pro-
survival protein kinases. In cultured rat cardiomyocytes an increase in intracellular cADPR 
and NAADP was found in response to extracellular NAADP, NAD or NF546 (a P2Y11 
agonist (Meis et al. 2010)). The intracellular effects of all 3 extracellular stimuli could be 
inhibited by NF157; implying extracellular NAADP can induce the production of 
intracellular NAADP via P2Y11 most likely via the activation of CD38. 
 
1.1.3.6 Pharmacological Regulation of NAADP Signalling 
Research into NAADP signalling has been greatly facilitated by the development of chemical 
analogues of the molecule. The first chemical analogue developed was an inactive caged 
form of the dinucleotide (H. C. Lee et al. 1997), which can be injected into cells and uncaged 
using ultraviolet light, allowing for precision activation of NAADP signalling (Aarhus et al. 
1996). While characterising the structural requirements for NAADP activity several 
analogues were created that could be used as antagonists, e.g. deA-NAADP (Lee and Aarhus 
1997). However, no use of any of these analogues has subsequently been reported; this may 
be due to them being impermeable to cells and acting via similar a method of desensitisation 
to NAADP, which unlike the analogues is commercially available.  Additionally as a result of 
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this study several active fluorescent analogues of NAADP were created (Lee and Aarhus 
1998), though again no further use has been reported. A radiolabelled form of NAADP, 
synthesised using 32P, has been used to show the distribution of NAADP binding in whole 
tissues (Patel et al. 2000). A membrane permeable analogue of NAADP has also been 
created, via the reversible addition of acetoxymethyl (AM) groups (Parkesh et al. 2008). 
NAADP-AM is a potent tool as it means NAADP signalling can be visualised in whole 
colonies of cells rather than in individual cells, and removes the previous intrusive techniques 
used to apply NAADP to cells. 
 As it has become apparent that NAADP-regulated Ca2+ signalling plays a vital role in a 
diverse range of mammalian cell there is a need for drugs to regulate abnormal signalling in 
patients. Such drugs could possibly be used to treat type 2 diabetes by stimulating insulin 
secretion (Arredouani et al. 2015), thrombosis by preventing platelet activation (López et al. 
2006), or help trigger an immune response by activating T-cells (Steen et al. 2007). The first 
reported antagonist of NAADP’s activity was thio-NADP (Chini et al. 1995; Perez-Terzic et 
al. 1995); however when this compound’s activity was analysed in sea urchin egg 
homogenate it was found to have the same profile as commercial NADP. This combined with 
HPLC evidence suggests that rather than thio-NADP being an NAADP antagonist, it is in 
fact an NAADP contaminate in the thio-NADP (similar to how NAADP was discovered as a 
contaminate of commercial NADP (Lee and Aarhus 1995)) that inhibits its own activity 
(Dickey et al. 1998). Pharmacological blockers of L-type Ca2+ -channels, e.g. Diltiazem, can 
inhibit NAADP signalling in excitable cells (Genazzani et al. 1997; López et al. 2006), 
though the effect of these compounds is nonspecific and may not be direct. Triazine dyes 
have been shown to be NAADP agonists in sea urchin eggs (Billington et al. 2004), though 
again this effect is nonspecific and has not been shown in mammalian cells. 
  
58 
 
Recently the existence of membrane permeable antagonists of NAADP-induced Ca2+ release 
have been published (Dammermann et al. 2009; Naylor et al. 2009). The first was identified 
using in silico screening of a library of compounds to identify ones with a similar 3D 
electrostatic structure to NAADP (Naylor et al. 2009). The 19th ranked hit of this search 
proved to be both membrane permeable and inhibit both NAADP’s activity and its binding to 
it receptor. Based on the name of the software application used to identify the compound and 
its hit number it was called NAADP EON Discovered 19 (Ned-19). As the key structural 
requirement for NAADP’s activity is its nicotinic acid residue (Lee and Aarhus 1995; Lee 
and Aarhus 1997) various chemical analogues of nicotinic acid were synthesised. One of 
these analogues named BZ194 was found to inhibit the NAADP-dependent proliferation of T 
cells, as well as NAADP-induced binding of [3H]ryanodine to purified RyR1 (Dammermann 
et al. 2009). These compounds have both been shown to inhibit responses to NAADP in 
several different cell types (Cordiglieri et al. 2010; Barceló-Torns et al. 2011; Coxon et al. 
2012; Aley et al. 2013; Nebel et al. 2013); with Ned-19 the most commonly used of the two, 
probably due to its commercial availability. 
 
1.1.4 Store-operated calcium entry 
Elevations in the [Ca2+]c are a ubiquitous signal, driving numerous physiological processes  
(Berridge et al. 2000); however prolonged elevations in [Ca2+]c are cytotoxic (Schanne et al. 
1979) to cells. This means any elevation in [Ca2+]c is rapidly dealt with via either extrusion 
(Brini and Carafoli 2011) or uptake into organelle stores (Prins and Michalak 2011) to return 
the [Ca2+]c back to resting levels. The ER comprises the largest Ca2+ store in most cells types, 
and is therefore the major source of Ca2+ release within cells (Lam and Galione 2013). Each 
time this store is stimulated to release Ca2+, some of that Ca2+ mobilized is lost via extrusion 
or uptake into other type of organelle (Berridge et al. 2003). This means without a specific 
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refilling pathway, the Ca2+ content of the ER would diminish, and cellular process driven by 
Ca2+ release from this store would become unviable. 
A model for this process based on previously published data was proposed by J Putney in 
1986 (Putney 1986); this biphasic model suggested that agonist-activated store depletion 
initiated rapid entry of extracellular Ca2+ into the cell, this influx of Ca2+ allowed for the 
refilling of depleted stores, which in turn terminates the influx of Ca2+. While Putney named 
the process he described capacitative Ca2+ entry (CCE), it has instead become known as 
store-operated Ca2+ entry (SOCE). 
SOCE can be reproduced pharmacologically by use of inhibitors of SERCA, e.g. Tg 
(Takemura et al. 1989); inhibition of SERCA prevents refilling of the ER, this leads to 
depletion of ER Ca2+ content due to loss through Ca2+ leak channels (Tu et al. 2006). This 
loss of ER [Ca2+]l activates an inward flux of Ca2+ through a plasma membrane channel 
called the Ca2+ release-activated channel (CRAC) (Penner et al. 1988; Matthews et al. 1989). 
The molecular identity of the CRAC channel was initially elusive, but obviously contained 
several elements: a sensor of ER lumen Ca2+ content, a Ca2+ permeable channel in the plasma 
membrane and mechanism to communicate between the two. 
The first CRAC channel component identified was the Ca2+ sensor, which was shown to be 
the Stromal interaction molecule 1 (STIM1) (Liou et al. 2005; Roos et al. 2005). This protein 
had previously been identified by cloning experiments of the novel gene GOK (Parker et al. 
1996 p.199), though at the time was of unknown function. STIM1 and its orthologue STIM2, 
have an ER location and are composed of a single pass transmembrane domain and two Ca2+ 
binding EF hand motifs in its N-terminal luminal region (Roos et al. 2005). 
After STIM1 was identified as the Ca2+ sensing component of the CRAC channel the plasma 
membrane channel was also identified (Feske et al. 2006). As T cells from sufferers of severe 
combined immune deficiency (SCID) syndrome were known to exhibit impaired SOCE, the 
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genomes of patients with this disorder were mapped to identify the mutation that cause the 
condition (Feske et al. 2005). A mutation was found in a novel protein that was dubbed 
Orai1, after the keepers of the gates of heaven in Greek mythology. Expression of wild type 
Orai1 in SCID T cells was found to restore normal SOCE, and so Orai1 was identified as the 
CRAC channel’s channel. Two other members of the Orai family (Orai2 and Orai3) have 
since been identified; while Orai1 is considered the major contributor to SOCE (Gwack et al. 
2007), both Orai 2 and Orai3 have been shown to be able to form active CRAC channels (Ay 
et al. 2013; Vaeth et al. 2017) and may provide a developmental or tissue specific role. Each 
Orai protein has 4 transmembrane domains, and while it has been suggested that they form 
tetrameric channels (Penna et al. 2008), the crystal structure of drosophila Orai1 instead 
shows that channels are formed of 6 Orai1  subunits (Hou et al. 2012). In addition to the 4 α-
helix transmembrane domains, each subunit has another helix after the 4th transmembrane 
helix (called the M4 extension helix) that probably interact with other proteins to activate the 
channel.  
As well as providing the Ca2+ sensing function of CRAC channels, STIM1 also provides the 
communication mechanism, directly gating Orai1 (Luik et al. 2006). At a resting ER [Ca2+]l 
Ca2+ is bound to both of STIM1’s EF hands, which stabilises the protein in its inactive state. 
Upon store depletion these bound Ca2+ dissociate from STIM1, activating the protein (Zhou 
et al. 2013). Active STIM1 proteins then dimerize through their luminal SAM motifs, this in 
turn induces a conformational change through the whole protein (Feske and Prakriya 2013). 
The result of this conformation change is the elongation of the protein and the extension of 
the SOAR domain which interacts with the M4 extension helix of Orai1. In addition to 
inducing a conformational change that allows STIM1 to interact with Orai1, dimerization 
also induces the STIM1 dimers to migrate through the ER membrane to ER-plasma 
membrane puncta where Orai1 channels are physically close to the ER (Cahalan 2009) (Fig. 
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1.1.4). It has been suggested that at rest Orai1 proteins are dimers that only form channels 
upon stimulation by STIM1 (Penna et al. 2008). 
CRAC channels show a biphasic form of inactivation, with both a quick and a slow phase 
(Parekh and Putney 2005). The initial quick phase is Ca2+ dependent, and is believed to be the 
result of Ca2+ binding the cytoplasmic ‘inactivation domain of STIM1’ (IDSTIM) domain 
(Mullins and Lewis 2016). When Ca2+ is bound to IDSTIM it promotes Orai1 channel 
inactivation, though the mechanism by which it does this is unknown. Slow inactivation of 
CRAC channels is the result of ER [Ca2+]l reaching resting levels (or close to them), and Ca2+ 
rebinding to the lumenal EF hands of STIM1. This then destabilises the active STIM1 dimers, 
returning STIM1 back to its resting state (Jacob 1990). 
As well as being located in the ER membranes, small amounts of STIM1 has been found on 
the plasma membranes of some cells; though its function there is contentious, with some 
reports that plasma membrane -STIM1 plays a role in Ca2+ (Spassova et al. 2006; Ambily et 
al. 2014) and others that it does not (Cahalan 2009; Roberts-Thomson et al. 2010 p.). 
Before Orai1 was identified it had been suggested that members of the canonical family of 
Transient receptor potential channels (TRPC) may fulfil the role of the CRAC channel’s 
channel (Yue et al. 2001; Cui et al. 2002; Mori et al. 2002; Philipp et al. 2003). While these 
channels have been reported to be able to act independently of the STIM1-Orai1 complex 
(DeHaven et al. 2009); they have also been shown to be directly gated by STIM1 (Huang et 
al. 2006; Yuan et al. 2007), and to form complexes with Orai1 in the plasma membrane, 
where they are indirectly activated by the action of STIM1 on Orai1 (Liao et al. 2007). While 
there is some confusion as to their mechanism of activation; TRPC channels have been 
shown to play a role in SOCE in some cell types, e.g. the influx of Ca2+ during SOCE in PAC 
from TRPC3-/- mice was found to be reduced to about half that observed in wild type cells 
(Kim et al. 2009). 
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A         B 
 
 
 
 
Fig. 1.1.4 STIM1 and Orai1 interact at ER-PM puncta to allow entry of extracellular 
calcium into the cell 
(A) mCherry tagged STIM1 and GFP tagged Orai1 are distributed throughout the ER and PM 
respectively in resting HEK293 cells (top). After thapsigargin-induced depletion of ER 
calcium content the proteins colocalize with each another (bottom). (B) When the ER lumen 
is filled with calcium STIM1 is dispersed throughout the ER membrane in its resting 
conformation, bound to calcium (top). Upon store depletion STIM1 losses its bound calcium, 
changes into its active conformation and migrates to ER-PM puncta (middle). STIM1 
activates Orai1, which allows entry of extracellular calcium across the PM into the cytoplasm 
(bottom).  
 
Adapted under terms of use from M Prakriya and S Lewis; Physiological Reviews; 2015 (Prakriya and Lewis 
2015). 
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While the function of STIM1 has clearly been identified, the function of its orthologue 
STIM2 is less clear. Due to overexpression of STIM2 reducing the size of the SOCE response 
it has been suggested that in may inhibit STIM1’s activity (Soboloff et al. 2006), possibly by 
competing to bind Orai1. However, it has also been suggested that STIM2 might regulate 
basal levels of Ca2+; sensing smaller changes in [Ca2+]l than STIM1 and triggering SOCE 
accordingly (Brandman et al. 2007 p.2). This action would ensure that the ER Ca2+ store is 
kept full under physiological conditions, despite loss of Ca2+ through leak channels (Tu et al. 
2006). 
 
1.1.5 Visualizing calcium signalling 
Real-time visualisations of changes in either the [Ca2+]c or [Ca2+]l is possible thanks to the 
use of florescent Ca2+ probes (Paredes et al. 2008). These Ca2+ probes are either florescent 
dyes based on Ca2+ chelators or recombinantly expressed Ca2+-sensing fluorescent proteins, 
which have a combined bioluminescence and Ca2+ sensing function. 
Probably the most commonly used type of florescent Ca2+ probes are fluorescent dyes, due to 
their ease of use and the varied characteristics (e.g. affinity to Ca2+ or absorption/emission 
spectra) of different dyes (Takahashi et al. 1999; Paredes et al. 2008). Two of the most 
widely utilized dyes are the Fluo and Fura families of dye, often in their cell permeable AM 
forms. The Fluo-1, Fluo-2 and Fluo-3 are part of a range of Ca2+ dyes created by Roger 
Tsien’s group (Minta et al. 1989), combining the 8-coordinate tetracarboxylate chelating site 
of 1,2-bis(2-amino-phenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) with a xanthene 
chromophore. These dyes gain their fluorescence upon binding of Ca2+ and have a single 
excitation and emission wavelength, making them easy to record and correlate to changes in 
[Ca2+]. Several derivatives of the original Fluo dyes have since been created, including Fluo-
4 and Fluo-5 (Gee et al. 2000). Fluo-4 is more sensitive to excitation at 488 nm, producing a 
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brighter fluorescence emission, and shows a higher rate of cell permeation than the original 
Fluo dyes. Fluo-5 and its analogues have a reduced sensitivity to Ca2+, making them suitable 
for recoding [Ca2+]l which is much higher at resting levels than that of the cytosol. This 
allows for the recording of the depletion of store content in response to a stimulus rather than 
an increase in [Ca2+]c (Gerasimenko, Sherwood, et al. 2006).  
Tsien group also created the Fura family of dyes; like Fluo dyes, Fura dyes are also based on 
BAPTA but use a stilbene chromophore rather than a xanthene to confer fluorescence 
(Grynkiewicz et al. 1985). While 3 Fura dyes were initially created, Fura-2 has proven to be 
the most popular and is still the most commonly used. These dyes are ratiometric and change 
excitation wavelength depending on if they are bound to Ca2+ or not; with Fura-2’s peak 
absorbance shifting from 340 nm when Ca2+ is bound to 380 nm when it is unbound. Both 
bound and unbound emit light at the same wavelength so a ratio of emission intensities in 
response to the two different excitation wavelengths can be calculated, giving a more 
accurate quantification of the Ca2+ concentration than single wavelength dyes, eg. Fluo-4. 
However, ratiometric dyes are sensitive to any background auto-fluorescence and require an 
excitation source that can switch between wavelengths and a senor that can record emitted 
light rapidly to make use of them.    
The salts of both Fluo and Fura dyes are easily modified with AM groups; removing their 
charge and making them readily cell permeable. AM versions of dyes do suffer from being 
compartmentalized into organelles and extruded from cells over prolonged periods of time  
(Blatter and Wier 1990). Conjugating the dye’s salts to dextran prevents loss of cytoplasmic 
location, but does not confer membrane permeability.  
A drawback of using Ca2+ dyes is that they only bind free ionic Ca2+, which due to native 
buffering in the cytosol is about 1 in every 100 ions present in the cytosol. As dyes are based 
on Ca2+ chelators they also have a buffering effect, so further reduce the availability of free 
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Ca2+ in the cytosol, which can affect the kinetics of Ca2+ signalling within cells being 
observed (Takahashi et al. 1999). Another disadvantage of using Ca2+ dyes is that they cannot 
be targeted to specific locations in the cell (Kwon et al. 2016); this has been one of the key 
reason for the development of recombinantly expressed Ca2+-sensing fluorescent proteins, 
which do have this ability (Button and Eidsath 1996; Sieberer et al. 2009). 
The first type of Ca2+-sensing fluorescent protein discovered was aequorin from the Aequorea 
victoria jellyfish (Shimomura et al. 1962), which is natively activated by Ca2+. A 
recombinant form of this protein can be expressed in mammalian cells (Shimomura et al. 
1990), and unlike Ca2+ dyes it does not suffer from extrusion from cells or 
compartmentalization into organelles. It can sense free Ca2+ in the range of 0.1 – 100 µM, 
and as its fluorescence does not need to be excited there is no chance of auto-fluorescence 
(Kendall et al. 1996). However, aequorin’s fluorescence needs a prosthetic group called 
coelenterazine, which is irreversibly cleaved upon stimulation by Ca2+ (Shimomura 1995). 
Cells need to be supplemented with this group before imaging, and provided with a continual 
supply for aequorin to produce more than one emission of light (i.e. to allow real time 
visualisation of Ca2+ levels). 
The second type of Ca2+-sensing fluorescent protein was developed from another of 
Aequorea victoria’s proteins GFP (Prasher et al. 1992). In Aequorea Victoria Ca2+ binds to 
aquorin causing it to cleave coelenterazine, this results in the release of blue light that excites 
GFP, which then emits green light (Morise et al. 1974). Experimentally this can be 
reproduced by stimulating GFP (or one of its alternative coloured variants, e.g. YFP (Aliye et 
al. 2015)) with the correct wavelength of light to excite its fluorescence. Tsien’s group 
created a ratiometric Ca2+ sensing protein based on the Ca2+ binding activity of calmodulin 
with the fluorescence of GFP and its analogues (Miyawaki et al. 1997). This protein named 
CaMeleon consists of two corresponding GFP derived domains (e.g. BFP and GFP or CFP 
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and YFP) joined by calmodulin and a M13 link domain. When the protein is in its resting, 
Ca2+ unbound state the two GFP derived domains are far apart and excitation of BFP or CFP 
results in emission of blue or cyan light that can be recorded. However, when Ca2+ binds to 
calmodulin the protein undergoes a conformational change, with the calmodulin domain 
wrapping around the M13 domain bringing the two GFP derived domains close together. 
When the BFP or CFP domain of activated CaMeleon is excited the light it emits then excites 
the other GFP derived domain (GFP or YFP respectively), which then emits either green or 
yellow light. This change in the wavelength of emitted light allows for the ratio of CaMeleon 
that has bound Ca2+ and that that does not to be calculated. Several other types of Ca2+-
sensing fluorescent protein have been developed from GFP and its derived florescent 
proteins, including Camgaroos and GCaMP (Whitaker 2010). 
 
1.2 The pancreas 
1.2.1 The structure and function of the pancreas 
The pancreas is an organ with two distinct functions, endocrine and exocrine, both of a 
secretory nature. Its structure varies between species; in some species, e.g. rabbits, it is 
diffusely distributed in the mesentery of the small bowel, while in humans and rodents it is 
compacted into a distinct organ (Tsuchitani et al. 2016). In humans the pancreas weighs 
between 50 - 100 g; is between 15 - 18 cm long, 2 – 9 cm wide and 2 -3 cm thick; and can be 
dived into three sections: the head (caput pancreatis), a C-shaped part aligned with the upper 
curvature of duodenum; the body (corpus pancreatis), located underneath the stomach; and 
the tail (cauda pancreatis), which touches the hilum of the spleen (Dolenšek et al. 2015). 
The bulk of the pancreas is given over to its exocrine function, which accounts for 96 -99 % 
of its total mass. Structurally the exocrine pancreas is lobular; subdividing into lobes, then 
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lobules and finally grape like structures called acini of pancreatic acinar cells (PAC) (Leung 
and Ip 2006) (Fig. 1.2.1B). These acini connect to intralobular  ducts comprised of pancreatic 
ductal cells; intralobular  ducts merge into larger extralobular ducts, which in turn merge to 
form the main collecting duct (Grapin-Botton 2005). The collecting duct connects with the 
common bile duct to form the ampulla of Vater, which empties into the duodenum (Fig. 
1.2.1A). Pancreatic stellate cells are present in the periacinar space, and have protrusions of 
membrane that encircle acini (Omary et al. 2007). When activated, under physiological 
conditions it is believed that they synthesise extracellular matrix components, which promote 
tissue repair, but under pathological conditions are involved in fibrosis of the pancreas. 
The endocrine pancreas is formed of clusters of cells called the islets of Langerhans, which 
are dispersed throughout the volume of the pancreas (Fig. 1.2.1D). Islets are comprised of 
five types of cell: α cells, β cells, δ cells, ε cells and Polypeptide (PP) cells (sometimes 
referred to as γ cells) (Pelletier 1977; Andralojc et al. 2009); the ratio and distribution of the 
different cell types within islets varies between species (Elayat et al. 1995).  
The organ is surrounded by a fibrous capsule with extensions into the organ’s body that 
delineate the parenchyma into its lobular sutures. Due to its endocrine function the pancreas 
is highly microvascularised, and receives about 1% of cardiac output (Lewis et al. 1998). It 
receives blood from both the celiac and the superior mesenteric artery, the first 2 of the 3 
major branches of the abdominal aorta; while its venous system drains into the portal vein 
(Wharton 1932). While only described in rodents, the pancreas has a sparse distribution of 
lymphatic vessels, that are physically distinct from acini, ducts and islets (O’Morchoe 1997). 
Intralobular lymphatic vessels join to form interlobular vessels running in the connective 
tissue between pancreatic lobes, which connect to a series of nodes surrounding the pancreas. 
The pancreas is also highly innervated by a mixture of sympathetic, parasympathetic and  
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Fig. 1.2.1 Structure of the human pancreas  
The pancreas is a secretory organ with two distinct functions, exocrine and endocrine; with 
the bulk of the pancreas given over to its exocrine function. (A) The exocrine pancreas is a 
branching structure, which joins to form the pancreatic duct. This joins with the common bile 
duct and empties into the duodenum. (B) The exocrine pancreas is organised into bundles of 
cells called acini that are connected to intralobular ducts, which merge into extralobular 
ducts. (C) Within an acinus structure pancreatic acinar cells are organised with their granular 
apical region facing the acinar lumen. (D) Dispersed throughout the exocrine pancreas are 
clusters of endocrine cells called islets of Langerhans, comprised of several different types of 
hormone secreting cells. 
Reprinted by permission from Macmillan Publishers Ltd: [Nature Reviews Cancer] (Bardeesy and DePinho 
2002), copyright 2002. 
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afferent neurones, which have a regulatory role for both the exocrine and endocrine pancreas 
(Ahrén 2000; Love et al. 2007). 
The pancreas develops from the endoderm germ layer, via the formation of two distinct buds 
(Rutter 1980). The dorsal anlagen is formed when the endoderm envaginates into a 
condensation of mesenchyme that had previously formed on its dorsal side (Gittes 2009). The 
ventral bud forms laterally from the primitive gut tube, close to the same region of endoderm 
that the forms the biliary and hepatic ducts (Puri and Hebrok 2010). The dorsal pancreas 
forms part of the developing head, the body and the tail of the organ, while the ventral 
pancreas forms part of the devolving head (Tsuchitani et al. 2016). The buds fuse after gut 
rotation (Kluth et al. 2003) and branch into the surrounding mesenchymal tissue. Both the 
endocrine and exocrine pancreas share the same linage and develop in tandem (Fishman and 
Melton 2002), rapidly forming the recognisable architecture of the organ (Pictet et al. 1972).   
While each type of cell composing the pancreas is highly specialised for its specific function, 
differentiation does not always appear to be irreversible. PAC have been found to revert to 
ductal-type cells during the development of pancreatic ductal adenocarcinoma (Rooman and 
Real 2012). Metaplasia of PAC into hepatocytes has been found to occur in vivo during 
regeneration of the pancreas (Shen et al. 2003). One of the most studied models of this is 
when rats are fed a copper (Cu2+)-deficient diet with Trien (a Cu2+-chelating agent) for 7-9 
weeks to induce a near complete loss of PAC, and then returned to normal feed. Using this 
model, hepatic cells have found to occupy over 60% of the pancreatic volume 6-8 weeks post 
recovery (Rao et al. 1988). This transdifferentiation  is likely due to the shared endodermal 
origin of both cell types; highlighted by the viability of islets transplanted from healthy 
donors into the liver of patients with type 1 diabetes (Iwanaga et al. 2006). 
The function of the endocrine pancreas is the secretion of various hormones, with each type 
of cell responsible for the production of a different hormone (Mastracci and Sussel 2012). α 
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cells and β cells secrete glucagon and insulin respectively, which are involved in blood 
glucose homeostasis; while δ cells, ε cells and PP cells respectively secrete somatostatin, 
ghrelin and pancreatic PP, which regulate pancreatic secretions. 
The exocrine pancreas’ role is the secretion of the digestive enzymes (including trypsin, 
chymotrypsin, pancreatic amylase and lipase (Case 1978)) required for digestion in the 
intestines. Enzymes are produced by acinar cells and secreted in their zymogen form, which 
are then activated in the duodenum. First by the activation of trypsinogen into trypsin by the 
brush-border glycoprotein peptidase, enterokinase; which in turn cleaves the other 
proenzymes into their active form (Rinderknecht 1986). Duct cells secret bicarbonate, which 
aids in the clearance of enzymes through the pancreatic duct system and neutralises the acid 
pH of the chyme produced by the stomach (Grapin-Botton 2005; Ishiguro et al. 2012). 
Pancreatic stellate cells normally exist in a quiescent state, however under pathological 
conditions they activate and are involved in fibrosis (Masamune and Shimosegawa 2013). 
 
1.2.2 Pancreatic acinar cells 
1.2.2.1 Structure and function of acinar cells 
Acinar cells account for roughly 90% of the total cells in the pancreas; and play the key role 
of synthesizing, storing and secreting digestive enzymes upon stimulation. Natively they have 
a pyramidal shape with a highly polarised intracellular layout consisting of an apical granular 
region and a basolateral region (Petersen and Tepikin 2008). The basolateral region 
comprised up to 90% of the cells volume and contain its nucleus and the bulk of the ER. 
When PAC form acini structures their granular regions face the acinar lumen (Fig. 1.2.1C); it 
is this region that contains the specialised secretory vesicles called zymogen granules, which 
store the digestive enzymes in their inactive proenzyme form (Rindler 2001). The granular 
and basolateral regions of the cell are separated by a mitochondrial belt; which has been seen  
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Fig 1.2.2 Pancreatic acinar cells have a highly polarized structure 
Bright field images (A and C) and florescent images (B and C) of a single pancreatic acinar 
cell (A and B) and a cell triplet (C and D) stained with the mitochondria-specific florescent 
dye MitoTracker Green. The bright field images show the cells are highly polarised, with a 
separate granular region at their apical pole. Fluorescence imaging shows a clear clustering of 
mitochondria into a belt separation cells apical and basal regions. 
 
 
Reproduced by permission from EMBO press; H Tinel et al., The EMO Journal, 1999, John Wiley & Sons, Inc. 
Copyright © 1999 European Molecular Biology Organization (Tinel et al. 1999). 
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acting as a ‘firewall’, preventing Ca2+ signals created in the granular region from propagating 
into the basolateral one (Tinel et al. 1999) (Fig. 1.2.2). While the majority of the ER is 
located in the basolateral region of the cell, extensions of the ER membrane cross the 
mitochondrial belt into the granular region. A tunnelling effect has been observed in the 
lumen of the ER, with Ca2+ migrating from the basolateral region of the cell into the 
protrusions in the granular region, keeping them filled (Mogami et al. 1997). Physiological 
fluid secretion from PAC is stimulated by either the neurotransmitter acetylcholine (ACh) or 
the digestive hormone cholecystokinin (CCK) (Cancela 2001). These secretagogues induce 
the production of intracellular secondary Ca2+ messengers in PAC, this results in the release 
of Ca2+ from intracellular stores (Low et al. 2010), which in turn drives the process required 
for secretion of enzymes from the zymogen granules (Söllner 2003; Stojilkovic 2005). 
Individual PAC cells show extensive coupling with neighbouring PAC via gap junctions 
(Meda et al. 1983); these cell-cell couplings show the ability to enhance and coordinate 
responses in connected cells (Michon et al. 2005). Endocrine cells in islets are also connected 
via gap junctions, which play a similar role as they do in PAC (Bertuzzi et al. 1999). 
Exocrine and endocrine cells express opposing connexion proteins, and therefore do not 
appear to form jap junctions between each other (Meda 1996).   
 
1.2.2.2 Physiological calcium signalling in acinar cells 
Physiological concentrations of both ACh and CCK typically induce small oscillations in the 
[Ca2+]c confined to the granular region of the cell (Li et al. 2014); though occasionally induce 
a Ca2+ wave initiated in the apical region that spread throughout the cell (Pandol et al. 2007; 
Sutton et al. 2008). It is believed that while Ca2+ oscillations induce fluid secretion; the 
function of Ca2+ waves is to trigger gene transcription (Cancela 2001), which can be a Ca2+ 
dependent process (van Haasteren et al. 1999). Supramaximal concentrations of CCK cause  
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hyperstimulation of PAC, producing a large sustain increase in [Ca2+]c that are cytotoxic and 
results in necrosis of PAC (Criddle et al. 2009). 
Receptors for both physiological secretagogues are concentrated on the basolateral plasma 
membrane (Pandol 2010) and are forms of metabotropic G-protein coupled receptors. 
(Schnefel et al. 1988). Structurally G-protein coupled receptors consist of a extracellular N-
terminus that interacts with its ligand, 7 transmembrane domains and an intracellular C-
terminus that typically (but not always) associated with a G protein complex (Bockaert and 
Pin 1999). The type of G protein required for physiological Ca2+ in PAC are the Gq class 
heterotrimers (comprised of a α, a β and a γ subunit) (Williams 2001), which in its inactive 
state is bound to the receptor and GTP. The associated receptor undergoes a conformational 
change when it binds its ligand; activating the GTPase activity of the complex, which 
converts the attached GTP to GDP. The G protein complex releases GDP and dissociates 
from the receptor, with the α subunit separating from the β and γ subunits, and performing 
downstream signalling functions.  
ACh is released by peripheral nerve endings in the pancreas, and acts on the M3 type 
muscarinic ACh receptor (M-AChR M3) (Schnefel et al. 1988). Phospholipase C (PLC), 
which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into IP3 and diglyceride (DAG) is 
known to be directly activated by the Gq α subunit (Park et al. 1993). 
CCK is secreted by the endocrine cells of the small intestine after food ingestion and by 
peripheral nerves in the gut (Liddle 1997), it is expressed as a 115 residue precursor and then 
cleaved into peptides of various length with 8-NH2 -CCK being the most biologically active. 
There are two types of CCK receptors, CCKA and CCKB, though both human and mouse 
PAC only express CCKA (Cancela 2001). The receptor has two CCK binding domains; the 
high affinity site couples CCK to physiological signalling by activation of CD38 via an  
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Fig. 1.2.2.2 Stimuli induced cytoplasmic calcium responses in pancreatic acinar cells  
(A) Calcium responses in pancreatic acinar cells upon short applications of acetylcholine are 
confined to the apical granular region. (B) Recordings of the apical areas (yellow), basal 
areas (purple) and nuclei (blue) of the cells in (A). (C) Prolonged exposure to ACh induce 
global calcium responses in the cells. 
 
 
Adapted with permission from Journal of Cell Science (Gerasimenko and Gerasimenko 2004), originally 
modified with permission of Springer (Gerasimenko et al. 1996). 
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unknown pathway (Cosker et al. 2010) and the low affinity site has been linked to the 
production of IP3 (Matozaki et al. 1990) and pathological signalling (Beil et al. 2002). 
Activation of CD38 by CCK produces both cADPR and NAADP (Yamasaki et al. 2005), 
though there have been conflicting finding as to the importance of each messenger in the Ca2+ 
response induced by CCK. The cADPR specific antagonist 8-NH2-cADPR inhibits responses 
to CCK, suggesting cADPR’s activity is vital for the response (Cancela and Petersen 1998 
p.2). However, 300 µM glucose, which inhibits cADPR-induced Ca2+ release in PAC, has no 
effect on the response to CCK, suggesting cADPR is not vital (Cancela et al. 1998). A high 
autoinhibitory concentration of NAADP has no effect on cADPR-induced Ca2+ release in 
PAC, but does inhibit their response to CCK, suggesting that NAADP is required for the 
hormone’s activity (Cancela et al. 1999). Based on these results it has been suggested that 
NAADP may be required to initiate the Ca2+ response to CCK, while cADPR plays a role in 
propagating it. 
As ACh and CCK receptors are primarily located on the basolateral membrane and secretory 
Ca2+ is confined to the granular region, it suggests that the secondary messengers produced in 
response to secretagogues must diffuse through the cell to their target region. PACs express 
all three isoforms of both IP3R (M. G. Lee et al. 1997) and RyR (Fitzsimmons et al. 2000). 
IP3Rs localise to the granular region of the cell (Thorn et al. 1993; Nathanson et al. 1994), 
while RyRs show a more dispersed localisation in both regions of the cell (Leite et al. 1999; 
Straub et al. 2000). 
While both IP3R and RyR are associated with being located in ER membranes in most cell 
types, antibody staining has shown RyR localized with a zymogen granule marker (Husain et 
al. 2005). While immunohistochemistry suggests that IP3R that do not localise to these 
vesicles (Yule et al. 1997; Husain et al. 2005), IP3 have been shown to mobilize Ca2+ in the 
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granular region after ER Ca2+ is depleted by Tg (Gerasimenko, Sherwood, et al. 2006). All 
three secondary Ca2+ messengers have been shown to be able to mobilise Ca2+ from both an 
ER and acidic store in the granular region of PAC. While not positively confirmed, selective 
disruption of other candidates implies that it is the zymogen granules that comprise this 
IP3/cADPR/NAADP sensitive store. This suggests that IP3R and RyR are both present and 
functional in the membranes of zymogen granules, with their non-ER location possibly due to 
the high rate of ER turnover required to produce and maintain the pool of zymogen granules 
present in PAC. As zymogen granules are an acidic organelle specific to PAC, present in 
large numbers concentrated to the granular region they provide a unique large pool of Ca2+ 
that can be mobilized in response to any of the secondary messengers. The expression and 
localisation of the two TPC isoforms has yet to be shown in PAC. 
It is believed that a combination of secondary messenger receptors being concentrated to the 
granular region, the process of CICR and the mitochondrial belt is the reason that most 
physiological Ca2+ in PAC is confined to their granular region. The high concentration of 
receptors in the granular region makes it prone to the initiation of Ca2+ release by secondary 
messengers; and also make it susceptible to CICR, which both IP3R and RyR are known to be 
sensitive to (Santulli and Marks 2015). This is highlighted in experiments where Ca2+ was 
uncaged in specific areas of the cell (Ashby et al. 2002); uncaging of Ca2+ in the granular 
region initiated a Ca2+ wave that spread throughout the cell, whereas uncaging in the 
basolateral region produced no response. This implies that the basolateral region is not 
sensitive to CICR, while the granular region is highly sensitive to it. It is possible that the 
combination of IP3R and RyR present in the granular region, compared to just RyR in the 
basolateral region, is the reason for this; suggesting both are a requirement for CICR. The 
majority of Ca2+ signals initiated in the granular region will be confined there due to the 
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buffering capacity of the mitochondrial belt that separates it from the basolateral region; 
therefore, for any response to propagate throughout the cell it must be of sufficient size to 
overcome this barrier. 
All three secondary Ca2+ messengers are also capable of mobilising Ca2+ from the Tg 
sensitive nuclear envelope (Gerasimenko et al. 2003). While the physiological relevance of 
this is unknown, there is a probable link to gene transcription. With the same messengers that 
induce PAC to secrete digestive enzymes, driving the synthesis of new enzymes to replenish 
the pool. 
 
1.2.3 Diseases of the exocrine pancreas 
The three most common diseases of the exocrine pancreas in order of severity are: acute 
pancreatitis (AP), chronic pancreatitis and pancreatic cancer. AP is the most common of the 
three conditions, but each is considered a key risk factor in developing the next most severe.  
AP is a single inflammatory incidence that often presents rapidly, initial symptoms include 
severe  abdominal pain, nausea and vomiting (Swaroop et al. 2004). 1 out of every 2000 
people suffer from the disease annually (Sutton et al. 2003), with key risk factors excessive 
alcohol consumption and gallstones (Lowenfels et al. 2005). The disease is the result of the 
pathological activation and secretion of the digestive enzymes stored within PAC (Petersen et 
al. 2011). The activity of the pathologically activated enzymes then autodigests the pancreas 
and surrounding tissue (Fagniez and Rotman 2001), causing necrosis and inflammation (Fig. 
1.2.3). There is no current specific treatment for AP and sufferers often require 
hospitalisation, with analgesics and prophylactic antibiotics often administered to patients 
(Johnson 2005) to treat the symptoms; supplementary fluids, nutrition and oxygen are also 
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sometimes required . Treatment of related complications can have a positive effect; if 
gallstones are a factor, a cholecystectomy is a possibility, though due to its invasive nature an 
established set of guidelines for when surgery should be performed have been established 
(Uhl et al. 2002).  Most incidences of AP resolve themselves after a 5-10 day period, 
however approximately one in five patients develop a more severe form of the disease, with 
more extensive necrosis and a systemic inflammatory response. This can result in multiple 
organ failure and about half of patients who develop the severe form of AP die within 2 
weeks of the disease’s progression (Swaroop et al. 2004).  
Between 10-15% of patients who suffer an initial incidence of AP will suffer a recurrence of 
the disease, with 6.4% progressing to suffer from chronic pancreatitis (Banks et al. 2010). Of 
the AP patients who progress to a chronic condition, over 65% will have had their initial 
incident of AP as a result of excessive alcohol consumption, making it a key risk factor for 
chronic pancreatitis (Joergensen et al. 2010). Alternatively, the chronic condition can have a 
hereditary link, with mutations to several proteins of varying function reported (Zator and 
Whitcomb 2017). Patients with the hereditary form of chronic pancreatitis tend to develop the 
condition much earlier (10-15 years) than is average for sufferers of the disease (35-55 years) 
(Rosendahl et al. 2007).  
Chronic pancreases is characterised by the loss of secretory years) the organ, irreversibly 
altering its morphology and structure (Brock et al. 2013). Fibrosis is caused by the activation 
of pancreatic stellate cells under pathological conditions, causing them to synthesise 
excessive amounts of extracellular matrix components (Haber et al. 1999; Apte et al. 2012). 
While levels of necrosis and inflammation in chronic pancreases are often low patients can 
suffer from chronic pain, as well as recurrent episodes of increased severity that mimic AP 
(Skipworth et al. 2010). Loss of pancreatic parenchyma can result in a range of complications  
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 A        B         C          D 
 
 
Fig. 1.2.3 Various agents can be used to reproduce acute pancreatitis in vivo  
Normal pancreatic histology (A) and the histopathology in three in vivo experimental models 
of acute pancreatitis: (B) hyperstimulation induced by intraperitoneal injections of cerulean (a 
peptide from the secretions of the Australian green tree frog Litoria caerulea that mimics the 
effect of CCK); (C) retrograde pancreatic ductal injection of the bile acid TLC-S; or (D) 
production of FAEEs by intraperitoneal injections of ethanol and palmitoleic acid. All three 
pathological agents induce inflammation, oedema and necrosis in the pancreatic tissue. 
 
 
 
 
 
 
 
 
Modified under the terms of the Creative Commons Attribution 4.0 License from L Wen et al.; 
Gastroenterology; 2015 (Wen et al. 2015).   
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including digestive issues caused by the loss of acini and Type 1 diabetes due to loss of 
endocrine tissue (Sarles 1992; Ewald and Hardt 2013), which occurs in 50-60% of chronic 
pancreatitis sufferers.  
As with AP there is no true treatment for chronic pancreatitis ; with management of symptoms 
(e.g. analgesics, pancreatic enzyme supplements, insulin injections) often all that is possible 
(Nair et al. 2007). Half of all patients with chronic pancreatitis undergo some form of surgery 
to try and treat their condition (Steer et al. 1995), with a lateral pancreaticojejunostomy the 
most common. This where all but the head of the pancreas is removed and the remaining 
pancreatic tissue attached to the duodenum with a duct-to-mucosa connection made so that 
pancreatic juices can drain directly from the common bile duct into the duodenum. A recently 
developed technique is a complete pancreatectomy with autotransplantation of islets into the 
liver (Ong et al. 2009). There is a clear correlation between chronic pancreatitis and 
pancreatic cancer (Raimondi et al. 2010); with sufferers of chronic pancreatitis 13.3 times 
more likely to develop pancreatic cancer than non-suffers (Yadav and Lowenfels 2013). 
Sufferers of hereditary chronic pancreatitis  have a significantly increased risk of developing 
cancer over those with other forms of the disease, and tend to develop tumours at younger 
cancer over those with other forms of the disease, and tend to develop tumours at younger 
ages (Lowenfels et al. 1997). 
While there is variation of rates of pancreatic cancer between populations (Ilic and Ilic 2016), 
it is generally more prevalent in western populations (7.4 per 100,000 people in Northern 
America and 7.3 per 100,000 people in Western Europe), believed to be due to lifestyle in 
these regions. Men have a higher risk of the disease than women, though both genders show 
an increased risk with age (Yadav and Lowenfels 2013). It is the 11th most common form of 
cancer worldwide, and has the lowest survival rate of 1% over 5 years (Jura et al. 2005). The 
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early symptoms of pancreatic cancer are nonspecific (e.g. diffuse abdominal pain, vomiting, 
diarrhoea and constipation), meaning the condition is often only diagnosed when it has 
progressed in severity and symptoms like acute abdominal pain, jaundice and significant 
weight loss (Malhotra et al. 2015). 
The majority of growths arise in the exocrine pancreas, with pancreatic ductal 
adenocarcinoma (PDAC) accounting for about 95% of all pancreatic tumours (Amundadottir 
2016). Due to their morphology PDAC had historically been though to solely originate from 
duct cells; however with the finding that PAC can be stimulated to revert to a pre-ductal like 
state (Wagner et al. 1998) it appears that these cells also play are role in tumorigenesis. Kras 
is mutated in most incidences of PDAC within the KrasG12D mutation found in the majority of 
tumours (Kolodecik et al. 2014). Mutation to Kras alone is not enough to develop PDAC, but 
it is believed to be the first step in pancreatic intraepithelial neoplasia, with mutations to 
several other genes required for the transformation into PDAC (Murtaugh 2014). Pancreatic 
stellate cells are activated in pancreatic cancer, where they help establish the tumour 
microenvironment by producing its stroma and possible signalling to PDAC cells in a 
protumorigenic manner (Apte et al. 2012; Haqq et al. 2014) 
While no direct cause of PDAC has been identified, a range of risk factors that significantly 
increase the probability of developing the disease have been identified. These risk factors 
include: smoking, obesity, diabetes, excessive alcohol consumption, diet, pancreatitis 
(especially the chronic form of the disease) (Ilic and Ilic 2016); infection by the  Helicobacter 
pylori bacteria has been cited by some as potential risk factor (Maisonneuve and Lowenfels 
2015), though this has been disputed (X.-Z. Chen et al. 2016).  
When tumours arise in the tail of the organ they can effectively be removed surgically; 
however as about 70% of tumours develop in the head of the pancreas they are often 
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inoperable due to the late stage of diagnosis (Malhotra et al. 2015). When surgery is viable it 
requires removal of the pancreatic head, common bile duct to above the ampulla of Vater and 
the attached section of the duodenum; with the remaining pancreatic tissue and bile duct 
reconnected to what is left of the duodenum (Ghaneh et al. 2007). PDAC shows a high 
resistance to traditional chemotherapy drugs, though use of Gemcitabine alone or in 
combination with other agents has shown positive effects (Teague et al. 2015). Modern 
therapeutic techniques targeting pathological signalling linked to growth of PDAC cells, e.g. 
inhibition of Epidermal growth factor receptor (EGFR) activity by antibodies, are currently 
being trialled (Fjällskog et al. 2003). 
All three diseases of the exocrine pancreas can be fatal, and currently there is no specific 
treatment for any of them. Due to the potential for each disease to progress to a more severe 
condition, the creation of a treatment for AP should reduce the incidence of all three. 
 
1.2.3.1 Acute pancreatitis 
1.2.3.1.1 Causes of acute pancreatitis 
AP can be the result of a number of causes, though 23.3% of cases are idiopathic (Joergensen 
et al. 2010). The mnemonic taught to medical students to remember the causes of AP 
(roughly in their order of incidence) is aptly I. G.E.T. S.M.A.S.H.E.D.; standing for: 
Idiopathic, Gallstones, Ethanol, Trauma, Steroids, Mumps, Autoimmune, Scorpion stings or 
Spider bites, Hyperlipidaemia or Hypercalcaemia, Endoscopic retrograde 
cholangiopancreatography, and Drugs. Smoking has previously described as an exacerbating 
factor in combination with known causes of AP, e.g. alcohol, however recently it has been 
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suggested as cause in and of itself (Barreto 2016). Of the known causes of AP, gallstones and 
alcohol together contribute over half of all incidences of the disease (Joergensen et al. 2010). 
Claude Bernard first suggested that reflux of bile into the pancreas’s main colleting duct 
could cause AP in 1856 (Wang et al. 2009). When in 1901 Opie described the case of a 
patient who had died and was found to have gallstone blocking the ampulla of Vater, he 
proposed that such a blockade might result in such a reflux of bile. Gallstones are formed 
from condensates of various components of the bile and are often highly calcified; the two 
most common types are primarily formed from either bilirubin or cholesterol (and its 
catabolites) and are referred to as black and brown pigment stones respectively (Trotman 
1991). 
While bile is known to contain a mixture of substances (including Bilirubin, excess heavy 
metals and phospholipids), bile acids (sometimes referred to as bile salts) make up about 61% 
of its composition (Kristiansen et al. 2007). Bile Acids have been shown to induce large 
sustained pathological increases in [Ca2+]c within PAC (Voronina et al. 2002 p.202; 
Gerasimenko, Flowerdew, et al. 2006) and resulting in necrosis of cells (Kim et al. 2002; 
Orabi et al. 2013). They have also been shown to cause necrosis in both pancreatic duct and 
stellate cells (Alvarez et al. 1997; Ferdek et al. 2016), implying they have a pathogenic effect 
throughout the exocrine pancreas. AP can be recreated experimentally in vitro by either 
ligation of the ampulla of Vater to recreate the gallstone blockage, or by injection of bile 
acids into the main colleting duct to simulate their reflux (Hue Su et al. 2006). PAC have also 
been shown to express active bile acid transporters, indicating some function for bile acid 
uptake in these cells (Kim et al. 2002).  
This has been disputed though as less than 10% of patients with symptomatic gallstone 
disease suffer an incident of AP (Armstrong et al. 1985). It has also been suggested that the 
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pressure built up in the common bile duct in response to its blockage is insufficient to cause 
reflux into the pancreas (Armstrong and Taylor 1986) and that the common duct is too short 
to allow efficient reflux to occur (Vonlaufen et al. 2008). This means despite a clear and 
obvious link between patients with AP and gallstones, the underlying pathological 
mechanism is yet to be definitively proven.  
Alcohol consumption also has a clear correlation to AP, with a linear relationship observed 
between the risk of contracting the disease and level of alcohol intake (Durbec et al. 1981). 
However only a small number of alcoholics develop AP (Steinberg and Tenner 1994); also 
intact PAC show a tolerance to high concentration of ethanol (Criddle et al. 2004) and long-
term intraperitoneal administration of ethanol does not induce AP (Lerch and Gorelick 2013). 
These findings suggest that it is not directly ethanol itself that is pathological in alcohol-
related AP. 
Elevated concentrations of fatty acid ethyl esters (FAEE) were observe.d in serum and 
pancreatic tissue of rats that displayed symptoms of AP after infusion of ethanol (Werner et 
al. 2002). FAEEs are nonoxidative metabolites of ethanol and can be produce in the pancreas 
via one of two pathways: oxidative or non-oxidative (Wilson and Apte 2003). The oxidative 
path way utilizes alcohol dehydrogenase (ADH) and possibly cytochrome P4502E1 to 
produce acetaldehyde, and is the major route for ethanol metabolism in the pancreas. 
Alternatively, the non-oxidative produces the FAEE linked to AP from ethanol and fatty 
acids (FA) via the enzyme FAEE synthases. Rats on a high-fat supplemented diet with a 
continuous intragastric infusion of ethanol were found to develop AP (and in some cases 
chronic pancreatitis) (Tsukamoto et al. 1988), indicating the importance of both fat and 
alcohol in the development of alcohol-related AP. 
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Like bile acids, FAEE’s are able to induce a pathological Ca2+ response in PAC (Criddle et 
al. 2004) via an IP3R dependent action (Criddle, Murphy, et al. 2006). Within PAC, FAEEs 
can be converted back to FAs; which have their own Ca2+ mobilizing activity (which is not 
sensitive to IP3R inhibition like FAEE’s) and disrupt ATP syntheses (Criddle, Sutton, et al. 
2006), which will affect the cells Ca2+ homeostasis. FAEEs have also been linked with an 
increased fragility of both lysosomes and zymogen granules (Haber et al. 1993; Haber et al. 
1994) and the activation of pro-inflammatory transcription factors, e.g NF-κB (Gukovskaya et 
al. 2002); all of which would have a pro-AP effect.   
Ethanol metabolites also seem to have an effect on pancreatic stellate cells, which have been 
shown to have ADH activity (Wilson and Apte 2003). Increased levels of extracellular matrix 
proteins have been observed in pancreases after exposure to FAEEs (Lugea et al. 2003), 
suggesting the activity of stellate cells, which synthesise these proteins (Robinson et al. 
2016).  
Both bile acids and FAEE have been shown to induce the death of PAC by inducing a 
sustained rise in [Ca2+]c at cytotoxic levels (Wen et al. 2015). The form that that death takes 
however can vary; in mild AP cells mainly have an apoptotic fate, and in severe AP a 
necrotic one (Klöppel and Maillet 1993). With the balance between pro-apoptotic and pro-
necrotic factors determining which form of cell death occurs, and hence the severity of the 
disease (Bhatia 2004). Several mechanisms have been observed in PAC, e.g. production of 
reactive oxygen species (ROS) in response to bile acids, where by the cell is steered toward 
an apoptotic fate (Bhatia et al. 1998; Booth et al. 2011). Recent attempts have been made to 
subdivide cell death into multiple categories, beyond that of just apoptosis and necrosis 
(Kroemer et al. 2009). One example is necrosis (which had typically been thought of as an 
uncontrolled pro-inflammatory process), now subdivided into necrosis (retaining its original 
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definition) and necroptosis (Feoktistova and Leverkus 2015). Necroptosis is effectively a 
controlled pro-inflammatory process; believed to occur when initiating a localised immune 
repose is advantageous, e.g. when a cell is viral infected. There is some evidence that 
necroptosis can occur in PAC during AP (Wang et al. 2016); like apoptosis this might be an 
attempt by PAC undergo a less harmful form of death than necrosis, and so be relevant for 
mild AP. It seems unlikely however, that necroptosis is involved in the severe form of AP 
due to the amount of inflammation and extent of damage to the pancreas that occurs. 
 
1.2.3.1.2 Bile acids 
Bile acids are a group of amphipathic steroids (Lefebvre et al. 2009) that play a key role in 
digestion acting as detergents and emulsifiers; they also act as surfactants to aid in the 
absorption of lipids and lipid-soluble vitamins (Insull 2006) by forming cylindrical micelles 
with them (Hjelm et al. 1995; Hofmann 1999). 
The majority of bile acids are synthesised by hepatocytes from cholesterol via one of two 
catabolic pathways (Chiang 2009); over 90% of bile acids are synthesised via the neutral 
classic pathway, though a small amount are synthesized via an acidic alternative pathway 
(Duane and Javitt 1999). The initial stage in conversion of cholesterol into 7-hydroxy-
Cholesterol by 7 α-hydroxylase (CYP7A1) is the only rate limiting step of bile acid synthesis 
(Chiang 2009). 7-hydroxy-Cholesterol can then follow one of two metabolic pathways (Fig. 
1.2.3.1.2.1): continued activity by CYP7A1 produces Chenodeoxycholic acid (CDCA) or by 
12α-hydroxylase (CYP8B1), which produces cholic acid (CA) (also referred to as cholate). 
The amount of CA and CDCA (collectively referred to as primary bile acids) synthesised by 
hepatocytes is about equal (Hofmann 1999). Most of the resultant CA and CDCA is then 
conjugated with either glycine or taurine by CoA:amino acid N-acyltransferase (Falany et al. 
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1994), with taurine conjugation the predominate form in mice (over 95% of all bile acids). 
Conjugation has several effects; it increases the solubility of bile acids (reducing their 
membrane permeability), makes them less suitable to Ca2+ precipitation and resistant to 
cleavage by pancreatic carboxypeptidases (Chiang 2013). Hepatocytes secrete bile acids into 
bile canaliculi, these are the smallest branch of the hepatic duct system, which eventually join 
up to form the common hepatic duct (Castaing 2008). From this duct bile components are 
taken up, concentrated and stored by the gallbladder ready to be secreted when stimulated by 
CCK (Housset et al. 2016). During this concentrating step the concentration and composition 
of the bile can change, meaning that the biliary bile excreted by the gallbladder is different to 
the hepatic bile secreted by the liver (Keulemans et al. 1998). 
Secondary bile acids are produced in the distal intestine; here they are unconjugated and CA 
is converted to lithocholic acid (LCA) and CDCA to Deoxycholic acid (DCA) by bacterial 
7α-dehydroxylase (Ridlon et al. 2014). About 95% of bile acids are reabsorbed by ileocytes 
(ileal enterocytes), with the rest eliminated in the faeces (Staels and Fonseca 2009). LCA is 
quite toxic, but induces its own detoxification by promoting expression of a sulfotransferase, 
which conjugated the bile acid by sulfation to reduce its toxicity (Hofmann 2004). Secondary 
bile acids are then recycled to the liver via the portal venous system for reuse, where they are 
either directed straight into the bile via uptake/extrusion by cholangiocytes or taken back up 
by hepatocytes for reconjugation to glycine or taurine (Chiang 2013). 
While most secondary bile acids are directly recycled (about 95% are reabsorbed in the 
ileum), some do enter the general circulatory system and are transported around the body. 
Bile acids can act as signalling compounds, via interaction with specific bile acid receptors; 
e.g. bile acids act on a farnesoid X receptor (FXR) in the lungs to activate lung fibroblasts (B. 
Chen et al. 2016). Circulating bile acids are reabsorbed in the kidneys (St-Pierre et al. 2001)  
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Fig. 1.2.3.1.2.1 Bile acid synthesis  
The key enzymes in the synthesis of primary bile acids from cholesterol in the human liver. 
CYP7A1 is the first enzyme in the classic (neutral) biosynthesis pathway, and therefore its 
activity is the rate limiting step of the pathway. The alternative (acidic) pathway occurs in the 
liver or macrophages and is initiated by the activity of CYP27A1. BACS and BAT are the 
key enzymes required for bile acid conjugation. In the intestine bile acids are deconjugated 
and converted into secondary bile acids by the activity of the intestinal flora. 
 
 
 
Reproduced under terms of free use from J Chiang; The Journal of Lipid Research; 2009 (Chiang 2009). 
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and returned to the liver through portal venous circulation. This system of circulation of bile 
from the liver to the intestines and back to the liver (with overflow being returned to the liver 
by the kidneys) is called enterohepatic circulation (Fitzsimmons et al. 2000) (Fig. 
1.2.3.1.2.2). 
As enterohepatic circulation creates an (almost) enclosed system there is need for 
homeostasis so energy is not wasted producing potentially toxic excesses of bile acids. This is 
achieved by feedback regulation of CYP7A1 expression. Bile acids act via a FXR called 
NR1H4 to supress CYP7A1 expression, while cholesterol acts via NR1H3 to induce it. 
(Redinger 2003). This ratio of pro- and anti-expression signalling controls the overall level of 
CYP7A1 expressed (and therefore rate of bile acids synthesised), as it catalyses the rate 
limiting step of their creation. 
As conjugated bile acids and secondary bile acids are not membrane permeable they have to 
be transferred into and out of cells. Multiple bile acid transporters have been identified (St-
Pierre et al. 2001) with evidence their expression is regulated by bile acid signalling (Dawson 
et al. 2009). Due to the polarized nature of epithelial cells different types of bile acid 
transporters can be separated between the apical and basal membrane to create directional 
flow of bile acids through the cell. At the apical membranes of enterocytes, cholangiocytes 
and renal proximal tubular cells bile acids are take-up into the cell via Na+ dependant 
transporters, using the Na+ gradient to facilitate movement of bile acids against their own 
concentration gradient. On the basal membrane Na+ independent organic anion transporters 
allow the transfer out of cells of bile acids along their concentration gradient. While in 
hepatocytes bile acid uptake occurs via a Na+ transporter; extrusion is performed by the bile 
salt export pump (BSEP), an ATPase used to actively remove bile acids from the cell (Stieger 
2010). Bile acid transporters have been found on other cell types not involved in  
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Fig. 1.2.3.1.2.2 Enterohepatic circulation of bile acids 
While some bile acids are lost in the faeces, most are reabsorbed from the intestinal lumen by 
ileocytes. Reabsorbed unconjugated secondary bile acids are then transported by the portal 
venous system where they can be directly returned to the biliary track by cholangiocytes or 
taken back up by hepatocytes to be reconjugated. Some bile acids enter the general 
circulatory system, where they are reabsorbed by renal proximal tubule cells and returned to 
the portal venous system. All cell types involved in bile acid reabsorption and transport show 
polarised transport, utilizing sodium cotransporters to move bile acids against their 
concentration gradients into the cell. Cholangiocytes, renal proximal tubule cells and 
ileocytes then use Na+ independent organic anion transporters to extrude bile acids, while 
hepatocytes use a ATPase to actively transport them out of the cell. 
 
Reproduced under terms of free use from P Dawson; The Journal of Lipid Research; 2009 (Dawson et al. 2009). 
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enterohepatic circulation, e.g. PAC cells express both Na+ dependant and Na+ independent 
bile acid transporters (Kim et al. 2002), while pancreatic stellate cells express Na+ dependent 
ones (Ferdek et al. 2016). 
 
1.2.3.1.3 Pathological calcium signalling of bile acids in acinar cells  
Taurolithocholic acid 3-sulfate (TLC-S) was the first bile acid shown to induce an increase in 
[Ca2+]c in PAC (Voronina et al. 2002), and while others have been shown to have a similar 
effect (e.g. taurocholate (TC) and taurodeoxycholate (TDC)), the mechanisms by which TLC-
S achieves this remains the best described.  
Lower concentrations of TLC-S induce cytoplasmic Ca2+ transients, while higher ones’ result 
in a single sustained elevation in [Ca2+]c (Husain et al. 2005). In both cases TLC-S induces 
these responses by inducing the release of Ca2+ from both ER and acidic intracellular stores 
in PAC, utilizing both IP3Rs and RyRs to do so (Gerasimenko, Flowerdew, et al. 2006). Ca2+ 
induced by higher concentrations of TLC-S deplete organelle stores of their Ca2+ content, 
triggering an influx of extracellular Ca2+ via SOCE (Kim et al. 2002; Wen et al. 2015). Bile 
acids can directly inhibit SERCA pumps, preventing ER refilling and therefore the slow 
inactivation of SOCE; together this creates the sustained Ca2+ response observed.  
TLC-S’s Ca2+ mobilizing effect (and by extension its necrotic effect) has been shown to be 
CD38 dependent, as a loss of response to TLC-S in CD38-/- mice (Orabi et al. 2013). This 
implies TLC-S’s effect is via the production of the secondary messengers cADPR and 
NAADP, in a similar manner as hyperstimulation with CCK. This corresponds with the 
response to TLC-S being diminished in the presence of either a high autoinhibitory 
concentration of NAADP or the cADPR specific antagonist 8-Br-cADPR (though 
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interestingly not in the presence of 8-NH2-cADPR). It is unknown how TLC-S activates the 
cyclase activity of CD38 and if it has the same effect on PLC to produce IP3; otherwise IP3Rs 
involvement in the response to TLC-S could be purely due to CICR in response to Ca2+ 
mobilized by cADPR and NAADP. There is also evidence that the related bile acid TC can 
directly gate RyR1 that have been purified and incorporated into a lipid bilayer (Geyer et al. 
2015). 
Release of Ca2+ from zymogen granules can affect the proenzymes they contain, which 
require a high [Ca2+]l to remain in stable inactive state (Petersen and Sutton 2006). The 
activity of bile aids cause an increase in [Na2+]i (Voronina et al. 2005) and zymogen granules 
are believed to contain a K+/Ca2+ exchanger (Yang et al. 2007). This means that because of 
the localised release of Ca2+ from zymogen granules there would be favourable conditions for 
the uptake of K+ into granules. The lumenal matrix of granules is a highly efficient exchanger 
of Ca2+ and K+ (Nguyen et al. 1998); therefore it could exchange its H+ and Ca2+ content for 
K+, which would create conditions for the auto-activation of trypsinogen to trypsin (Moreland 
and Sanyal 1985). 
Ca2+ increases in PAC, to either physiological or pathological stimuli, result in an increase in 
mitochondrial Ca2+ content, inducing the production of ROS (Booth et al. 2011). A 
combination of ROS and elevated mitochondrial Ca2+ induces opening of the mitochondrial 
Permeability Transition Pore (mPTP) and the release of cytochrome c into the cytosol 
(Baumgartner et al. 2009; Odinokova et al. 2009). Combined with TLC-S induced caspase 
activation (Criddle et al. 2007), this pushes the cell toward a controlled apoptotic death before 
conditions are favourable for a necrotic one. 
Sustained mitochondrial Ca2+ levels induced by TLC-S result in the depolarization of the 
mitochondrial membrane (Voronina et al. 2004). Prolonged depolarization of the membrane 
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impairs ATP production and creates a switch from an apoptotic fate to a necrotic one 
(Nicotera et al. 1998; Tsujimoto 1997). The prolonged cytotoxic levels of Ca2+ caused by 
TLC-S activates calcineurin (Muili, Wang, et al. 2013), which in turn activates NF-κB (Muili, 
Jin, et al. 2013), one of several inflammation associated signals caused by bile acids (Kim et 
al. 2002). Ultimately PAC undergo necrosis, lose their membrane integrity and release pro-
inflammatory factors (Hoque et al. 2012); triggering an inflammatory response (Kang et al. 
2014). 
 
1.3 Aims of the study 
The main aim of this study is to use the recent advancements in the field of NAADP research 
to better characterise the mechanism of NAADP-induced Ca2+ in PAC, and that role that it 
plays in both physiological and pathological Ca2+ in these cells.  
In PAC NAADP has been shown to act on both acidic and ER Ca2+ stores, mobilising Ca2+ in 
a RyR dependent manner (Gerasimenko et al. 2003; Gerasimenko, Sherwood, et al. 2006). 
TPC channels have recently been identified as NAADP-sensitive ion channels (E. Brailoiu et 
al. 2009; Calcraft et al. 2009; Zong et al. 2009) but their activity in PAC has yet to be 
characterised. Therefore, this study aims to determine the requirements for both TPC and 
RyR in NAADP-induced Ca2+ release in PAC. Use of knockout animals and isoform specific 
antibodies will allow for the targeted inhibition of individual isoforms of TPC and RyR and 
discern their relative requirements for NAADP’s activity. 
Both ACh and CCK act on PAC as physiological secretagogues, though only CCK activity 
has been shown to contain an NAADP component (Cancela 2001). It has been suggested that 
this NAADP component is required to initiate the response to CCK, which is then sustained 
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by its cADPR component (Cancela et al. 1999). Using the recently discovered NAADP 
specific-antagonists Ned-19 (Naylor et al. 2009) and BZ194 (Dammermann et al. 2009), this 
study aims to identify the importance of the NAADP component in the CCK-induced Ca2+ 
response in PAC.  
Ca2+ responses to the bile acid TLC-S in PAC have been shown to contain a NAADP-
sensitive component (Gerasimenko, Flowerdew, et al. 2006), and both TLC-S induced Ca2+ 
release and necrosis have been shown to involve the activity of the NAADP synthesis 
enzyme CD38 (Orabi et al. 2013). Based on these previous findings, this study aims to 
investigate if either of the NAADP-specific antagonists can protect against the pathological 
effects of TLC-S. 
While the harmful effects of a range of bile acids towards PAC have been reported (Kim et 
al. 2002; Voronina et al. 2002), the effect of the primary bile acid cholate has yet to be tested. 
As such, this study aims to characterise the effect of cholate on PAC and test to see if it, like 
TLC-S, contains a NAADP-sensitive component. 
Finally, this study also aims to investigate the effect of knocking out the TPC2 protein, which 
forms NAADP-sensitive Ca2+ channels, has on Ca2+ release in PAC in response to both 
physiological and pathological stimuli. 
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Chapter 2: Materials and Methods  
 
2.1 Reagents  
The following compounds were purchased from Sigma-Aldrich, Gillingham, UK: CCK-8 
(Cat. C2175), ACh (Cat. A6625), NAADP (Cat. N5655), cADPR (Cat. C7344), IP3 (Cat. 
I9766), taurolithocholic acid 3-sulfate (Cat. T0512), sodium cholate hydrate (Cat. C6445); 
TPEN (Cat. P4413), Ryanodine (Cat. SML1106) and FFP-18 K+ salt (Cat. 17089). 
Fluorescent dyes for calcium measurement: Fluo-4-AM (Cat. F14201), Fluo-5N-AM (Cat. 
F14204), Fura-2-AM (Cat. F1221), Texas Red® dextran (Cat. D1863) and Propidium Iodide 
(Cat. P3566) for cell death assays were obtained from ThermoFisher Scientific, 
Loughborough, UK. 
Type V Collagenase came from Worthington Biochemical Corporation (Cat. LS004194), 
Lakewood, NJ, USA. 
Trans-Ned-19 was purchased from Tocris Bioscience, Bristol, UK (Cat. 3954). 
Rabbit Anti-TPC1 (Cat. LS-C95184) and Anti-TPC2 (Cat. LS-C95187) polyclonal antibodies 
were obtained from LifeSpan BioSciences, Nottingham, UK.  
Rabbit Anti-RyR1 (Cat. AB9078, Anti-RyR2 (Cat. AB9080) and Anti-RyR3 (Cat. AB9082) 
polyclonal antibodies; Mouse IgG Negative Control antibody (Cat. CBL600B); and the 
compounds Thapsigargin (Cat. 586005) and ATP (Cat. 130124) were purchased from Merck 
Millipore, Watford, UK. 
Caffeine (Cat. 205548) was purchased from Calbiochem, Nottingham, UK. 
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Molecular biology dH2O (Cat. M830C), dNTPs Mix 10 mM (Cat. U151B), 5x GoTaq 
reaction buffer (Cat. M791B) and GoTaq DNA Polymerase (Cat. M830C) were purchased 
from Promega, Southampton, UK.  
Custom TPC2 primers were sourced from Eurofins Genomics, Ebersberg, Germany. 
GSK-7975A was provided by GlaxoSmithKline, Stevenage, United Kingdom; and is 
compound 36 from patent WO 2010/1222089. 
BZ194 was kind gift from Prof Barry Potter, University of Bath, and was synthesised as 
previously described (Dammermann et al. 2009). 
Unless otherwise stated all other chemicals were supplied by Sigma-Aldrich, Gillingham, 
UK. All stock solutions were created in either NaHEPES solution without supplemental Ca2+ 
or in DMSO depending on their solubility and stored at either -80, -20 or 4°C, when required 
stock solutions were protected from light. Unless stated all active solutions were prepared 
from stock solutions in NaHEPES solution supplemented with 1 mM Ca2+, active solutions 
made from stocks solutions in DMSO had a final DMSO concentration of 0.1% or less. 
Sodium cholate hydrate was made up on day of use. 
 
2.2 Animals  
Wild type male C57BL6/J mice were purchased from Charles Rivers, UK; and maintained 
under low barrier conditions on a 12 h light cycle on a standard rodent chow diet with free 
access to water. 
TPC2 knockout mice were a gift from Dr. John Parrington, Oxford University, and were 
created as previously described (Calcraft et al. 2009) using a gene trap strategy (Stryke et al. 
2003). A colony of TPCN2-/- mice produced from those supplied was maintained in-house 
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under low barrier conditions on a 12 h light cycle on a standard rodent chow diet with free 
access to water. Female TPCN2-/- mice were found to occasionally develop abdominal or 
uterine fluid filled cysts; both genders are also prone to over-grooming, resulting in areas of 
discoloured fur or bald patches (Fig. 2.2.1). After several generations the number of litters 
produced by the colony significantly decreased, suggesting fertility issues; to increase the 
yield several breeding pairs of wild type male C57BL6/J mice crossed with female TPCN2 -/- 
mice (which are from a C57BL6/J back ground) were established. The resultant male 
heterozygous offspring were then crossed with female TPCN2-/- mice to produce 
homozygous knockout offspring, these new TPCN2-/- mice showed no loss of breeding 
capacity. The genotype of each mouse in the colony was confirmed by PCR reaction, using 
specifically designed primers. 
RyR3 knockout mice were provided by Dr. K. Mikoshiba's Lab, Riken Brain Science 
Institute, Japan; and were created as previously described (Futatsugi et al. 1999). 
 
2.3 Genotyping  
Tissue samples were taken from mice in the TPCN2-/- colony by ear punching and stored at -
20°C until use. A PureLink® Genomic Mini Kit (ThermoFisher Scientific, Loughborough, 
UK; Cat. K182001), was used as described in the manufacturer’s manual to isolate DNA 
from the samples taken. 3 µl of DNA per sample was combined in a PCR tube with 34.25 µl 
Molecular biology dH2O, 10 µl DreamTaq Green Buffer, 1 µl dNTPs, 5 µl primer 1 
(CTTCGGAGCCTTCTTTCCTT), 5 µl primer 2 (CTGTCCCTGACGAGTGGTTT), 5 µl 
primer 3 (GTCGGGGCTGGCTTAACTATG) and 0.25 µl Taq polymerase. A TC-312 
Thermal Cycler A (Techne, Stone, UK) was programed to 5 min at 94 °C, then 30 cycles of 
94 °C for 15 s, 56 °C for 30 °C and 72 °C for 1 min; and finally 6 min at 72 °C. The  
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Fig. 2.2.1 Wild type and TPC2 knockout mice 
(A) Male wild type C57BL6/J mouse. (B) Male TPC2 knockout mouse (C57BL6/J 
background) with signs of over-grooming. 
 
 
 
 
Wt TPCN2-/- 
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amplified DNA was resolved on a 1% agarose gel for 30 min at 90 V and then photographed 
using a ChemiDoc™ XRS+ System (Bio-Rad Laboratories, Hercules, CA, USA). Mice were 
identified as wild type, heterozygous or TPCN2 null based on the number and location of 
bands on the gel (Fig. 2.3.1). 
 
2.4 Preparation of NaHEPES solution 
A standard extracellular buffered solution of ‘NaHEPES’ was prepared as follows: 140 mM 
sodium chloride; 4.7 mM potassium chloride 10 mM HEPES, free acid; 10 mM D(+)-
Glucose; 1 mM magnesium chloride. The pH was adjusted to 7.2 with sodium hydroxide. 
Unless otherwise stated 1 mM calcium chloride was added before use. The buffer solution 
was stored at 4°C and used within a week.                                                                      
 
2.5 Preparation of K-HEPES solution 
A standard intracellular buffered solution of ‘K-HEPES’ was prepared for use in 
permeabilization experiments as follows: 20 mM sodium chloride; 127 mM potassium 
chloride 10 mM HEPES, free acid; 2 mM ATP; 1 mM magnesium chloride; 0.1 mM EGTA; 
0.05 mM calcium chloride. The pH was adjusted to 7.2 with sodium hydroxide. The buffer 
solution prepared on the day of its use. 
 
2.6 Preparation of Collagenase 
 4000 U stock of type V collagenase was diluted with 20 ml of freshly prepared NaHEPES 
solution supplemented with 1 mM Ca2+ to produce a 200 U/ml solution, which was used to  
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Fig. 2.3.1 Genotyping results for the offspring of a Male TPC2 heterozygous and female 
TPC2 null homozygous breeding pair  
(A) Mendelian cross for the breeding pair used. (B) Gel electrophoresis image displaying the 
genotyping result for the resultant litter; two bands represent heterozygous offspring, while 
one band in the lower position represent TPC2 null offspring. 
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create 1 ml aliquots, which were stored at -20°C. The activity of each batch of collagenase 
was tested to ensure it was used optimally. 
 
2.7 Preparation of fluorescent calcium indicators 
2 mM stock solutions of all three Ca2+ indicators (Fluo-4-AM, Fluo-5N-AM and Fura-2-AM) 
were prepared in DMSO and divided into 5 µl aliquots for Fluo-5N-AM and Fura-2-AM, and 
4 µl aliquots for Fluo-4-AM. Stocks of the Ca2+ indicators protected from light and stored at -
20°C. 
 
2.8 Isolation of pancreatic acinar cells  
Preparations of acinar cells (single, or clusters of two or three cells) were isolated from the 
pancreases’ of wild type or knockout mice aged 1.5-3 months as previously described (Thorn 
et al. 1993). Mice were sacrificed in accordance with Schedule 1 of the Animal (Scientific 
Procedure) Ac, 1986, by cervical dislocation, and the pancreas was immediately excised. The 
organ was washed twice in Ca2+ supplemented NaHEPES solution, then injected with 1 ml of 
the type V collagenase stock. The pancreas and any excess collagenase solution was then 
placed in a snap-top tube and left to be digested for 15-17 min (dependant on the assayed 
activity of the specific batch of collagenase) in a water bath with an in-built shaker set to  
37°C and a low speed. Gentle pipetting was used to mechanically separate the tissue; isolated 
cells and clusters were then removed by separating the top fraction, with no visible fragments 
of tissue, into a 15 ml polystyrene tube from Sarstedt, Leicester, UK (Cat. 62.553.041). This 
was repeated several times, each time replacing the fraction removed with fresh NaHEPES 
solution, until several ml of cell solution was collected. The isolated cells were then pelleted 
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in a centrifuge for 1 min at 1200 g twice; replacing the supernatant with fresh buffer and 
resuspending the pellet between the spins. The final pellet was resuspended in 2 ml 
NaHEPES buffer for calcium measurement experiments and 3 ml buffer for necrosis assays.  
 
2.9 Calcium measurements in intact cells 
Freshly isolated acinar cells were loaded using the membrane permeable AM form of either 
of the calcium sensitive dyes Fluo-4 or Fura-2. The final concentrations of the dyes were 4 
µM Fluo-4 or 5 µM Fura-2 in DMSO (4 or 5 µl of 2 mM stock into 2 ml of cell suspension, 
respectively). Cells were incubated with the dye for 45 min at room temperature on an orbital 
shaker set to a low speed, whilst protected from light. 
After the incubation, loaded cells were pelleted in a centrifuge for 1 min at 1200 g and 
resuspended in 2ml of fresh NaHEPES buffer. The loaded cells were kept at room 
temperature, protected from light and used within 3-4 h of loading. 
For imaging experiments, 20 µl of loaded cell solution was placed on a 32 x 32 mm thickness 
No 1 glass coverslip purchased from VWR international, Lutterworth, UK (Cat. 631-0129) 
secured to a custom-made cell bath by silicone grease. During imaging experiments, reagents 
made up in NaHEPES buffer were perfused over cells using a custom-made gravity-fed 
perfusion system. 
 
2.10 Calcium measurements in permeabilized cells 
Freshly isolated acinar cells were loaded using the membrane preamble AM form of the 
calcium sensitive dye Fluo-5N. The final concentration of the dye was 5 µM Fluo-5N in 
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DMSO (5 µl of a 2 mM stock into 2 ml of cell suspension). Cells were incubated with the dye 
for 50 min in a water bath with an in-built shaker set to 37°C and a low speed, whilst 
protected from light. Under these loading conditions the dye preferentially accumulates 
within organelles, allowing for depletion of the calcium content of their lumens to be 
visualised. 
After the incubation, loaded cells were pelleted in a centrifuge for 1 min at 1200 g and 
resuspended in 2ml of fresh Na-HEPES buffer. The loaded cells were kept at room 
temperature, protected from light and used within 3-4 h of loading. 
20 µl of loaded cell solution was placed on a 32 x 32 mm thickness No 1 glass coverslip 
secured to a custom- made cell bath by silicone grease. Cells were permeabilized by two-
photon laser; then perfused by reagents made up in K-HEPES solution using a custom made 
gravity- feed perfusion system during imaging. Localised permeabilization of the plasma 
membrane results in loss of cytosolic content, including any dye not taken up by organelles, 
which is replaced by K-HEPES solution; intracellular stores remain intact and are loaded 
with Fluo-5N. 
For antibody blocking experiments, permeabilized cells were preincubated with the relevant 
antibody/antibodies for 20 min at a dilution of 1:100. 
 
2.11 Two-photon permeabilization  
The technique of two-photon permeabilization of pancreatic acinar cells was developed by 
our research group (Gerasimenko, Sherwood, et al. 2006) from a previously described 
protocol to temporarily perforate mammalian cells for in vitro transfection of foreign DNA 
(Tirlapur and König 2002). Before the cells were permeabilized they were perfused with K-
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HEPES to replace the NaHEPES they were prepared in; and then incubated with 1 µM of the 
‘near membrane’ Ca2+ indicator FFP-18 for 5 min prior to permeabilization to help pore 
formation. A small area, preferentially in the apical region of the cell, was then selected and 
exposed to a high intensity two-photon laser beam from a Mai Tai two-photon laser 
(Spectraphysics, Didcot, UK) in pulse mode at between 720-760 nm with a 100 fs width for 
1-3 frames. Creation of a membrane pore by permeabilization was confirmed by monitoring 
the uptake of fluorescence of the membrane impermeable dye Texas Red dextran added to the 
extracellular medium. Conformation of the pore’s stability was then confirmed by washing 
the dextran dye out of the cell by perfusion. 
 
2.12 Cell death assay 
Levels of necrosis were assessed as previously described (Ferdek et al. 2012). Post isolation, 
the cell preparation produced was separated in 0.5 ml volumes and exposed to selected 
reagents at their required concentrations for a 1 h period at room temperature on orbital 
shaker set to a low speed or in a water bath with an in-built shaker set to 37°C and low speed. 
The start of each treatment was staggered by 15 min from the previous to allow for imaging 
of the previous treatment. 6 µM Propidium Iodide was added and mixed by gentle pipetting 
directly before imaging. 20 µl of cell solution was place on a 32 x32 mm thickness No 1 glass 
coverslip secured to a custom made cell bath by silicone grease. Multiple pictures were taken 
over a 10 min period with a minimum of 20 pictures taken per treatment. 
 
2.13 Equipment 
Cell imaging and cytosolic calcium measurements with Fluo-4 were performed using: (1) a 
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Leica SP5 MP inverted confocal microscope system (Leica Microsystems AG, Wetzlar, 
Germany) with a x63 1.2 NA water objective using the Leica software, LAS X.  (2) a Leica 
DMI 4000B inverted confocal microscope with a x63 1.2 NA oil objective using the Leica 
software, LAS X. (3) a custom built Carl Ziess ZEN 2011 TIRF System with Axio 
Observer.Z1 inverted microscope, CSU-X1 Spinning Disc Unit (Carl Zeiss Ltd., Cambridge, 
UK), an Evolve 512 Delta EMCCD camera (Photometrics, Tucson, AZ, USA)  and a x63 1.2 
NA oil objective using the Ziess software, Zen blue. For all systems fluorescence was excited 
at 488 nm and emission collected between 510-640 nm. 
Cell imaging and cytosolic calcium measurements with Fluo-5N were performed using a 
Leica SP5 MP inverted confocal microscope system with a x63 1.2 NA water objective using 
the Leica software, LAS X. Fluorescence was excited at 476 nm and emission collected 
between 500-600 nm.         
Cell imaging and cytosolic calcium measurements with Fura-2 were performed using a Nikon 
Diaphot 200 inverted microscope system (Nikon Instruments, Kingston-Upon-Thames, UK) 
with a x40 oil objective using Image-Pro software (Media Cybernetics, Rockville, MA, 
USA). Cells were excited at 355 and 385 nm and emission recorded between 510-550 nm.  
Necrosis experiments were performed using a Carl Zeiss ZEN 2011 TIRF System with Axio 
Observer Z1 Inverted Microscope, CSU-X1 Spinning Disc Unit, an Evolve 512 Delta 
EMCCD camera (Photometrics, Tucson, AZ, USA)  and a x63 1.2 NA oil objective using the 
Zeiss software, Zen blue. Propidium Iodide was excited at 514 nm and emission was recorded 
at 629 nm, additionally a bright-field image was taken. 
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2.14 Data analysis  
To allow for comparison between experiments; all calcium measurements were conducted 
using identical laser power, photomultiplier sensitivity and were processed using identical 
values for contrast and brightness.  
For experiments conducted using Fluo-4 or Fluo-5N the data produced was normalised by 
dividing the fluorescence by the initial fluorescence (F/F0). When using Fura-2 the ratio of 
fluorescence when cells were excited at 355 nm and at 385 nm was calculated (F355:F385) and 
then normalised by dividing by the initial fluorescence ratio (which can be simplified to 
R/R0). 
For comparative analysis of Ca2+ responses, areas under individual traces recorded between 
the periods stated in the text were calculated and then averaged (for experiments using Fluo-
5N values were multiplied by -1 to obtain a positive value) and presented as bar charts with 
standard errors.  
For cell death assays, a minimum of three experiments using cells isolated from different 
animals were performed, with a maximum of five treatments tested per experiment. The 
number of viable and necrotic cells were then counted by eye based on the Propidium iodide 
staining observed, and the percentage of necrotic cells in each treatment for every experiment 
was calculated. Average values and standard errors of the mean were calculated and results 
presented as bar charts.  
Statistical analysis was performed using ANOVA or Student's t-test, with two-tailed 
distribution and two-sample unequal variance (heteroscedastic) as its parameters. The 
significance threshold was set at 0.05. Where applicable, n indicates the total number of 
individual cells recorded/counted for the data displayed. 
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2.15 Software 
LAS X, Zen blue and Image-Pro software were used with their respective microscope 
systems to program experiments; collect recordings of fluorescence in real time and calculate 
the intensity of regions of interest; and take fluorescent and bright field images. 
Microsoft Word 2016 was used to write and edit this report. Microsoft Excel 2013 and 2016, 
and GraphPad Prism version 7.03 were used to view and edit data, prepare graphs and charts, 
make calculations and perform statistical analysis. Microsoft PowerPoint 2016 was used to 
produce and edit some images. The free referencing software Zotero version 4.0.29.17 was 
used to insert references and compile the bibliography with the addition of the ‘Cardiff 
University – Harvard’ referencing format application; the required plugins for Word and the 
Google Chrome web browser were installed. 
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Chapter 3: NAADP-induced calcium release from intracellular organelle stores requires 
the activity of both ryanodine receptors and two-pore channels 
 
3.1: Overview of NAADP-induced calcium release in pancreatic acinar cells  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
The function of PAC is to synthesise digestive enzymes in their inactive proenzyme form, 
store them in zymogen granules and then secrete them when required. Secretion is triggered 
by either of the external signals, the neurotransmitter ACh or the hormone CCK binding to 
their respective cell surface receptors (Mukherjee et al. 2008). These external signallers are 
then converted into an internal one via the production of intracellular secondary calcium 
messengers (Zhao et al. 2012). IP3 is produced in response to ACh by the activation of 
phospholipase C, while CCK stimulates the production of both cADPR and NAADP via an 
ADPR cyclase believed to be CD38. The secondary messengers then trigger the release of 
Ca2+ from organelle stores, which in turn drives the secretion process. 
IP3 and cADPR are known to act on IP3R and RyR respectively, mobilising Ca2+ stored in the 
lumen of the ER. The action of NAADP has been harder to characterise however, with 
several different channels identified as possible candidates (Hohenegger et al. 2002; Calcraft 
et al. 2009; Zhang et al. 2009). Though the suitability of each of these candidates fulfilling 
the role of a NAADP-sensitive Ca2+ channel has been questioned (Copello et al. 2001; Pryor 
et al. 2006; Wang et al. 2012), leading to disagreement within the field. The most recently 
identified candidate, the TPC family of proteins (Calcraft et al. 2009), is currently believed 
by many to fulfil the role. However, it has been shown that these channels do not interact 
directly with NAADP (Lin-Moshier et al. 2012), but instead must do so via one or more 
separate NAADP-binding proteins.  
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Fig 3.1.1 NAADP induced calcium release from a calcium store in the nuclear envelope 
of isolate nuclei from pancreatic acinar cells 
(A) Representative trace showing NAADP induces the release of calcium from the nuclear 
envelope, depleting the stores calcium content. (B) Representative trace showing the IP3R 
antagonist 2-APB has no effect on NAADP’s ability to mobilise calcium from the nuclear 
envelope. (C) and (D) Representative traces showing inhibition of RyR by either ryanodine 
or ruthenium red prevented NAADP-induced calcium release from the nuclear envelope.  
 
 
Modified with permission © 2003 JV GERASIMENKO et al. The Journal of Cell Biology 163(2):271-82 
DOI: 10.1083/jcb.200306134 (Gerasimenko et al. 2003) 
B 
C D 
A 
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Fig 3.1.1 (continued) 
(E) Representative trace showing refiling of the nuclear envelope store was inhibited in the 
absence of ATP, as IP3 failed to elicit a response after NAADP was removed. (F) 
Representative trace showing NAADP failed to induce a secondary response after the nuclear 
envelope store was depleted by Tg. (G) and (H) Representative traces showing NAADP was 
able to induce an increase in the amount of calcium in the nucleoplasm even after acidic 
stores were disrupted by the use of either bafilomycin A1 or nigericin. 
 
Modified with permission © 2003 JV GERASIMENKO et al. The Journal of Cell Biology 163(2):271-82 
DOI: 10.1083/jcb.200306134 (Gerasimenko et al. 2003) 
E F 
G H 
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This requirement for a separate NAADP-binding protein opens the possibility for a greater 
complexity to NAADP signalling than if it acted directly on an ion channel. Potentially there 
could be multiple such binding proteins and therefore cell specific expression and interactions 
with more than one type of ion channel is conceivable. Such a possibility would explain the 
findings of Gerasimenko et al., who have shown that NAADP can mobilise Ca2+ through 
RyR (Gerasimenko et al. 2003) and from the ER (Gerasimenko, Sherwood, et al. 2006).   
In one study Gerasimenko et al. used centrifugation to isolate nuclei from PAC to study the 
effect of NAADP on the organelle (Gerasimenko et al. 2003). Nuclei were loaded with Mag-
Fura Red, a low affinity Ca2+ sensitive dye, to visualise depletion of Ca2+ from within the 
nuclear envelope or with Fluo-4 dextran to visualise Ca2+ increases in the nucleoplasm. Like 
the other secondary messengers NAADP was able to deplete the [Ca2+]l (Fig 3.1.1A), though 
showed auto-inhibition when its concentration exceeded 10 µM. The presence of an auto-
inhibitory concentration of NAADP did not block release of Ca2+ from the nuclear envelope 
induced by either IP3 or cADPR. NAADP-induced depletion of the envelope store was 
insensitive to the IP3R inhibitor 2-APB (Fig 3.1.1B), but was sensitive to both ryanodine and 
ruthenium red (Fig 3.1.1C and D), inhibitors of RyR. These results imply that NAADP 
mobilises Ca2+ from the lumen of the nuclear envelope via RyR; though via a mechanism 
distinct from cADPR, which also acts on these channels. 
Reloading of the envelope store after NAADP-induced depletion was inhibited in the absence 
of ATP (Fig 3.1.1E) and NAADP failed to elicit a response after the store was emptied by Tg 
(Fig 3.1.1F); indicating that NAADP’s effect on the nuclear envelope is dependent on the 
activity of the SERCA Ca2+ pump. Bafilomycin A1, an inhibitor of the vacuolar H+ ATPase, 
and the protonophore nigericin both disrupt acidic Ca2+ stores and are known to inhibit 
NAADP-induced Ca2+ release in some cell types (Davis et al. 2012). However neither of  
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Fig 3.1.2 NAADP only induces alcium 
release form the apical granule area of 
permeabilized pancreatic acinar cells 
after the ER store is depleted by 
thapsigargin 
(A) Representative trace of a whole cell 
recoding showing NAADP induced 
calcium release was substantially reduced 
after the ER calcium store was depleted 
by Tg. (B) The corresponding trace of the 
highlighted time period on trace (A) 
when the region of interest (ROI) was 
solely place in the apical granular region. 
(C) Average trances from the highlighted 
final 100 s period of traces (B) and (D) (n 
= 20). (D) The corresponding trace of the 
highlighted time period on trace (A) 
when the ROI was solely place in the 
basal region.  
 
 
 
Adapted with permission from JV Gerasimenko; Journal Cell Science; 2006 (Gerasimenko, Sherwood, et al. 
2006). 
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these agents had any effect on NAADP’s ability to mobilise Ca2+ from the nuclear envelope 
(Fig 3.1.1G and H). These results conflict with the belief held by some that NAADP can only 
induce Ca2+ release from a non-ER, Tg-insensitive acidic store (Galione and Churchill 2002). 
The outer nuclear envelope is continuous with the ER membrane, containing the same Ca2+ 
channels and pumps, and therefore should act in a similar manner to the ER. As NAADP 
induced release from the isolated nuclei was insensitive to inhibitors of Ca2+ release from 
acidic stores any argument of a native acidic store or contamination by a non-nuclei acid 
store can be dismissed. The function of a Ca2+ store within the nuclear envelope that is 
sensitive to the activity of secondary messengers, is likely to drive gene transcription by 
inducing localised increases of Ca2+ within the nucleoplasm. As these messengers are 
produced in response to secretagogues it is possible that this would trigger the synthesis of 
new digestive enzymes to replace those secreted by the cell in response to the same incident 
of cell stimulation. 
In a second study Gerasimenko et al. (Gerasimenko, Sherwood, et al. 2006) examined the 
activity of all three secondary Ca2+ messengers on release from both the ER and acidic stores 
in PAC. The acidic store can be isolated from the ER one by first depleting the ER store 
using Tg and then applying a stimulus after a new baseline is established. Under such 
circumstances all three secondary messengers were still able to mobilize a small amount of 
Ca2+, with NAADP having a greater effect than the other two messengers. NAADP induced 
release was specific to the apical granular region of the cell, with none observed in the basal 
region (Fig 3.1.2). Conversely the ER store can be isolated in a similar manner using either 
bafilomycin A1 or nigericin to deplete the cells acidic stores. Under such conditions both 
NAADP and IP3 were still able to mobilize Ca2+ (Fig 3.1.3A and B); however, when Tg was 
used in combination with either bafilomycin A1 or nigericin neither messenger had any effect  
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Fig 3.1.3 NAADP can induce calcium release from a none acidic calcium store in 
permeabilized pancreatic acinar cells  
(A) and (B) Representative traces of whole cell recordings showing NAADP was able to 
induce a release of calcium from a none acidic store after the acid store was disrupted by the 
use of either nigericin or bafilomycin A1. (C) and (D) Representative traces of whole cell 
recordings showing that depletion of both the ER and acidic calcium stores by thapsigargin 
with either nigericin or bafilomycin A1 inhibited NAADP-induced calcium release.  
Adapted with permission from JV Gerasimenko; Journal Cell Science; 2006 (Gerasimenko, Sherwood, et al. 
2006)  
B 
C D 
A 
  
117 
 
(Fig 3.1.3C and D). 
Use of GPN or brefeldin A to disrupt lysosomes and the Golgi body respectively, in 
combination with thapsigargin had no effect on NAADP-induced Ca2+ release. This suggests 
that neither of these type of acidic organelle is the store that NAADP acts on. The most 
probable candidate for the store is therefore the secretory zymogen granules, a type of 
organelle specific to PAC that is present only in the apical region of the cell and in a suitably 
large number to explain the size of the acidic pool in this region of the cell. These results 
indicate that in PAC all three secondary Ca2+ messengers can mobilize Ca2+ from both the ER 
and an acidic store. This contradicts the conventional model of secondary messenger induced 
Ca2+ release, where IP3 and cADPR only release Ca2+ from the ER while NAADP acts on a 
separate acidic store, believed to be lysosomes. This pattern of signalling reported might be 
unique to PAC due to their large pool of a type of acidc organelle specific to this cell type, 
the zymogen granules. IP3R and RyR, which typically exhibit an ER location, could be 
present on these unique PAC organelles due to the high rate of ER turnover required to 
produce the large number of these vesicles. Combined with the potential for there being 
NAADP binding proteins specifically expressed in PAC, this would explain any contradiction 
is secondary messenger activity.  
NAADP-induced Ca2+ releases in the apical region of the cell was completely abolished in 
the presence of ryanodine or RR (Fig 3.1.4A and B), indicating a key role for RyR in this 
process. When the Ca2+ concentration was clamped to prevent CICR, NAADP was unable to 
induce a response in the presence of thapsigargin (Fig 3.1.4D), while IP3 and cADPR were 
still able to. In the absence of thapsigargin NAADP was still able to mobilize Ca2+ (Fig 
3.1.4C); this suggests NAADP acts via different mechanisms on the two stores, with release 
from the acidic stores dependent on CICR. Like the Ca2+ release seen from the nuclear  
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Fig 3.1.4 NAADP-induced calcium release in permeabilized pancreatic acinar cells 
utilizes ryanodine receptors and calcium-induced calcium release   
(A) and (B) Representative traces of the granular area showing NAADP-induced calcium 
release was inhibited by ryanodine and ruthenium red, both inhibitors of RyR. (C) 
Representative trace of a whole cell recording showing NAADP is still able to mobalise 
calcium when the calcium concentration was clamped at 100 nM using a calcium/BAPTA 
mixture with a high concentration of BAPTA to prevent calcium-induced calcium release. 
(D) Representative trace of a whole cell recording showing NAADP is unable to mobilise 
calcium when the ER store is depleted by thapsigargin and calcium concentration clamped at 
100 nM.  
Adapted with permission from JV Gerasimenko; Journal Cell Science; 2006 (Gerasimenko, Sherwood, et al. 
2006) 
A B 
C D 
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envelope, NAADP and cADPR release from the acid store suggests the two messengers 
employ different mechanisms of action despite both involving RyR, as cADPR-induced 
release was not dependent on CICR. 
Calibration experiments using ionomycin to estimate the size of the two stores suggest that 
while in the whole cell the ER store is twice the size of the acidic one (Gerasimenko, 
Sherwood, et al. 2006), in the apical region where the majority of secondary messenger 
signalling is thought to occur the size of the two stores is larger than the ER one. A large 
acidic Ca2+ store in the apical region of PAC that is sensitive to all three secondary Ca2+ 
messengers would be useful in this cell type; localised Ca2+ release from these organelles 
could drive the migration, docking and membrane fusion required for them to secrete the pro-
enzymes they contain. Since these two studies, the TPC family of ion channels located with 
the endolysosome system have been identified as potential NAADP sensitive Ca2+ channels. 
While disruption of lysosomes with GPN was found to have no effect on NAADP-induced 
Ca2+ release from the acidic store in PAC (Gerasimenko, Sherwood, et al. 2006) it is 
important to clarify if these ion channels play a role in PACs response to NAADP. 
 
3.2 TPC and RyR isoform requirements for NAADP activity in pancreatic acinar cells  
PACs from either wild type or knockout animals were loaded with Fluo-5N and 
permeabilized via a two-photon laser to visualise the amount of Ca2+ within organelle stores. 
As previously shown NAADP induced a decrease in intensity corresponding to a reduction in 
the amount of Ca2+ within stores (Fig 3.2.1A). In the presence of the NAADP specific 
antagonist Ned-19 this release was significantly reduced, down to 32.2% compared to when 
Ned-19 was not present, though a complete inhibition was not observed (Fig 3.2.1B). As 
expected due to Ned-19’s specificity, it had no significant effect on either cADPR or IP3-  
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Fig 3.2.1 The effect of Ned-19 on secondary messenger induced calcium release in 
permeabilized pancreatic acinar cells 
(A) Representative trace of the effect of 100 nM NAADP on store calcium in permeabilized 
pancreatic acinar cells. (B) Representative trace of the effect of 100 nM NAADP followed by 
10 µM IP3 on store calcium in permeabilized pancreatic acinar cells in the presence of 100 
µM Ned-19. (C) Representative trace of the effect of 10 µM cADPR on store calcium in 
permeabilized pancreatic acinar cells. (D) Representative trace of the effect of 10 µM cADPR 
followed by 10 µM IP3 on store calcium in permeabilized pancreatic acinar cells in the 
presence of 100 µM Ned-19.  
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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Fig 3.2.1 (continued) 
(E) Summary of data comparison of secondary messenger induced calcium release from 
stores in permeabilized pancreatic acinar cells with and without the presence of Ned-19. 
NAADP (control 26.7 ± 1.8%, n = 13; with Ned-19 8.6 ± 1.1, n = 5, p = 0.00002), cADPR 
(control 21.2 ± 0.9%, n = 10; with Ned-19 18.3 ± 0.9%, n = 4; p = 0.1) or IP3 (control 
23.6 ± 1.5%, n = 11; with Ned-19 21.2 ± 1.1%, n = 6, p = 0.3) Error bars represent ± SEM.  
 
 
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
* 
n/s 
n/s 
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induced Ca2+ release (Fig 3.2.1D and E). 
The importance of TPC channels in the response to NAADP was tested by inhibiting their 
activity via either allosteric inhibition via pore targeted antibodies or the use of PAC from 
TPCN2-/- mice. The response to NAADP in TPCN2-/- cells (Fig 3.2.2B) was 36% the size of 
that in wild type cells (Fig 3.2.2 A), a similar decrease of 72% was observed in wild type 
cells preincubated with a TPC2 antibody after permeabilization (Fig 3.2.2C). The antibody’s 
blocking activity was specific against NAADP-induced Ca2+ release as it had no significant 
effect on IP3 or cADPR’s ability to mobilize Ca2+ (Fig 3.2.2E). Inhibition of TPC1 by its 
antibody produced a less drastic effect, reducing the NAADP response to 75.5% of the 
control (Fig 3.2.2D). Use of the TPC1 antibody either in combination with the TPC2 
antibody or TPCN2-/- cells resulted in a similar level of inhibition down to 19.4% and 14.3% 
respectively (Fig 3.2.2F).  These results suggest that while both TPC isoforms form part of 
the PAC’s response to NAADP, there is a much greater requirement of the TPC2 isoform.  
As TPC proteins have been shown to be expressed on acidic organelles, the ER’s Ca2+ 
content was depleted by thapsigargin to prevent CICR enhancing responses from acidic 
stores. Under such conditions antibody blockade of TPC1 resulted in a non-significant 
reduction in the NAADP response from the control, however blockage of TPC2 reduced the 
response to 19.1% of the control (Fig 3.2.2G). Inhibition of both TPC isoforms by antibodies 
further reduced the response to 7% of the control; confirming the previous findings that 
NAADP can moblise Ca2+ via TPC channels in PAC, with TPC2 having a much greater role 
than TPC1. 
As NAADP activity displayed different requirements for the two TPC isoforms it was 
decided if there was a similar varying requirement of the three isoforms of RyR; which have 
previously shown to play a key role in NAADP induced Ca2+ release in PAC. Cells from  
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Fig 3.2.2 TPC channels are involved in NAADP-induced calcium release in 
permeabilized pancreatic acinar cells 
(A) Representative trace of the effect of 100 nM NAADP on permeabilized pancreatic acinar 
cells from wild type mice (n = 13). (B) Representative trace of the effect of 100 nM NAADP 
on permeabilized pancreatic acinar cells from TPC2 knockout mice (n = 5). (C) 
Representative trace of the effect of 100 nM NAADP on permeabilized pancreatic acinar 
cells from wild type mice after pre-treatment with a TPC2 antibody (20 min 1:100) (n = 8). 
(D) Representative trace of the effect of 100 nM NAADP on permeabilized pancreatic acinar 
cells from TPCN2 Knockout mice after pre-treatment with a TPC1 antibody (20 min 1:100) 
(n = 11).  
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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Fig 3.2.2 (continued)  
(E) Summary of data comparison of the amplitudes of responses to secondary calcium 
messengers in permeabilized pancreatic acinar cells with and without the presence of the 
TPC2 antibody. 100 nM NAADP (n = 13 control; n = 8 with TPC2 antibody treatment), 
10 μM IP3 (n = 9 control; n = 8 with TPC2 antibody treatment) or 10 μM cADPR (n = 9 
control; n = 5 with TPC2 antibody treatment). (F) Summary of the role the two TPC isoforms 
play in NAADP-induced calcium release in permeabilized pancreatic acinar cells.  A TPC1 
antibody (20.6 ± 0.7%, n = 11) or TPC2 antibody (7.6 ± 1%, SEM, n = 8) were used alone or 
in a mixture of the two (5.3 ± 0.2%, n = 4), in cells from wild type mice compared to 
responses in permeabilized cells isolated from TPC2 KO mice and treated (3.9 ± 0.3%, n = 7) 
or non-treated with TPC1 antibody (9.8 ± 1.0%, n = 5). 
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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Fig 3.2.2 (continued)  
(G) Summary of the role the two TPC isoforms play in NAADP-induced calcium release 
after ER store depletion by 10 µM thapsigargin in permeabilized pancreatic acinar cells; in 
the presence of a TPC1 antibody (9.8 ± 0.5%, n = 5, p > 0.08), or aTPC2 antibody 
(1.63 ± 0.3%, n = 6), or a mixture of both (0.83 ± 0.1%, n = 6), or a mixture of antibodies 
against RyR1 and RyR3 (0.75 ± 0.1%, n = 5) as compared to control NAADP responses 
(12.4 ± 1.1%, n = 5). Error bars represent ± SEM. Cells were loaded with Fluo-5N in AM 
form.  
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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RyR3-/- mice show a reduction of about 52% compared to wild type cells (Fig 3.2.3B), and 
when used in combination with a RyR1 pore-blocking antibody increased this inhibition to 
90% (Fig 3.2.3C).  Use of the RyR1 alone resulted in the NAADP response being reduced to 
approximately 18.7% of the control (Fig 3.2.3E). Antibody blockade of RyR3 produced a 
less significant inhibition of the NAADP response (Fig 3.2.4C), while doing so for RyR2 had 
no significant effect (Fig 3.2.4C). Combining antibodies for RyR1 and RyR2 showed no 
additional inhibition compared to using the RyR1 antibody alone (Fig 3.2.4G), reducing the 
response to 17.4% of the control. A combination of RyR1 and RyR3 did however show an 
additive effect, with a 93.0% reduction compared to the control (Fig 3.2.4G). This inhibition 
was only slightly enhanced to 95.2% when all antibodies for all three RyR isoforms were 
utilised (Fig 3.2.4G). Use of antibodies for RyR1 and RyR3 after the ER was depleted by 
thapsigargin showed a 94% inhibition of the control NAADP response (Fig 3.2.2G), a level 
nearly identical to when both TPC1 and TPC2 were blocked. These results suggest that there 
is a variable requirement of RyR isoforms for NAADP induced Ca2+ release in PAC with the 
type 1 isoform the most important and type 2 having minimal involvement.  
As NAADP’s Ca2+ mobilizing activity had displayed a clear preference for certain RyR 
isoform it is logical that cADPR, which also has been shown to act via this family of ion 
channels, might do so. Blocking RyR1 had a much less significant effect against cADPR than 
NAADP, with a response 70.0% of the control observed (Fig 3.2.3E). The effect of blocking 
RyR2 was much more significant for cADPR, inhibiting the response by about 54.8% (Fig 
3.2.4D). The combination of RyR1 and RyR3 antibodies that was most effective against 
NAADP only produced a 49.3% inhibition against cADPR (Fig 3.2.4G), with a similar 49% 
inhibition seen when RyR3-/- cells were used in combination with the RyR1 antibody (Fig 
3.2.3D). The combination of RyR1 and RyR2 antibodies proved highly effective, displaying  
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Fig 3.2.3 NAADP-induced calcium release is reduced in permeabilized pancreatic acinar 
cells isolated from RyR3 knockout mice 
(A) Representative trace of the effect of 100 nM NAADP on permeabilized pancreatic acinar 
cells from wild type mice (n = 12). (B) Representative trace of the effect of 100 nM NAADP 
on permeabilized pancreatic acinar cells from RyR3 knockout mice (n = 8). (C) 
Representative trace of the effect of 100 nM NAADP on permeabilized pancreatic acinar 
cells RyR3 knockout mice after pre-treatment with a RyR1 antibody (20 min 1:100) (n = 10). 
(D) Representative trace of the effect of 10 µM cADPR on permeabilized pancreatic acinar 
cells from RyR3 knockout mice after pre-treatment with a RyR1 antibody (20 min 1:100) (n 
= 9).  
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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Fig 3.2.3 (continued) 
(E) Summary of data comparison of the amplitudes of responses to secondary calcium 
messengers and thapsigargin (10 µM) in permeabilized pancreatic acinar cells from wild type 
and RyR3 knockout mice, with and without RyR1 antibody pre-treatment (n > 4 for each 
group). Data represent mean values ± SEM.  
 
 
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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an 83.4% inhibition (Fig 3.2.4G). Antibody blocking of all three RyR isoforms had the 
greatest effect, reducing the response to 10.6% of the control (Fig 3.2.4B). Together these 
results suggest that cADPR-induced Ca2+ release in PAC is highly dependent on the type 2 
isoform of RyR, with a small involvement of the type 1 and minimal involvement of the type 
3 isoforms. This would mean that despite both NAADP and cADPR utilising all three 
isoforms of RyR there is a clear segregation of the two messenger’s effects by the respective 
involvements of the various isoforms.  
Genetic knockout of RyR3 or inhibition of any of the three RyR isoforms had no significant 
effect on IP3’s ability to mobilize Ca2+ from stores within PAC (Fig 3.2.3E and Fig 3.2.4G). 
Neither did they have any effect on the amount of Ca2+ within organelle stores, observed by 
emptying them by using either thapsigargin (Fig 3.2.3E) or TPEN (Fig 3.2.4G).  
To compare the relative importance of RyR and TPC proteins in PAC’s response to NAADP 
their activity was blocked; ryanodine or antibodies for all three RyR isoforms were used to 
inhibit RyR activity, and a combination of antibodies for both TPC isoforms or TPC2 -/- cells 
with TPC1 antibodies was used to inhibit the activity of TPC channels (Fig 3.2.5). Inhibition 
of RyR by either method had a greater effect than inhibition of TPC channels, with the RyR 
antibody mixture displaying a 95% inhibition of NAADP-induced release. A smaller effect 
was observed when both TPCs were inhibited; using antibodies alone produced an 80% 
inhibition and the combination of TPC1 antibody and TPCN2-/- cells an 86% inhibition. 
These results show that while inhibiting TPCs significantly reduces the response to NAADP 
in PAC, inhibition of RyR causes a near complete inhibition. This could be due to RyR 
potentially acting as both an NAADP sensitive ion channel and being able to enhance any 
response to NAADP through CICR, while TPC’s act only as a NAADP sensitive channel. 
Interestingly 100 µM Ned-19, a concentration shown to inhibit NAADP responses in several  
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Fig 3.2.4 NAADP and cADPR-induced calcium release in permeabilized pancreatic 
acinar cells is inhibited by antibodies for different RyR isoforms  
(A) Representative trace of the effect of 100 nM NAADP in the presence or absence of a 
RyR1 antibody (20 min 1:100) followed by 10 µM IP3 (n = 5). (B) Representative trace of the 
effect of 10 µM cADPR in the presence or absence of a mixture of antibodies for all three 
RyR isoforms (20 min 1:100) (n = 3). (C) Representative trace of the effect of 100 nM 
NAADP after pre-treatment with a RyR2 antibody (20 min 1:100) (n = 6). (D) Representative 
trace of the effect of 10 µM cADPR after pre-treatment with a RyR2 (20 min 1:100) (n = 5).  
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
  
131 
 
 
 
Fig 3.2.4 (continued) 
(E) Representative trace of the effect of 100 nM NAADP after pre-treatment with a RyR3 
antibody (20 min 1:100) (n = 5). (F) Representative trace of the effect of 10 µM cADPR 
followed by 10 µM IP3 after pre-treatment with a RyR2 (20 min 1:100) (n = 4). (E) Summary 
of data comparison of the amplitudes of responses to secondary calcium messengers and 
TPEN (200 µM) in permeabilized pancreatic acinar cells from wild type and mice, with and 
without pre-treatment using antibodies for the three RyR isoforms applied either alone or in 
combination (n > 4 for each group). Data represent mean values ± SEM.  
 
Modified under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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cell types, only showed a 68% inhibition, and was therefore less effective than inhibiting 
either family of ion channel. 
 
3.3 Discussion 
NAADP is produced by PAC in response to the external stimulus CCK and drives fluid 
secretion in this cell type (Mukherjee et al. 2008). Classically, it has been believed that 
NAADP can only mobilise Ca2+ from a small acidic store distinct from the ER, this initial 
release then triggers the release of Ca2+ from the larger ER store via CICR amplifying the 
response to NAADP (Churchill and Galione 2001). Gerasimenko et al. have previously 
shown that this might not be the case in PAC, where they have previously shown NAADP 
induced release independent of acidic stores (Gerasimenko, Sherwood, et al. 2006) and in a 
RyR dependent manner (Gerasimenko et al. 2003). 
The results above expand on this and show the involvement of the TPC family of ion 
channels in NAADP-induced Ca2+ release within PAC, with a much greater involvement of 
the TPC2 isoform than the TPC1 isoform (Fig 3.2.2). The activity of these channels is unique 
to the response to NAADP, and show no involvement in either IP3 or cADPR induced 
release. The previous finding that RyRs play a key role in NAADP’s activity (Gerasimenko, 
Sherwood, et al. 2006) are also supported, again in an isoform specific manner (Fig 3.2.3 and 
Fig 3.2.4). Inhibition of either TPC channels or RyR failed to produce a complete inhibition 
of NAADP activity, though a combined inhibition of both families of ion channel was not 
tested and may provide a complete inhibition. While inhibition of TPC channels was found to 
provide a near complete inhibition of NAADP-induced release from acidic stores (Fig 
3.2.2G), blocking their activity only showed a maximum of an 86% inhibition of the whole 
cells response to NAADP (Fig 3.2.5). This suggests that while these channels play a key role  
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Fig 3.2.5 Comparison of the relative importance of the RyR and TPC families of ion 
channels for NAADP-induced calcium release in permeabilized pancreatic acinar cells  
Calcium responses were measured in permeabilized pancreatic acinar cells from wild type 
mice were exposed to either NAADP alone (27.3 ± 1.8%, n = 12); in presence of either 
100 μM Ryanodine (0.71 ± 0.30%, n = 7) or Ned-19 (8.6 ± 1.12%, n = 5); or after pre-
treatment with a mixture of antibodies for either all three RyR isoform (1.27 ± 0.15%, n = 3) 
or both TPC isoform (5.3 ± 0.24%, n = 7). Calcium responses were also measured in 
permeabilized pancreatic acinar cells from TPC2 knockout mice after pre-treatment with a 
TPC1 antibody (3.9 ± 0.27%, n = 7). Error bars show ± SEM.  
 
Reproduced under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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in NAADP’s activity there is a separate independent mechanism through which NAADP can 
act on a none acidic store. This would support previous findings that NAADP can directly 
mobilise Ca2+ from the ER in PAC (Gerasimenko, Sherwood, et al. 2006) and T-cells via 
RyR (Dammermann and Guse 2005). Futher corroboration could be provided by examining 
the effect of blocking RyR’s after emptying acidic stores using either bafilomycin A1 or 
nigericin. Blockade of RyR1 and RyR3 also provided a near complete inhibition of NAADP-
induced Ca2+ release from acidic stores, this would suggest that any Ca2+ mobilized via TPC 
channels is further enhanced via CICR through RyR’s present in the membranes of the acidic 
zymogen granules.  
When inhibiting the activity of both TPC channels a greater inhibition was observed when 
cells from TPCN2-/- mice were used in combination with a TPC1 pore-targeted antibody 
compared to when antibodies for both isoforms were used in wild type PACs (Fig 3.2.2F and 
Fig 3.2.5). This difference is possibly because knocking the channel out physically removes it 
from the cell, thereby completely preventing its activity; whereas treatment with pore-
targeted antibodies may not provide a complete inhibition, as not all of the target channels 
may be bound by antibodies. Therefore, an improvement to the techniques utilised in this 
study would have been to have used PAC cells from TPCN1-/- mice (Ruas et al. 2014) and 
from the TPCN1/2-/- double knockout mouse (Ruas et al. 2015). Use of cells from these mice 
would ensure the most efficient inhibition of the target channels activity was achieved. It 
should be noted that, due to the diverse range of cellular functions NAADP had been shown 
to play a role in (Lee 2001), the viability of TPCN1/2-/- double knockout mice suggests that 
NAADP may also be able to act via a TPC independent process, like observed in PACs. 
The size of the response to cADPR in PAC (Fig 3.2.4G) was 79.5% the size of that of the 
NAADP (Fig 3.2.3A). This could be the result of NAADP-induced Ca2+ release involveing 
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both TPC and RyR, while cADPR-induced release involves only RyR. Alternatively, it could 
be because Ca2+ release induced by the two secondary messengers has differing involvements 
of the three RyR isoforms. Gerasimenko et al. had previously described that the two 
messengers did not act in the same manner despite their responses both utilising RyR. 
cADPR-induced release from the nuclear envelope was insensitive to an auto-inhibitory 
concentration of NAADP; and while no response to NAADP was seen from acidic stores 
when CICR was blocked by clamping the [Ca2+]i, cADPR still induced a response. These 
previous findings could suggest that cADPR acts directly on RyR and NAADP does not, or 
could be due to the differences seen in the involvement of the various RyR isoforms. RT-
qPCR could be used to measure the different expression levels of the various isoforms in 
PAC and antibody staining of the various isoforms could identify their relative locations 
within PAC. Together these experiments would identify any segregation of isoforms within 
the cell and see if a particular isoform has a greater expression than the other, which could 
enhance the response to a particular secondary messenger over another.  
Similarly, while TPC channels have been shown to be expressed on endolysosomes (Calcraft 
et al. 2009) it would be useful to perform antibody staining for TPC channels to identify their 
location in PAC; especially as the role of lysosomes in NAADP-induced Ca2+ release in these 
cells has previously been questioned via the use of GPN (Gerasimenko, Sherwood, et al. 
2006). As zymogen granules create the largest acid store in PAC’s, and are believed to 
contain other Ca2+ not normally found on acidic organelles, it would be interesting to 
discover if they also contain TPC channels. NAADP-induced Ca2+ release from acidic stores 
via TPC channels is enhanced by CICR via RyR, therefore an antibody based FRET 
technique to identify puncta between the two types of channel could identify potential 
domains where CICR occurs. CICR can also occur via IP3R, and while the involvement of 
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this type of channel was ruled out of NAADP-induced Ca2+ release from the nuclear envelope 
by the use of 2-APB, it would be useful to repeat some of the previous whole cell 
experiments in the presence of a more specific IP3R inhibitor e.g. Xestospongins (Gafni et al. 
1997). If either NAADP or cADPR induced release was shown to be affected by an IP3R 
inhibitor, similar experiments to dissect the involvement of the various IP3R isoforms and 
identify puncta between them and the other channels involved in response to the messenger 
would be required.  
Based on the results above, NAADP can mobilize calcium from lysosomes and endosomes 
via TPC2, and Zymogen granules or the ER via RyR1 and RyR3 isoforms. Whereas cADPR 
acts only on the Zymogen granules or the ER stores, mobilizing calcium through RyR2 and 
RyR1 isoforms. Responses to either messengers would then be amplified by CICR from the 
zymogen granules and the ER via RyRs and IP3Rs.   
Together these findings can be used to describe a more complex picture of NAADP-induced 
Ca2+ release in PAC than the standard ‘trigger hypothesis’ (Churchill et al. 2002). In these 
cells NAADP can mobilise Ca2+ from endo-lysosomal stores though TPC channels, 
predominantly TPC2. This response is then enhanced by CICR from either zymogen granules 
or the ER via RyRs, with RyR1 having the greatest involvement assisted by RyR3. NAADP 
is likely to also act directly on these RyR isoforms, especially to mobilise Ca2+ from the ER 
store (Fig 3.3.2). Conversely, cADPR acts only on RyR; mobilising calcium from both the 
ER and zymogen granules or the ER predominantly through RyR2, and to a lesser extent 
RyR1. 
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Fig 3.3 Graphical representation of NAADP and cADPR induced calcium release from 
organelle stores in pancreatic acinar cells  
 
 
 
 
Reproduced under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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Chapter 4: The NAADP antagonist ned-19 has an inhibitory effect on cholecystokinin-
induced calcium release in pancreatic acinar cells 
 
4.1 Overview of the effect of Ned-19 
Use of pharmacological agents that alter the activities of individual components of 
physiological signalling pathways have greatly aided out understanding of their roles in these 
pathways and the cellular processes they are involved in. These agents can highlight a 
signalling molecule’s function either by blocking its activity or enhancing it. As well as 
increasing our physiological knowledge these compounds can play a potential therapeutic 
role, either in their existing state or acting as lead compound for development. 
The three intracellular secondary calcium messengers IP3, cADPR and NAADP are produced 
within cells in response to external stimuli to mobilise Ca2+ from intracellular organelle stores 
(Gerasimenko, Sherwood, et al. 2006). Their activity has been shown to be required in a wide 
range of cellular process as diverse as fertilisation (Moccia et al. 2004), neuronal plasticity 
(Sarkisov and Wang 2008) and muscle contraction (Ge et al. 2003). However, studying their 
activity can be difficult due to all of their structures carrying a large negative net charge 
meaning they are not membrane permeable. As they are both synthesized and act on ion 
channels within the cell, their charged structures are an advantage for these molecules’ 
physiological activity; as it prevents them from diffusing out of the cell or into organelles, 
maximising their activity within the cytosol. But this also means to discern their effect on 
cells they either need to be either microinjected into cells (James and Freedman 1977), 
applied to permeabilized or homogenised cells (Gerasimenko, Sherwood, et al. 2006; Morgan 
and Galione 2014) or converted into a membrane-permeable analogue (Rosen et al. 2012). 
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This increases the need for membrane permeable pharmacological agents specific to the 
activity of these molecules to study them in intact cell and whole organism levels. 
Traditionally such compounds may be developed by modifying the structure of the active 
compound, e.g. creating an inhibitor by modifying the compound so that it still binds to its 
receptor, but is functionally inactive. While such techniques have been used for NAADP (Lee 
and Aarhus 1997), their cell permeability was not considered at the time and so still have the 
large negative charge that makes NAADP membrane impermeable. As increasing NAADP’s 
membrane permeability would require removing multiple negatively charge groups, several 
of which are required for its binding and activity, it is a poor lead compound for a structural 
modification approach. Modern in silico techniques are a possible alternative solution; rather 
than altering the existing structure they allow potential compounds of interest to be identified 
via high throughput screening of libraries of large numbers of compounds that conform to 
specific criteria, e.g. a neutral net charge but contain a specific active group in a specific 
conformation. 
One such compound identified using in silico screening, is the membrane permeable NAADP 
specific antagonist Ned-19 (Naylor et al. 2009). Naylor et al. used the ZINC (Zinc Is Not 
Commercial) database (Irwin and Shoichet 2005), which is only comprised of commercially 
available compounds with biological relevant representations of the molecules, in 
combination with the free-to-use OpenEye software (Nicholls et al. 2004; Rush et al. 2005), 
to generate and compare 3D structures. NAADP’s 3D structure was used as a starting point; 
though as its bioactive 3D conformation is currently unknown, 40 possible conformations had 
to be generated using The OpenEye Omega application. This application was also used to 
produce up to 100 possible conformations for each compound in the ZINC library. The 3D 
conformations of the ZINC compounds were then screened against those generated for  
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A              B 
       
C     D 
          
Fig. 4.1.1 Ned-19 has a similar electrostatic structure to NAADP and can inhibit its 
activity  
(A) Schematic of the in silico process used to identify compounds similar 3D or electrostatic 
structures to NAADP. (B) The two-dimensional chemical structures of NAADP and Ned-19. 
(C) 3D electrostatic surface representations of NAADP and Ned-19, red represents areas of 
negative charge and blue those of positive charge. (D) Ned-19 inhibits NAADP-induce 
calcium release, but not IP3 or cAPDR-induced release in sea urchin egg homogenate.  
Adapted by permission from Macmillan Publishers Ltd: [NATURE CHEMICAL BIOLOGY] (Naylor et al. 
2009) copyright (2009) 
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NAADP using OpenEye’s ROCS (Rapid Overlay of Chemical Structures) application and 
ranked based on their Tanimoto score. The top 500 ranked compounds from the ROCS 
comparison were then compared to NAADP again using the EON application, which 
compared compounds based on their 3D electrostatic structures, and ranked again based on 
this second comparison. Compounds from the ROCS search were referred to as Nrd (NAADP 
ROCS Discovered) compounds and those from the EON search Ned (NAADP EON 
Discovered) compounds; all compounds were given a number based on their ranking, e.g. 
Nrd-6 was the 6th highest ranked compound in the ROCS comparison. The activity of the 10 
highest ranked Nrd and 15 highest ranked Ned available for purchase were then tested in 
vitro. 
The compounds purchased were tested in a plate reader assay to test their effect on NAADP’s 
ability to induce Ca2+ release from sea urchin egg homogenate. 4 of the 25 compounds 
provided a significant inhibition against NAADP-induced Ca2+ release, with Ned-19 having 
the most potent effect. When used at a concentration of 100 µM it provided a 94.6 ± 1.0% 
inhibition against NAADP, but had no significant effect against either cADPR or IP3-induced 
release. Conflicting data was produced as to Ned-19’s mechanism of inhibition against 
NAADP, though the kinetics of its dissociation from homogenates suggested it was a 
functionally irreversible non-competitive inhibitor. Ned-19 exists as two diastereomers (and 
was initially used as a mixture of the two), with the trans form of Ned-19 showing a much 
greater inhibitory effect than the cis form. It is this trans form that has since been utilized by 
multiple groups in subsequent studies and is generally referred to as just Ned-19 (Coxon et al. 
2012; Aley et al. 2013; Ali et al. 2016). Significantly, Ned-19’s effect on NAADP-induced 
Ca2+ release in intact cells was demonstrated in two ways; pre-incubation with Ned-19 
blocked NAADP-induced responses when the messenger was microinjected into either intact 
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sea urchin eggs or murine pancreatic β cells. Naylor et al. highlighted the usefulness of Ned-
19 by showing that at a sufficient concentration it could inhibit glucose-induced Ca2+ 
oscillations in isolate murine pancreatic islets when either applied as a pre-treatment or 
acutely, further implying NAADP plays a role in glucose sensing (Johnson and Misler 2002; 
Masgrau et al. 2003; Mitchell et al. 2003). As a tryptophan derivative, Ned-19 is fluorescent 
and shows a second possible use as it can label NAADP binding sites within cells; which in 
pancreatic β cells was found to co-localise with Lysotracker red fluorescence (Naylor et al. 
2009).  
Since Ned-19’s discovery as a membrane-permeable NAADP antagonist it has been used in 
multiple mammalian cell systems to inhibit NAADP-induced Ca2+ release and thereby 
highlight the physiological role that the secondary messenger plays in those cell types 
(Esposito et al. 2011; Arndt et al. 2014; Khalaf and Babiker 2016; Pereira et al. 2016). As 
well as being used to highlight NAADP role in cells by inhibiting its activity Ned-19 has 
been used to provide experimental data supporting the long held belief within the field that 
the ‘NAADP receptor’s’ activity is regulated by two NAADP-binding sites. In Sea urchin 
eggs the application of a sub-activating concentration of NAADP is auto-inhibitory to a 
subsequently applied activating concentration of NAADP (Aarhus et al. 1996; Genazzani et 
al. 1996). Alternatively, in mammalian cells NAADP shows a bell-shaped activation curve, 
inducing Ca2+ release from intracellular cells until a threshold is reached where it becomes 
auto-inhibitory (Cancela et al. 1999; Berg et al. 2000). Together these mechanism of auto-
inhibition both suggest that the ‘NAADP receptor’ has two separate NAADP-binding sites, 
with one inducing channel opening and the other inhibiting it.  
Using the sea urchin egg homogenate model, Rosen et al. examined the effect of Ned-19 and 
the two closely related compounds Ned-20 and Ned-19.4 on NAADP’s binding to its receptor  
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B      C 
    
Fig. 4.1.2 Analogues of Ned-19 have varying effects on NAADP-induced Ca2+ release 
and binding 
(A) Comparison of the two-dimensional chemical structures of NAADP; Ned-19 and its 
structural analogues, Ned-19.4 and Ned-20. Regions with share structural similarity are 
highlighted in the same colours. (B) Comparisons of the effect of Ned-19 and its analogues 
on NAADP-induced calcium release from sea urchin egg homogenate. (C) Comparisons of 
the effect of Ned-19 and its analogues on NAADP binding to its receptor in sea urchin egg 
homogenate.  
This research was originally published in Journal of Biological Chemistry. D Rosen et al. Analogues of the 
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonist Ned-19 Indicate Two Binding Sites on 
the NAADP Receptor. Journal of Biological Chemistry. 2009; 284(50):34930-4. © the American Society for 
Biochemistry and Molecular Biology. (Rosen et al. 2009). 
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and ability to induce Ca2+ release (Rosen et al. 2009). Both these compounds are identical to 
Ned-19’s except for one structural modification, the carboxylic acid group substituted for a 
methyl ester group in Ned-19.4 and Ned-20 has its fluorine atom in the para rather than the 
ortho position. As previously shown by Naylor et al. (Naylor et al. 2009), Ned-19 is able to 
inhibit both NAADP’s ability to bind to its receptor and NAADP-included Ca2+ release. Ned-
19.4 was able to inhibit NAADP-induced Ca2+ release, though to a lesser extent than Ned-19, 
but had no effect on its binding. Conversely Ned-20 had no effect on Ca2+ release but did 
affect binding in a pattern constant with allosteric displacement (Christopoulos and Kenakin 
2002). These results suggest that the Ned-19’s inhibition of NAADP-induced Ca2+ release is 
independent of its ability to disrupt its binding and vice versa. Unlike Ned-19 and Ned-19.4, 
pre-incubation with Ned-20 blocked auto-inhibition by a sub-activating concentration of 
NAADP. 
Together with the previous findings this lead Rosen et al. to propose a three state model of 
the ‘NAADP receptor’, based on it having both a low affinity orthosteric and a high affinity 
allosteric for NAADP. In the absence of NAADP the receptor exists in a close resting state; 
addition of a sub-activating concentration of NAADP will lock the channel in it closed state 
by binding to the allosteric site, preventing the effect of a second application of a normally 
activating concentration. An initial application of an activating concentration of NAADP will 
instead bind to the orthosteric site, which induces channel opening. The experimental data 
suggests Ned-20 prevents NAADP from binding to the allosteric site, thus preventing the 
formation of the channel’s locked state. Ned-19.4 instead prevents the channel changing from 
its inactive state to active open state when NAADP is bound to the orthosteric site. How Ned-
19 interacted with the ‘NAADP receptor’ could not be deduced from this study, with Rosen 
et al. suggesting how it could act on either site independently or both.    
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There is no data published on the effects of Ned-20 and Ned-19.4 in mammalian cells to 
build a model of NAADP’s activity; although based on its bell shaped activation curve 
(Cancela et al. 1999; Berg et al. 2000) it can be speculated that a mutation has led to the 
affinity of the allosteric site to decrease below that of the orthosteric site. Such a mutation 
would increase the required concentration of NAADP for it to bind to the allosteric site and 
produce its bell shaped activation curve. However, this would mean that the ‘NAADP 
receptor’ in mammalian cells can change between its open and locked states without 
transitioning through its resting state.  
The discovery that TPC channels form NAADP sensitive ion channels (E. Brailoiu et al. 
2009; Calcraft et al. 2009; Zong et al. 2009) has added an extra degree of complication to 
NAADP’s activity; since it has been shown that in neither sea urchin eggs or mammalian 
cells does the messenger act directly on these channels (Lin-Moshier et al. 2012; Walseth et 
al. 2012), but instead must do so via one or more as yet unidentifed NAADP-binding 
proteins. How these binding proteins interact with the channel forming ones, if more than one 
NAADP binding protein exists, and if both the orthosteric and allosteric site are on the same 
binding protein are all currently unknown and increase the complexity of NAADP-induced 
Ca2+ release. Identification of TPC channels has allowed for a better insight into Ned-19’s 
activity, as at sub-inhibitory concentrations it has been shown to induce the opening of 
recombinant TPC2 expressed in lipid bylayers (Pitt et al. 2010). This suggest that Ned-19 
may act in a similar manner to NAADP, activating TPC channels at low concentrations and 
inhibiting them at high concentrations.  
PAC have been shown to produce both the intracellular secondary Ca2+ messengers cADPR 
and NAADP in response to the physiological secretagogue CCK (Yamasaki et al. 2005). This 
is understandable as both messengers are produced by the same ADPR cyclase, the 
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ectoenzyme CD38 (Malavasi et al. 2008); the knockout of which is known to abolish the 
presence of cADPR in PAC (Fukushi et al. 2001). Interestingly microinjection of a high auto-
inhibitory concentration of NAADP into PAC is able to inhibit CCK-induced Ca2+ responses 
but not cADPR-induced responses (Cancela et al. 1999). This suggests that NAADP may be 
key to the creation of CCK-induced Ca2+ release, acting upstream of cADPR; with cADPR 
aiding in the amplification of the initial response induced by NAADP by reducing the 
requirement of CICR.  
If NAADP is the initial messenger required for the generation of CCK-induced Ca2+ release 
in PAC, it was predicted that the membrane permeable NAADP-specific antagonist Ned-19 
would have an inhibitory effect against formation of the response.  It was also predicted that 
Ned-19 might show a protective effect against necrosis in the CCK hyperstimulation model 
of acute pancreatitis (Han et al. 2001). 
 
4.2. The effect of Ned-19 on CCK-induced calcium oscillations in pancreatic acinar cells  
The response of PAC to a physiological concentration of either of the secretagogues ACh or 
CCK is well characterised (Cancela 2001) (Fig. 4.2.1 A-B). An extracellular application of 
either stimulant triggers a series of Ca2+ oscillations in the cytoplasm of the cell, localised to 
the apical region of the cell (Thorn et al. 1993; Park et al. 2001). These short lived repetitive 
increases in [Ca2+]c initiate the migration of zygomorphic granules to the plasmalemma; upon 
reaching the cell membrane granules will fuse with it, releasing the proenzymes they contain 
into a intralobular duct (Williams 2010). Removal of the secretagogue from the extracellular 
solution results in the rapid cessation of the Ca2+ oscillations it initiated (Fig. 4.2.1 B), thus 
ending secretion from the cell.  An immediate resumption of oscillations occurs upon 
reapplication of the secretagogue, implying there is no desensitisation of the cell to the  
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A
 
B 
 
Fig. 4.2.1 CCK and ACh-induced calcium responses 
Representative traces obtained upon treatment of pancreatic acinar cells with: (A) 5 pM CCK 
(n = 11) and (B) 20 pM Ach, including wash-off and reapplication of ACh (n = 6). 
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C  
 
D 
 
Fig. 4.2.1 (continued) 
(C) Representative trace of pancreatic acinar cells responding to an increasing concentration 
(1, 5 and 10 pM) of CCK (n = 8). (D) Bar Chart showing the average area under the trace for 
the cells sampled (Data represents mean ± SEM, n = 8; *, P ≤ 0.05). 
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Fig. 4.2.1 (continued) 
(E) Representative trace of the effect of a high concentration of caffeine (20 mM) on the Ach 
response in pancreatic acinar cells (n = 12). 
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stimulant after the first application.  
The size of the Ca2+ response observed within a cell corresponds to the amount of the 
secretagogue applied to it (Fig. 4.2.1 C). Across a physiological range of CCK concentrations 
(1-10 pM) tested, all elicited a measurable Ca2+ response, with an apparent increase in the 
intensity and length of the response in accordance with the increasing concentration. 
Quantification of the responses observed by calculating the area under the curve (Fig. 4.2.1 
D) confirms the increases observed on the trace. A student’s t-test for each change in 
concentration shows that each increase is significant (p = 0.02 between 1 pM and 5 pM, and p 
= 0.03 between 5 pM and 10 pM), indicating a clear dose-response relationship. 
An increase in [Ca2+]c can come from one of two sources: an influx of extracellular Ca2+ 
across the plasmalemma or by release of Ca2+ stored in the lumen of one or more of the cell’s 
organelles. ACh mobilizes Ca2+ from organelle stores via the production of IP3 and therefore 
the increase in [Ca2+]c it induces can be blocked by caffeine (Fig. 4.2.1 E), which at high 
concentrations is an inhibitor of IP3R channel activity (Parker and Ivorra 1991). 
100 µM Ned-19 has been shown to inhibit NAADP-induced Ca2+ release in several different 
mammalian cell types (Naylor et al. 2009; Barceló-Torns et al. 2011; Coxon et al. 2012); 
therefore it was decided to test the effects of concentration against secretagogue induced Ca2+ 
release in PAC. Addition of Ned-19 on top of a CCK-induced Ca2+ response causes a 
complete abolition of the Ca2+ oscillations (Fig. 4.2.2 A). This effect is temporary, as when 
both Ned-19 and CCK were washed out of the cells the reapplication resulted in a resumption 
of Ca2+ oscillations. Unlike for CCK-induced Ca2+ oscillations, Ned-19 had no effect on 
ACh-induced responses (Fig. 4.2.2 B).    
The experiments using the ratiometric Ca2+ sensitive dye Fura-2 (Fig. 4.2.1 and Fig. 4.2.2) 
were conducted using an LED microscope system taking whole cell recordings of intact PAC.  
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A 
 
B 
 
Fig. 4.2.2 The effect of Ned-19 on physiological calcium signalling in pancreatic acinar 
cells 
(A) Representative trace showing the effect of exposing pancreatic acinar cells to 5 pM CCK 
followed by 100 µM Ned-19, both agents were removed from the bath solution and then 
CCK was reapplied (n = 10). (B) Representative trace showing the effect of exposing 
pancreatic acinar cells to 15 nM ACh followed by 100 µM Ned-19 (n = 21). 
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As the apical granular region is where physiological secondary messenger signalling in PAC 
is initiated (Thorn et al. 1993; Park et al. 2001), the Ned-19 experiments were repeated using 
a confocal microscope and the non-ratiometric Ca2+ dye Fluo-4. This allowed for imaging of 
PAC at a higher resolution and for recordings to accurately be taken specifically from the 
granular region. These results showed an identical pattern to those previously observed; alone 
5 pM CCK induces an oscillation in the [Ca2+]c in PAC, however when 100 µM Ned-19 was 
applied acutely onto of these oscillations they were completely inhibited (Fig. 4.2.3A). 
Alternatively, when 20 nM ACh was used to induce Ca2+ oscillations acute application of 
Ned-19 had no visible effect (Fig. 4.2.3B). The average areas under the curve for the 300 s 
periods that cells were exposed to CCK or ACh alone and with Ned-19 (Fig. 4.2.3C-D). 
These areas were compared using a Student’s t-test, which showed a significant difference in 
the response to CCK in the presence and absence on Ned-19 (p < 0.01), but no significant 
difference for the response to ACh (p = 0.78).   
As Ned-19 was able to inhibit the Ca2+ response induced by a physiological concentration of 
CCK, it is possible that it would be able to do so against a pathological concentration of the 
secretagogue. Supramaximal concentrations of CCK cause hyperstimulation of PAC, 
resulting in sustained cytotoxic increases in [Ca2+]c and resulting in pro-inflammatory 
necrotic cell death (Mukherjee et al. 2016). Cell were exposed to 10 nM CCK with and 
without 100 µM Ned-19 at room temperature for 1 hour and then 6 µM PI was added before 
multiple images of cells were taken. The total amount of necrosis for a particular treatment 
was then calculated as the percentage of cells showing PI staining (Kaiser et al. 1995) 
compared to the total number of number of cells imaged. Under these conditions there was 
6.6 ± 0.58% necrosis observed for the untreated control cells; in the presence of 10 nM CCK 
this was increased to 10.5 ± 1.29%, which was not deemed significant by ANOVA  
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Fig. 4.2.3 Ned-19 inhibits CCK but not ACh-induced calcium release in pancreatic 
acinar cells  
Representative traces of responses to (A) 5 pM CCK (n = 9) or (B) 20 nM ACh (n = 14) in 
pancreatic acinar cells with subsequent application of 100 µM Ned-19. (C-D) Quantification 
of the area under the curve for the experiments shown in (A) and (B) for the two 300 s 
periods where cells were exposed to CCK or ACh alone, and in the presence of Ned-19 (41.3 
± 4.2 a.u. for 5 pM CCK, and 0.5 ± 0.6 a.u. for 5 pM CCK and 100 μM Ned-19; 35.7 ± 12 
a.u. for 20 nM ACh, and 37.9 ± 11.6 a.u. for 20 nM ACh and 100 μM Ned-19). Data 
represents mean ± SEM; *, P ≤ 0.05; n/s, not significant.  
 
 
Reproduced under terms of free use as author from JV Gerasimenko; Cell Calcium; 2015 (Gerasimenko et al. 
2015).  
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comparison (p = 0.0448). When 100 µM Ned-19 was also present with CCK, only 6.8 ± 
0.50% of cells showed PI staining, however this was not deemed significant (p = 0.0558). 
There was no significant difference between the amount of necrosis observed in the control 
cells and those treated with both CCK and Ned-19 (p = 0.9826); therefore, it surprising that 
Ned-19 did not significantly reduce the amount of necrosis induced by CCK. It is possible 
that this is a result of the relatively low amount of necrosis induced by the supramaximal 
concentration of CCK used. 
When tested using the assay described, 100 µM Ned-19 showed no toxic effect to PAC (Fig. 
4.2.4D). This corresponds with previous reports that the compound was not cytotoxic at this 
concentration in human platelets (Coxon et al. 2012) or in vivo in mice (Favia et al. 2016). 
As the amount of necrosis induced by 10 nM CCK was very low (Fig. 4.2.4B), the toxicity 
assay was repeated with the incubation step occurring in a water bath at 37°C (Fig. 4.2.4C) to 
induce a higher level of necrosis in response to CCK. Under such conditions the amount of 
necrosis observed was increased for all treatments, with the lowest amount of necrosis 
observed in the cells treated with CCK and Ned-19. In these experiments the amount of 
necrosis in the cells treated with CKK and Ned-19 was deemed significantly different to 
those treated with CKK alone by ANOVA comparison (p = 0.0018), but not significantly 
different from the untreated control cells (p = 0.9488). These results strongly indicate that 
Ned-19 has a protective effect against the toxic effect of a supramaximal concentration of 
CCK. 
Permeabilized PAC from TPCN2-/- mice showed a reduced response to NAADP compared to 
PAC from wild type animals, with the amount of Ca2+ mobilized from intracellular stores 
reduced by 64% (Gerasimenko et al. 2015). While this reduction in the size of the response 
was significant, it does also show that there is reasonable amount of the NAADP response in 
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Fig. 4.2.4 Effect of Ned-19 on CCK-induced cell death in acinar cells  
(A) Brightlight image, (a) and (b), and image of emission at 629 nm, (c) and (d), 
representative of PI staining. (a) Untreated control cells show a clearly define plasma 
membrane and distinct granular region. (b) Necrotic cells exposed to pathological agents like 
10 nM CCK have poorly defined plasma membranes and dispersed granules. (c) Viable cells 
have no loss of plasma membrane integrity and as such display no PI staining. (d) Necrotic 
cells loss plasma membrane integrity; allowing PI to stain DNA, hence the intense nuclear 
staining. 
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Fig. 4.2.4 (continued) 
(B) The results of cell death assays performed on pancreatic acinar cells treated with 10 nM 
CCK alone or in the presence of 100 µM Ned-19 for 1 hour at room temperature. Data 
represents the number of necrotic cells as a percentage of the total number of cells counted 
for that specific treatment (Data represents mean ± SEM, n = 3888 cells; n/s, not significant). 
(C) The results of cell death assays performed on pancreatic acinar cells treated with 100 µM 
Ned-19 for 1 hour at room temperature (Data represents mean ± SEM, n = 881 cells; *, P ≤ 
0.05; n/s, not significant). 
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Fig. 4.2.4 (continued) 
(D) The Results of cell death assays performed on pancreatic acinar cells treated with 10 nM 
CCK alone or in the presence of 100 µM Ned-19 for 1 hour at 37°C. Data represents the 
number of necrotic cells as a percentage of the total number of cells counted for that specific 
treatment (Data represents mean ± SEM, n = 9192 cells; *, P ≤ 0.05; n/s, not significant).  
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PAC that is independent of TPC2 channels. To test the impact on physiological signalling, 
PAC from the same TPCN2-/- mice were tested for responses to 5 pM CCK. 
As in wild type PAC cells, 5 pM CCK induced visible Ca2+ oscillations in all the cells 
sampled (Fig. 4.2.5A). Indicating the remaining NAADP sensitive element of the CCK 
response in TPCN2-/- PAC is enough to induce the classic physiological Ca2+ response to 
CCK. There is evidence that NAADP signalling is these cells involves both types of TPC 
channel and all three RyR channels as well, with a varying importance of each channel’s 
isoform and signs of overlapping function between the two channels; therefore, there is 
enough redundancy between these channels to compensate for the loss of TPC2’s activity. 
CCK-induced Ca2+ oscillations in TPCN2-/- PAC also showed the same sensitivity to Ned-19 
as wild type PAC, with a complete inhibition of oscillations when 100 µM Ned-19 was 
applied acutely (Fig. 4.2.5B-C). This shows that the inhibitory effect of Ned-19 is not 
dependent on the inhibition of TPC2 activity and it must also act on whichever channels are 
responsible for the NAADP-induced Ca2+ release in TPCN-/- PAC. 
Together these results show that loss of TPC2 activity alone is not enough to inhibit 
physiological CCK signalling in PAC, and that one or more other NAADP sensitive channels 
must be involved in the response to CCK. 
 
4.3 Discussion 
Upon stimulation with CCK PAC are known to produce both of the intracellular secondary 
Ca2+ messengers, cADPR and NAADP (Yamasaki et al. 2005). Cancela et al. observed that a 
high autoinhibitory concentration of NAADP applied by patch pipette could inhibit CCK 
induced Ca2+ spikes, but had no effect on those induced by cADPR (Cancela et al. 1999). 
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A 
 
B 
 
Fig. 4.2.5 The effect of TPC2 knockout on CCK induced calcium oscillations in 
pancreatic acinar cells 
(A) Representative trace of the CCK response in pancreatic acinar cells isolated from 
TPCN2-/- mice. (B) Representative trace of the effect of 100 µM of Ned-19 on the CCK 
response in pancreatic acinar cells isolated from TPCN2-/- mice. 
0
0.5
1
1.5
2
2.5
3
0 100 200 300 400 500 600 700 800
F/
F 0
Fl
u
o
-4
 (4
8
0
 n
m
)
Time (s)
0
0.5
1
1.5
2
2.5
3
0 100 200 300 400 500 600 700 800
F/
F 0
Fl
u
o
-4
 (4
8
0
 n
m
)
Time (s)
5 pM CCK 
5 pM CCK 
100 µM Ned-19 
  
161 
 
 
 
C 
 
Fig. 4.2.5 (continued) 
(C) Bar Chart showing the average area under the trace for the cells sampled; CCK between 
200 s and 500 s and CCK & Ned-19 between 500 s and 800s (Data represents mean ± SEM, n 
= 26; *, P ≤ 0.05). 
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This led them to hypothesis that NAADP may be the vital element required to induce the 
response to CCK in PAC; with cADPR acting on RyR to reduce the requirement for CICR, 
which would enhance the size and length of the initial response induced by NAADP.  
The NAADP specific antagonist Ned-19 (Naylor et al. 2009) showed the ability to 
completely inhibit CCK-induced cytoplasmic Ca2+ oscillations in PAC when applied acutely 
(Fig. 4.2.2 and Fig. 4.2.3) at a concentration known to inhibit NAADP-induced Ca2+ release 
in several different mammalian cell types (Naylor et al. 2009; Barceló-Torns et al. 2011; 
Coxon et al. 2012). Like previously shown in sea urchin eggs (Naylor et al. 2009), Ned-19 
was found to have no significant impact on either cADPR or IP3 induced Ca2+ release in this 
cell type (Fig. 3.2.1E). As the effect of Ned-19 is specific to NAADP-induced release, this 
means the inhibition of this specific component of the CCK response is enough to inhibit the 
Ca2+ oscillations induced by the secretagogue, and therefore secretion of the digestive 
enzymes stored within the cell (Petersen and Ueda 1976).  
While this does in part support the hypothesis of Cancela et al. that the activity of NAADP is 
required to generate the response to CCK, it also indicates that the secondary messenger’s 
activity is also required to sustain the response to CCK due to its acute effect. If NAADP’s 
activity was only required to initiate CCK-induced Ca2+ oscillations, then the acute 
application of Ned-19 to pre-existing oscillations would have little to no effect. This would 
suggest that it also plays a role in the continued response to CCK; and as seen, inhibiting its 
activity is enough to terminate the response to CCK in PAC. 
The cADPR antagonist 8-NH2-cADPR has been shown to have a similar inhibitory effect on 
CCK induced Ca2+ release to that of Ned-19 (Cancela and Petersen 1998), which may suggest 
that cADPR’s activity is also vital for CCK-induced Ca2+ oscillations in PAC. However, as 
Cancela et al. found NAADP induced Ca2+ spikes were inhibited by this compound (Cancela 
  
163 
 
et al. 1999) the importance cADPR can be questioned. Inhibition of NAADP-induced Ca2+ 
spikes by 8-NH2-cADPR, suggests that the compound is an inhibitor of RyR activity rather 
than a specific antagonist of cADPR activity like previously suggested (Walseth and Lee 
1993). Inhibition of RyR activity has been shown to significantly reduce the amount of Ca2+ 
mobilized in response to NAADP in PAC (Gerasimenko et al. 2015); this could suggest the 
inhibition of CCK-induced Ca2+ spikes by 8-NH2-cADPR was the result of the compound 
blocking Ca2+ release via RyR stimulated by NAADP, rather than the activity of cADPR on 
these channels. While NAADP and cADPR-induced Ca2+ release was shown to involve the 
different RyR isoforms to different extents, cADPR-induced release was shown to involve all 
three and therefore it is likely 8-NH2-cADPR could inhibit the activity of all three isoforms. 
There is the suggestion that NAADP may act directly on RyR in PAC and induce the opening 
of this family of ion channels (Gerasimenko et al. 2003; Gerasimenko, Sherwood, et al. 2006; 
Gerasimenko et al. 2015). If NAADP and cADPR act on these channels in a similar manner, 
then it is possible that a specific antagonist for one of these messengers may inhibit the 
activity of both. If this is true then the suggestion would be that it is the activity of RyR, 
rather than that of a specific secondary messenger, that is the key requirement for CCK 
induced Ca2+ oscillations in PAC. Due to the synthesis of the two messengers occurring via 
the same enzyme (Chini et al. 2002) and the overlapping nature of their signalling 
mechanisms (Gerasimenko et al. 2015) untangling the activity of the two messengers is near 
impossible without an antagonist for cADPR whose specificity has definitively been proven. 
The overlap in synthesis of NAADP and cADPR may also suggest another mechanism that 
Ned-19 could inhibit NAADP signalling other than by preventing its Ca2+ mobilizing 
activity. Ned-19 was unable to provide a complete inhibition of NAADP-induced Ca2+ 
release in permeabilized cells (Fig. 3.2.5), but was able to completely inhibit the CCK 
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response in intact cells (Fig. 4.2.3) which involves both NAADP and cADPR. This could 
indicate an inhibitory role for Ned-19 upstream of both NAADP and cADPR’s Ca2+ 
mobilizing activates. Ned-19 was identified due to its 3D electrostatic homology to NAADP 
(Naylor et al. 2009), therefore there is a chance that under physiological conditions it may 
interact with and inhibit the enzyme involved with NAADP’s metabolism due to its structural 
homology. If this is the case it could also inhibit cADPR production, due to the synthesis of 
these two messengers sharing a single enzyme (Zhao et al. 2012), but would not inhibit 
cADPR’s activity when it was directly added to cells (Fig. 3.2.1). Alternatively, if Ned-19 
were to disrupt the degradation of NAADP by competitive inhibition of its catabolic enzyme 
it could cause a ‘build-up’ of the messenger, increasing the concentration of NAADP until it 
reached a level which is auto-inhibitory (Aarhus et al. 1996).  
The potential inhibition of CD38 by Ned-19 is an interesting prospect as it would explain 
several inconsistencies in the effect of Ned-19. Firstly, as it would occur upstream of the 
synthesis of cADPR and NAADP it would explain how Ned-19 can inhibit CCK-induced 
Ca2+ossicalitons, which involves both messengers and so should have a cADPR component 
that is insensitive to Ned-19. Secondly, it could provide a reason for why it failed to provide a 
complete inhibition against NAADP-induced Ca2+ release in permeabilized cells but did so 
against CCK. If Ned-19 is only an effective NAADP antagonist against certain NAADP 
sensitive ion channels it would mean that the channels insensitive to Ned-19 provided the 
NAADP-induced Ca2+ release observed with Ned-19 present in permeabilized PAC. 
However, in the case of CCK signalling in intact cells Ned-19 would be able to inhibit both 
the channels sensitive to its action and CD38, reducing the amount of NAADP produced 
below that required to activate the channels sensitive to its action. Conformation of this 
conjecture would require analysis of the amount of NAADP and cADPR synthesised by 
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CD38 (Yamasaki et al. 2005) under both biochemical and physiological conditions in the 
presence and absence of Ned-19 . 
Heparin, which inhibits IP3R (Ghosh et al. 1988), showed a similar inhibitory effect to 8-
NH2-cADPR on NAADP-induced Ca2+ spikes (Cancela et al. 1999). IP3 has been shown to 
only be involved in the response to high concentrations of CCK (Sjödin and Gylfe 2000), 
rather than the low physiological ones used in this study. This could potentially highlight the 
importance of the cADPR component of CCK-induced Ca2+ release. CICR occurs via both 
IP3R and RyR (Finch et al. 1991; Endo 2009), blockade of just IP3R activity shows the ability 
to inhibit NAADP-induced release, despite RyR still being capable of being activated by this 
process.  
PAC from TPCN2-/- mice showed no obvious loss of sensitivity to CCK (Fig. 4.2.5) despite 
loss of this channels activity being shown to significantly inhibit the amount of Ca2+ 
mobilised in response to NAADP (Fig. 3.2.2). This suggests that small amount of Ca2+ 
mobilised in response to NAADP independent of TPC2 is enough to induce the Ca2+ 
oscillations observed (Fig. 4.2.5A). This release could either occur via TPC1 channels, by the 
TPC independent release observed (Fig. 5.2.5) (believed to be the result of NAADP 
activating RyR), or a combination of the two. This reduced amount of Ca2+ in TPCN2-/- cells 
would then still be amplified by CICR, producing the Ca2+ oscillations observed and 
compensating for the loss of TPC2 activity. This again could highlight the importance of the 
cADPR produced in response to CCK, as lowering the requirement for CICR could be key to 
this process occurring in response to the reduced amount of Ca2+ mobilised in response to 
NAADP. These knockout cells also still showed a sensitivity to Ned-19, which supports the 
theory that NAADP induced release is key for the initiation and propagation of CCK-induced 
Ca2+ oscillations. Even though the amount of Ca2+ mobilised in response to NAADP in the 
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knockout cells is already substantially reduced, inhibiting it enough to completely inhibit 
CCK-induced Ca2+ oscillations. 
While TPCN2-/- cells show no loss in their ability to produce Ca2+ oscillations in response to 
CCK, the amount of Ca2+ mobilized in the knockout cells could potentially be reduced. This 
can be calculated by permeabilizing cells post experiment with ionomycin and then 
calibrating the recording fluorescence with the Ca2+ concentration using EGTA (Schoutteten 
et al. 1999). Also testing the effect of CCK on PAC from TPCN1/2-/- mice could be used to 
see if CCK induced Ca2+ can occur independent of TPC activity. Loss of a response to CCK 
in these double knockout cells would not only show that TPC channels are essential for 
responses to this secretagogue, but would confirm that NAADP and not cADPR is vital for 
initiation of the response. Similarly, if there was still a response and it showed sensitivity to 
Ned-19 it would definitely prove the existence of a TPC independent method of NAADP-
induced Ca2+ release in PAC.   
As well as inhibiting the effect of a physiological concentration of CCK, Ned-19 showed the 
ability to inhibit the pathological effects of a supramaximal concentration of the secretagogue 
(Fig. 4.2.4). This shows that NAADP plays a key role in this process and can have a 
protective effect against CCK hyperstimulation. When the necrosis assay was conducted at 
room temperature a small, but significant increase in necrosis was observed when cells were 
exposed to CCK alone. Co-incubation with Ned-19 reduced the amount of necrosis in the 
CCK exposed cells to a level not significantly different to the control; however, this reduction 
was not deemed significant. As this was believed to due to the small increase in necrosis 
observed in response to CCK, rather than a lack of protective effect by Ned-19, the 
experiment was repeated with the incubation step of the assay in a water bath set to 37 °C to 
replicate body temperature. While the amount of necrosis observed was higher in all three 
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treatments, the effect was most prominent in the cells treated with CCK alone. As with the 
experiments conducted at room temperature, co-incubation of CCK with Ned-19 reduced the 
number of necrotic cells counted, however this time the effect was deemed significant. This 
suggests than Ned-19 could be used therapeutically against AP, though this would need to be 
tested against more physiologically relevant models of AP (Su et al. 2006). 
Together this work highlights the key role that the intracellular secondary Ca2+ messenger 
NAADP plays in the response to the hormone CCK in PAC. Acute application of the 
membrane permeable NAADP antagonist Ned-19 is capable of completely inhibiting CCK-
induced Ca2+ oscillations. This supports the previous suggestion that NAADP-induced Ca2+ 
release is vital for the response to CCK, but also suggest that it plays a key role in 
propagating this response. The CCK-response was unaltered in TPCN2-/- PAC, despite them 
having been shown to produce a significantly diminished response to NAADP. CCK 
responses in these knockout cells were still sensitive to Ned-19, showing that there was still a 
functional NAADP-dependent component left in them. Hyperstimulation of PAC by a 
supramaximal concentration of CCK was reduced by Ned-19, indicating a key role for 
NAADP in this process and a potential role for Ned-19 in preventing AP.  
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Chapter 5: The NAADP antagonist Ned-19 has an inhibitory effect on pathological 
calcium release induced by the bile acid TLC-S in pancreatic acinar cells 
 
5.1: Overview of TLC-S-induced calcium release in pancreatic acinar cells 
Gallstones are solid masses formed in the gallbladder from various components of bile; they 
are mainly composed of cholesterol, bilirubin and calcium (Schafmayer et al. 2006). They are 
believed to be one of the leading causes of AP, and that by physically blocking the ampulla of 
Vater they cause a reflux of bile into the pancreas. Bile acids are catabolic products of the 
metabolism cholesterol (Russell DW 2003), synthesised by various hepatic enzymes in a 
variety of distinct pathways and together comprise the major component of bile (Farina et al. 
2009). They have been shown to induce severe AP experimentally (Lerch et al. 1993; Kim et 
al. 2002), therefore there has been much interest into their effects on PAC and how they 
induce necrosis in this cell type.  
While bile acids have been shown to have several effects in PAC, including increasing the 
intracellular concentration of Na+ (Voronina et al. 2005) and depolarizating of the inner 
mitochondrial membrane (Voronina et al. 2004), it has been suggested their major 
pathological effect is the ability to induce sustained pathological increases in [Ca2+]i 
(Voronina et al. 2002; Gerasimenko, Flowerdew, et al. 2006; Orabi et al. 2013).  These Ca2+ 
increases initiate a cascade of events including the vacuolization of zymogen granules 
(Raraty et al. 2000; Sherwood et al. 2007; Mareninova et al. 2009) and premature activation 
of the proenzymes stored within them (Krüger et al. 2000; Husain et al. 2005), characteristic 
of AP. This leads to the expression of pro-inflammatory cytokines (Han and Logsdon 2000; 
Muili, Jin, et al. 2013), loss of ATP production due to mitochondrial depolarization 
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(Voronina et al. 2004; Criddle, Murphy, et al. 2006), the loss of plasmalemma integrity 
(Orabi et al. 2010) and ultimately death of PAC.  
Bile acids have been shown to induce increases in [Ca2+]i initially via the release of Ca2+ from 
intracellular stores (Gerasimenko, Flowerdew, et al. 2006; Orabi et al. 2013) and then 
subsequently via the entry of extracellular Ca2+ through CRAC channels as a result of SOCE 
(Kim et al. 2002). It has also been suggested that bile acids may allow the entry of 
extracellular Ca2+ either by disrupting the plasmalemma by acting as a detergent (Kim et al. 
2002) or by creating pores in it by forming oligomers (Zimniak et al. 1991).  
Taurolithocholic acid 3-sulfate (TLC-S) is bile acid that is often used experimentally to 
represent bile acids and study their effects on PAC (Voronina et al. 2002; Gerasimenko, 
Flowerdew, et al. 2006; Muili, Jin, et al. 2013; Orabi et al. 2013; Lewarchik et al. 2014; Wen 
et al. 2015; Huang et al. 2017). Gerasimenko et al. found that in permeabilized PAC TLC-S 
caused the release of Ca2+ in comparable levels to the secondary messengers IP3 and cADPR 
(Gerasimenko, Flowerdew, et al. 2006) (Fig. 5.1.1A). Application of a combination of TLC-S 
and cADPR elicited no greater effect than TLC-S alone; while 8-amino-cADPR, a cADPR 
antagonist, had no effect. These results indicate TLC-S induces a maximal Ca2+ response, 
hence no additive effect when coapplied with cADPR, and that its effect is independent of 
cADPR. Inhibition of IP3R by either caffeine or 2-APB, or of RyR by RR caused a significant 
reduction in the amount of Ca2+ released in response to TLC-S; indicating both types of 
channel play a key role in Ca2+ release. A close to total inhibition of TLC-S-induced release 
was seen when both types of receptor were inhibited by a combination of 2-APB and RR. 
Both IP3R (Huang et al. 2017) and RyR (Lewarchik et al. 2014) have subsequently been 
shown to directly play a role in TLC-S induced AP as well as Ca2+ release induced by the bile 
acid.  
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Fig. 5.1.1 Inhibition of TLC-S-induced calcium release in pancreatic acinar cells  
(A) Summary of Ca2+ responses relative to 200 µM TLC-S alone (100%) in permeabilized 
pancreatic acinar cells; concentrations of other compounds used were: 10 µM IP3, 10 µM 
cADPR, 10 µM 8-amino-cADPR, 10 µM RR, 100 µM 2-APB, 10 mM caffeine or 10 µM 
NAADP. (B) Summary of Ca2+ responses relative to 200 µM TLC-S alone (100%) in 
permeabilized pancreatic acinar cells after treatment with Tg; concentrations of 8-amino-
cADPR, RR, 2-APB, caffeine and NAADP used were the same as before; 50 µM GPN or 1 
µM rotenone and 1 µM oligomycin were used to disrupt lysosomes and mitochondria 
respectively. (C) Summary of Ca2+ responses relative to 200 µM TLC-S alone (100%) in 
presence of 20mM caffeine with and without 10 µM RR in intact pancreatic acinar cells.  
This research was originally published in Journal of Biological Chemistry. JV Gerasimenko et al. Bile Acids 
Induce Ca2+ Release from Both the Endoplasmic Reticulum and Acidic Intracellular Calcium Stores through 
Activation of Inositol Trisphosphate Receptors and Ryanodine Receptors. JBC. 2006; 281:40154-40163. © the 
American Society for Biochemistry and Molecular Biology (Gerasimenko, Flowerdew, et al. 2006) 
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At the time of Gerasimenko et al.’s report TPC channels had yet to be identified as NAADP- 
sensitive ion channels, so their role in the TLC-S response is unknown. However a high 
autoinhibitory concentration of NAADP (Aarhus et al. 1996) did reduce the amount of Ca2+ 
released in response to TLC-S, with a near total inhibition reached when a combination of 
NAADP and 2-APB was applied. These results suggest that TPC’s may be sensitive to the 
activity of TLC-S, as both RyR and TPC channels have been shown to be involved in the 
response to NAADP in PAC (Gerasimenko et al. 2015). As there is currently no NAADP 
antagonist whose activity is TPC specific, a similar pharmacological approach to study the 
effect of TLC-S on these channels is not possible. However, through use of knockout mice 
for either TPC isoform (Calcraft et al. 2009; Hooper et al. 2015) or the TPC double knockout 
mice (Ruas et al. 2015), their importance can be investigated. 
Using a similar pharmacological approach in permeabilized PAC after depletion of ER Ca2+ 
by Tg Gerasimenko et al. found that TLC-S can mobilize Ca2+ from acidic organelles via 
both IP3R and RyR (Fig. 5.1.1B). PAC cells are known to express both types of Ca2+ channel 
on acidic organelles; meaning, unlike other cell types, some Ca2+ can be mobilized through 
these channels in a Tg-insensitive manner (Gerasimenko, Sherwood, et al. 2006). NAADP-
induced Ca2+ is characterised by being Tg insensitive, therefore understandably a high 
concentration of NAADP was also inhibitory after treatment with Tg (Genazzani et al. 1996). 
As before combining 2-APB with either RR or a high concentration of NAADP provided a 
further inhibition than any of the 3 antagonists alone, though in neither case total inhibition 
was achieved. 
Various candidates for the IP3 and cADPR sensitive acidic store in PAC have been ruled out 
by selective pharmacological disruption; with TLC-S still inducing an increase in [Ca2+]i after 
disruption of lysosomes with GPN, mitochondria with rotenone and oligomycin or the Golgi  
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Fig. 5.1.2 Use of a cADPR antagonist or knockout of CD38 protects against TLC-S-
induced cell death in pancreatic acinar cells  
(A) Representative trace of the effect of 8-Br-cADPR on TLC-S induced calcium release in 
pancreatic acinar cells. (B) Summary of the protective effect of 8-Br-cADPR against TLC-S 
induced PI uptake as a measure of cell death in pancreatic acinar cells; for * and # p < 0.05 
compared with the control and TLC-S alone respectively. RLU, relative light units (n =3). (C) 
Summary of TLC-S induced PI uptake as a measure of cell death in pancreatic acinar cells 
isolated from either wild type of CD38 null mice; for * and # p < 0.05 compared with the 
control and TLC-S alone respectively. RLU, relative light units (n =3).  
This research was originally published in Journal of Biological Chemistry. AI Orabi et al. Cluster of 
Differentiation 38 (CD38) Mediates Bile Acid-induced Acinar Cell Injury and Pancreatitis through Cyclic ADP-
ribose and Intracellular Calcium Release. JBC. 2013; 288:27128-27137. © the American Society for 
Biochemistry and Molecular Biology (Orabi et al. 2013) 
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body with brefeldin A. By process of elimination it is therefore believed that identity of this 
unique Ca2+ store in PAC is the zymogen granules, specialist organelles characteristic of the 
exocrine pancreas. In intact PAC, caffeine still reduced the amount of Ca2+ released in 
response to TLC-S (Fig. 5.1.1C) and a further reduction was seen when RR was applied in 
addition to caffeine. These results are important as it shows that the findings in the 
permeabilized cell model are relevant under more physiological conditions and that 
preventing the release of Ca2+ from organelles stores can prevent the non-physiological levels 
of [Ca2+]i seen in AP. 
Recently Orabi et al. has shown that PAC isolated from CD38-/- mice are protected against 
TLC-S-induced necrosis (Orabi et al. 2013) (Fig 4.1.2C); indicating that TLC-S mobilizes 
Ca2+ indirectly via the production of secondary messengers like NAADP, rather than acting 
directly on Ca2+ channels itself. CD38 is known to be able to catalyse the synthesis of both 
the secondary messengers NAADP and cADPR, dependent on the conditions (Aarhus et al. 
1995). Previously Gerasimenko et al. had found that the cADPR antagonist 8-NH2-cADPR 
had no effect on TLC-S-induced Ca2+ release (Gerasimenko, Flowerdew, et al. 2006), 
concluding that cADPR had no role in PAC’s response to TLC-S. Conversely Orabi et al. 
found an alternative antagonist 8-Br-cADPR both reduced TLC-S induced Ca2+ release and 
cell death (Orabi et al. 2013) (Fig. 5.1.2A-B). Combined with the CD38-/- data, this suggests 
that in PAC CD38 does in fact produce cADPR in response to TLC-S. This discrepancy 
could be either due to the different types of antagonist used or because the second study used 
3 times the concentration of antagonist the first did. Whether TLC-S-induced Ca2+ release via 
IP3R is the result of it stimulating the synthesis of IP3 via PLC, CICR, or TLC-S directly 
activating the channels is unknown.  
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Currently there is no form of direct treatment for AP, with pain relief the only solution for 
patients suffering from an incident until it resolves itself. Some compounds used 
experimentally to investigate the effects of bile acids like TLC-S have low membrane 
permeability or nonspecific effects, meaning they unsuitable for clinical use. Therefore, it is 
important to identify compounds that may both have a protective effect against biliary AP 
and be clinically relevant. One example of this is the CRAC channel blocker GSK-7975A, 
which prevents SOCE by inhibiting Orai1 and has also been shown to have a protective effect 
against several models of AP, including a TLC-S-induced biliary model (Wen et al. 2015). 
The cell permeable NAADP antagonist Ned-19 has been shown to inhibit CCK-induced Ca2+ 
release in PAC (Gerasimenko et al. 2015), though its effect on TLC-S-induced Ca2+ release is 
unknown. Because TLC-S induced release is known to contain a NAADP sensitive 
component it is probable that Ned-19 with have a protective effect against the bile acid and 
requires investigating.   
 
5.2: The effect of Ned-19 on TLC-S-induced calcium release in pancreatic acinar cells 
As TLC-S-induced Ca2+ release in PAC has been shown to contain an NAADP sensitive 
element (Gerasimenko, Flowerdew, et al. 2006), it was predicted that the recently discovered 
NAADP antagonist Ned-19 would have an inhibitory effect on the amount of Ca2+ released in 
response to TLC-S. As 100 µM Ned-19 had an inhibitory effect against CCK-induced Ca2+ 
release (Gerasimenko et al. 2015) it was decided to use this concentration against 200 µM 
TLC-S, the concentration used by Gerasimenko et al. in their previous study (Gerasimenko, 
Flowerdew, et al. 2006). 
As previously described when PAC are exposed to TLC-S it either induces Ca2+ oscillations  
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A
 
B  
 
Fig. 5.2.1 The effect of Ned-19 pre-treatment on TLC-S induced calcium release in 
pancreatic acinar cells 
(A) Representative trace showing the cytoplasmic calcium response to 200 µM TLC-S in 
pancreatic acinar cells. (B) Representative trace of the effect pre-treatment with 100 µM Ned-
19 on the response to 200 µM TLC-S in pancreatic acinar cells.  
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
0 100 200 300 400 500 600 700 800 900
R
/R
0
Fu
ra
-2
 (3
5
5
:3
8
5
 n
m
)
Time (s)
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
0 100 200 300 400 500 600 700 800 900
R
/R
0
Fu
ra
-2
 (3
5
5
:3
8
5
 n
m
)
Time (s)
200 µM TLC-S 
200 µM TLC-S 
100 µM Ned-19 
  
177 
 
C 
 
D 
 
Fig. 5.2.1 (continued) 
(C) Bar Chart showing the average area under the trace for the cells sampled in (B); Ned-19 
between 0 s and 300 s, TLC-S & Ned-19 between 300 s and 600 s, and TLC-S between 600 s 
and 900s (Data represents mean ± SEM, n = 35; *, P ≤ 0.05). (D) Bar Chart showing the Ned-
19 was added to PAC there was no Ca2+ response, however when TLC-S was also added 
average area under the trace for the 300 s after addition of TLC-S (between 300 s and 600 s)  
for the cells sampled in (A) and (B) (Data represents mean ± SEM, n = 8 for TLC-S alone 
and n = 35 for TLC-S and Ned-19; *, P ≤ 0.05). 
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(Fig. 5.2.1A) or a sustained increase in [Ca2+]I (Voronina et al. 2002); the latter of which 
would be cytotoxic and induce the pathological effects associated with bile acids. To test if 
Ned-19 could prevent TLC-S-induced Ca2+ release, cells were first exposed to Ned-19 alone 
for 300 s, before the addition of TLC-S; after another 300 s interval Ned-19 was removed to 
expose cells to TLC-S alone for a final 300 s period (Fig. 5.2.1B). When PAC were perfused 
with just Ned-19 there was no visible effect. Addition of TLC-S to the perfusion solution in 
the continued presence of Ned-19 27 of the 35 cells observed responded with an increase in 
[Ca2+]i. After Ned-19 was removed there was a sustained increase in [Ca2+]i  observed in 34 
of the 35 cells sampled, indicating that Ned-19 may provide a protective effect against TLC-
S. The average area under the trace was calculated for the three 300 s periods where cells 
were exposed to Ned-19 alone, both Ned-19 and TLC-S, and TLC-S alone (Fig. 5.2.1C). A 
significant increase in area was seen in each subsequent period as determined by a Student’s 
t-test, p < 0.01 for both; implying that Ned-19 has a significant effect on the amount of Ca2+ 
release in response to TLC-S, even though a significant increase in the [Ca2+]i is still 
observed. To confirm this observation, the average area under the trace was calculated for the 
initial 300 s period after TLC-S was applied either alone or in the presence of Ned-19 (Fig. 
5.2.1D). A Student’s t-test determined a significant reduction in the amount of Ca2+ released 
in response to TLC-S when Ned-19 is present, p = 0.04.  
Together these results show that Ned-19 reduced the amount of Ca2+ released by PAC from 
organelle stores in response to TLC-S.  
As Ned-19 significantly reduced the TLC-S-induced Ca2+ response it is possible that it will 
provide a protective effect against TLC-S-induced cell death in PAC; as has been seen for 
other compounds that reduce the amount of Ca2+ released in response to TLC-S (Wen et al. 
2015 p.1; Huang et al. 2017). As before (Fig. 4.2.4C), incubation with 100 µM Ned-19 for 1  
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Fig. 5.2.2 Effect of Ned-19 on TLC-S-induced cell death in acinar cells  
The results of cell death assays performed on pancreatic acinar cells treated with 200 µM 
TLC-S and/or 100 µM Ned-19 for 1 hour. Data represents the number of necrotic cells as a 
percentage of the total number of cells counted for that specific treatment (Data represents 
mean ± SEM, n = 7093 cells; *, P ≤ 0.05; n/s, not significant).  
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hour caused no significant difference in the number of necrotic cells according to a ANOVA 
comparison (p = 0.9745). Incubation for the same time with 200 µM TLC-S however, 
doubles the amount of necrosis, which is deemed significant (p = 0.0045). The amount of 
necrosis observed when TLC-S and Ned-19 were co-incubated together is a significantly 
smaller than that observed when TLC-S applied alone (p = 0.0082); down to a level not 
significantly different from that seen in the control (p =0.991). 
Both caffeine, which at high concentrations block Ca2+ release via IP3R (Wakui et al. 1990), 
and GSK-7975A, which prevents SOCE by blocking Orai1’s channel pore (Derler et al. 
2013), have been shown to have a protective effect against TLC-S-induced cell death (Wen et 
al. 2015; Huang et al. 2017). It was decided to compare the protective effects of these two 
compounds to Ned-19 and test if they provided any further effect when used in combination 
with Ned-19. 
Like in the previous experiment (Fig. 5.2.2) TLC-S induced an increase in necrosis, deemed 
significant by ANOVA comparison (p = 0.005 and p = 0.0008 for the caffeine and GSK-
7975A experiments respectively). For both sets of experiments Ned-19 showed a significant 
protective effect against TLC-S induced necrosis (p = 0.04 and p = 0.0189 for the caffeine 
and GSK-7975A experiments respectively). Both caffeine (Fig. 5.2.3) and GSK-7975A (Fig. 
5.2.4) alone had a significant protective effect against TLC-S (p = 0.0048 and p = 0.0053 
respectively); with both reducing the amount of necrosis observed below that when Ned-19 
was used, though neither decrease was deemed significant. Use of caffeine and Ned-19 
together appeared to have an additive protective effect, reducing the number of necrotic cells 
close to that of the untreated control, however this extra protection was not deemed 
significant compared to using either Ned-19 or caffeine alone. A combination of GSK-7975A 
and Ned-19 produced no further decrease in necrosis compared to using GSK-7975A alone.  
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Fig. 5.2.3 Effect of Ned-19 and caffeine on TLC-S-induced cell death in acinar cells  
The results of cell death assays performed on pancreatic acinar cells treated with 200 µM 
TLC-S, 100 µM Ned-19 and/or 20 mM caffeine for 1 hour. Data represents the number of 
necrotic cells as a percentage of the total number of cells counted for that specific treatment 
(Data represents mean ± SEM, n = 3632 cells; *, P ≤ 0.05; n/s, not significant).  
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While there was no obvious difference in CCK-induced Ca2+ oscillations in PAC isolated 
form TPCN2-/- mice (Fig. 4.2.5), the knockout of this ion channels function may provide a 
protective effect against TLC-S toxicity. As such the level of necrosis in PAC preparations 
from both wild type and TPCN2-/- mice exposed to TLC-S were compared to examine if loss 
of TPC2 activity had any effect on TLC-S induced necrosis. 
Despite the preparations from TPCN2-/- mice showing a slightly lower amount of necrosis 
than that in wild type preparations for all treatments tested (Fig 5.2.5), none of them was 
deemed as significantly different by a student’s t-test (control p = 0.997, Ned-19 p > 0.9999, 
TLC-S p = 0.999, and TLC-S & Ned-19 p = 0.9897). As such the TPCN2-/- preparation 
showed the same significant increase in necrosis when treated with TLC-S (p = 0.0006) 
which was significantly reduced when Ned-19 was also present (p = 0.0005). Therefore; 
knockout of TPC2 has no significant effect on TLC-S’s ability to induce a toxic [Ca2+]c in 
PAC, despite this involving an NAADP component. As against CCK-induced Ca2+ 
oscillations, TPCN2-/- cells showed no loss of sensitivity towards Ned-19, which displayed a 
protective effect against the toxic effects of TLC-S. 
 
5.3 Discussion 
The primary bile acid TLC-S is known to mobilize Ca2+ in PAC from both the ER and a 
separate acid store believed to be the zymogen granules (Gerasimenko, Flowerdew, et al. 
2006) (Fig. 5.1.1). TLC-S-induced Ca2+ release has been shown to involve the ectoenzyme 
CD38 (Orabi et al. 2013) (Fig. 5.1.2) and be sensitive to a high autoinhibitory concentration 
of NAADP in permeabilized cells (Aarhus et al. 1996). Inhibition of IP3R and RyR reduces 
the amount of Ca2+ released in response to TLC-S, as does use of 8-Br-cADPR, an inhibitor 
of cADPR induced Ca2+ release. 
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Fig. 5.2.4 Effect of Ned-19 and GSK-7975A on TLC-S-induced cell death in acinar cells  
The results of cell death assays performed on pancreatic acinar cells treated with 200 µM 
TLC-S, 100 µM Ned-19 and/or 10 µM GSK-7975A for 1 hour. Data represents the number 
of necrotic cells as a percentage of the total number of cells counted for that specific 
treatment (Data represents mean ± SEM, n = 5099 cells; *, P ≤ 0.05; n/s, not significant).  
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As predicted the NAADP antagonist Ned-19 (Naylor et al. 2009) significantly reduced the 
amount of Ca2+ released in response to TLC-S compared to when Ned-19 was not present 
(Fig. 5.2.1D). The increase in Ca2+ induced by TLC-S observed in the presence of Ned-19 
was deemed as significant, but was also significantly smaller than that observed when Ned-19 
was removed (Fig. 5.2.1C). As a high autoinhibitory concentration of NAADP was only 
reported as being capable of achieving a partial inhibition of TLC-S-induced release, it was 
not expected for Ned-19 to achieve a complete inhibition. In permeabilized PAC the same 
concentration of Ned-19 did not show a complete inhibition of NAADP-induced Ca2+ release 
(Gerasimenko et al. 2015), suggesting there is component of NAADP induced Ca2+ release 
that is Ned-19 insensitive, at least at a concentration of 100 µM. 
Ned-19 does not need to completely inhibit TLC-S-induced Ca2+ to have a protective effect 
against TLC-S induced necrosis, so long as it reduces the amount of Ca2+ released in response 
to TLC-S below a cytotoxic amount (Festjens et al. 2006). This was seen in the case of 
caffeine; where Gerasimenko et al. only observed a partial inhibition of TLC-S-induced Ca2+ 
release by caffeine (Gerasimenko, Flowerdew, et al. 2006), but it has been found to have a 
protective effect against another model of AP induced by caerulein (Huang et al. 2017). 
Applying Ned-19 acutely on top of a TLC-S-induced Ca2+ response would be useful for 
visualising any protective effect it may have; as in a therapeutic setting any drug to treat AP 
would be given to a patient who is already suffering from a pathological incident. 
The initial cell death experiments with Ned-19 showed that application of Ned-19 and TLC-S 
significantly reduced the amount of necrosis compared to when cells were incubated with 
TLC-S alone (Fig. 5.2.2). This was also the case in both  the experiments with caffeine (Fig. 
5.2.3) and the CRAC channel blocker GSK-7975A (Derler et al. 2013) (Fig. 5.2.4). Together 
these experiments show that NAADP-induced Ca2+ release plays a key part in the  
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Fig. 5.2.5 Effect of TPC2 knockout on TLC-S-induced necrosis in acinar cells  
The necrosis results of cell death assay performed on pancreatic acinar cells isolated form 
wild type and TPC2 knockout mice treated with 100 µM Ned-19 and/or 200 µM TLC-S for 1 
hour where applicable. Yellow bars represent the necrosis observed in wild type cells as a 
percentage of the total number of cells counted for that specific treatment and orange 
represent the necrosis observed in TPCN2-/- cells as a percentage of the total number of cells 
counted for that specific treatment (Data represents mean ± SEM, n = 7093 WT cells and n = 
9529 TPCN2 cells; *, P ≤ 0.05; n/s, not significant). 
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pathological response to TLC-S, and that Ned-19 can provide a significant protective against 
the bile acids effect. 
Either caffeine or GSK-7975A alone had a greater protective effect against TLC-S-induced 
necrosis than Ned-19, though neither’s effect was significantly greater than Ned-19’s. Using 
caffeine and Ned-19 together further reduced the amount of necrosis observed compared to 
using either of them alone; although the additional decrease was not significant compared to 
using either compound alone. This could be due to either compound reducing the amount of 
necrosis observed down to an amount not statistically significant from the control. This 
additive effect corresponds to Gerasimenko et al.’s findings that TLC-S-induced Ca2+ release 
involves the components of all three intracellular secondary Ca2+ messengers signalling 
pathways, and that blocking release via the channels involved in two messages signalling has 
a greater effect on amount of Ca2+ released in response to TLC-S than just blocking one 
(Gerasimenko, Flowerdew, et al. 2006) (Fig. 5.1.1).  
Despite displaying a slightly stronger protective effect than Ned-19 when used alone, GSK-
7975A had no additive effect when used in combination with Ned-19. This could suggest that 
the effects of Ned-19 and GSK-7975A are overlapping rather than additive, as was the case 
with caffeine. The NAADP sensitive ion channel TPC2 (Calcraft et al. 2009) has been shown 
to modulate SOCE via interaction with the CRAC channel proteins STIM1 and Orai1 (López 
et al. 2012), though the effect of Ned-19 on SOCE has not yet been reported. It is possible 
that inhibition of NAADP-induced Ca2+ via TPC2 with Ned-19 could disrupt the channel’s 
interactions with the CRAC channel components and have an inhibitory effect on SOCE. 
This would explain the lack of additional inhibition by use of both Ned-19 and GSK-7975A, 
though this would need confirming by testing Ned-19’s effect on Ca2+ entry. Alternatively, 
the inhibition of the NAADP sensitive component of TLC-S-induced Ca2+ release by Ned-19 
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could be reducing the amount of Ca2+ mobilized from organelle stores bellow the amount that 
triggers SOCE; or at least reduces it to a level that inhibiting it with GSK-7975A has a 
minimal effect. 
As Ned-19 has shown the ability to reduce TLC-S induced necrosis, its protective effects 
should be tested against other models of AP, e.g. alcohol metabolites (Gerasimenko et al. 
2013). It may also be beneficial to test how effective Ned-19 is at preventing Ca2+ release and 
necrosis induced by other bile acids, which may prove to act in a more NAADP independent 
manner. If Ned-19 does prove to exhibit a protective effect against a wide range of cell 
models of AP, it would be desirable to progress it to animal models of the disease.  
The greatest protective effects may be provided when Ned-19 is used in combination with 
compounds that affect other elements of intracellular Ca2+ release than just NAADP, as was 
seen when it was coapplied with caffeine. Caffeine blocks Ca2+ release via IP3R, which can 
be activated by either IP3 itself or Ca2+ via CICR (Taylor and Tovey 2010); though it is not 
known which is the case in TLC-S-induced Ca2+ release. TLC-S activity involves the activity 
of CD38, indicating it acts via the production of secondary messengers rather than direct 
interaction with intracellular Ca2+ channels itself. Testing if TLC-S-induced Ca2+ release is 
also mediated by PLC, e.g. by inhibition with U-73122 (Bleasdale et al. 1990; Smith et al. 
1990), would help resolve if this is true. Identifying compounds other than caffeine that have 
an additive effect with Ned-19 could be useful, as caffeine when used at a high concentration 
is known to have a range of side effects (Blanchard and Sawers 1983; Mahmud and Feely 
2001; Rapuri et al. 2001; Winston et al. 2005).  
NAADP induced Ca2+ release has been shown to involve the activity of both TPC and RyR 
channels (Gerasimenko et al. 2015); with RyR1 providing a larger contribution for NAADP 
induced release and RyR2 doing so for cADPR induced release. This would suggest that 
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Dantrolene, which specificly inhibits RyR1 and RyR3 (Zhao et al. 2001) and that has been 
shown to protect against caerulein-induced AP (Orabi et al. 2010), would not have an 
additive effect if used in conjunction with Ned-19. However, combining Ned-19 with an 
inhibitor of RyR2, e.g. flecainide (Mehra et al. 2014), may do so, as both NAADP and 
cADPR induced Ca2+ release would be inhibited. A similar effect may be possible 
independent of Ned-19 by inhibiting CD38 directly, and preventing the formation of the two 
secondary messengers rather than their activity. Recently it was shown the antibacterial agent 
Rhein inhibited CD38 dependent glioma progression by preventing microglia activation 
(Blacher et al. 2015), and therefore could be a useful compound to test against TLC-S-
induced Ca2+ release and necrosis.  
The toxic levels of cytoplasmic Ca2+ released in response to TLC-S involves all three 
secondary Ca2+ messenger pathways (Gerasimenko, Flowerdew, et al. 2006). Therefore, it is 
unsurprising that knocking out TPC2 had no significant effect on the amount of necrosis 
induced by TLC-S (Fig. 5.2.5) because of the multiple sources of Ca2+ release still available. 
However as pharmacological inhibition of one or more of these pathways did diminish the 
amount of necrosis observed in wild type cell in response to TLC-S (Huang et al. 2017), it 
was possible that TPCN2-/- cells would be less sensitive to TLC-S’s toxic effects. Due to 
there being no loss of sensitivity to TLC-S in the knockout cells it would be assumed that 
Ned-19’s protective effect would be conserved, as was seen in the case of CCK-induced Ca2+ 
oscillations (Fig. 3.2.5). The NAADP antagonist obviously affects enough other elements of 
NAADP signalling that is effect is not dependent on TPC2.  
The results in the chapter show that Ned-19 protects against TLC-S-induced necrosis by 
reducing the amount of Ca2+ mobilized in response to the bile acid. Similar protective effects 
were observed when IP3R were inhibited with caffeine or SOCE was blocked by GSK-
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7975A, though neither of these compounds when used in combination with Ned-19 had a 
significant additive protective effect. Genetic knockout of TPC2 channels, which has been 
shown to significantly reduce the amount of Ca2+ mobilized in PAC in response to NAADP, 
had no effect on TLC-S-induced necrosis or on the protective effect of Ned-19. This further 
suggests that PAC have enough NAADP-sensitive ion channels to compensate for the loss of 
TPC2 activity in both physiological and pathological Ca2+ signalling. 
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Chapter 6: Inhibition of pancreatic acinar cell necrosis induced by the bile acid cholate 
requires inhibition of both NAADP-induced calcium release and store operated calcium 
entry 
 
6.1: Overview of calcium entry and GSK-7975A 
As non-excitable cells, PAC are known to utilise the process of SOCE to allow for refilling of 
the ER organelle store after it has been depleted by release of Ca2+ induced by secondary 
messengers (Krause et al. 1996). This process is required to refill the store as not all of the 
Ca2+ released from the ER is taken back up into its lumen via SERCA pumps (Ponnappa et al. 
1981), but instead is either taken up by other organelles (Okorokov et al. 2001) or transported 
outside the cell by the PMCA and NCX (Muallem et al. 1988). 
The loss of Ca2+ from the ER lumen is detected by the protein STIM1 (Liou et al. 2005); 
which at resting [Ca2+]l binds Ca2+ to its lumenal domain, but loses these bound ions when 
the [Ca2+]l is depleted by secondary messenger-induced release. When STIM1 loses its bound 
Ca2+ it oligomerizes (Luik et al. 2008), inducing a conformational change in the protein 
(Zhou et al. 2013) and causes it to migrate to regions of the ER membrane that are physically 
close to the plasmalemma (Zhang et al. 2005). At these ER-PM puncta, STIM1 interacts with 
Orai1 channels in the plasmalemma (Rothberg et al. 2013) forming a CRAC channel complex 
and inducing the opening of these channels, allowing extracellular Ca2+ to enter the cell 
(Zhou et al. 2010). Entry of external Ca2+ increases the [Ca2+]c, allowing for refilling of the 
ER, increasing the [Ca2+]l back to resting levels and causing Ca2+ to rebind to STIM1 
(Soboloff et al. 2012). Once it has bound Ca2+ again STIM1 reverts back to its resting state, 
causing dissociation of the CRAC channel complex and an end to Ca2+ entry.  
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Several other types of ion channel have been shown to affect SOCE, including several 
members of the TRPC family located in the plasma membrane (Salido et al. 2009). It has 
been suggested that these channels form complexes with Orai channels where the TRPC 
components are activated by the Orai ones after stimulation by STIM (Liao et al. 2007). PAC 
isolated from TRPC3-/- mice showed a substantial reduction in the amount of Ca2+ that 
entered the cell upon store depletion down about 50% compared to wild type cells (Kim et al. 
2009). The NAADP sensitive ion channel TPC2 has also been shown to affect SOCE in 
MEG01 and HEK293 cells (López et al. 2012). Knockout of TPC2, but not TPC1, reduced 
the rate and extent of SOCE in both cell types upon ER depletion by Tg, or stimulation of 
MEG01 cells by thrombin. While no co- immunoprecipitation was observed in resting 
MEG01 cells; after store depletion TPC2 was found to associate with both Orai1 and STIM1, 
while TPC1 was not. Interestingly TPC2 showed no association with TRPC1 in depleted 
MEG01 cells, silencing expression of this gene in MEG01 cells with ShRNA has been shown 
to reduce the size of the SOCE response (López et al. 2013). These results suggest that TPC2, 
but not TPC1, can regulate SOCE in these cell types independent of TRPC1; it also links the 
acidic Ca2+ store to a process commonly associated with only the ER store. In PAC there is 
evidence of two ‘pools’ of Orai1; a basolateral pool that interacts with STIM1 and an apical 
pool that interacts with IP3R (shown by co-localization and co-immunoprecipitation of IP3R 
and Orai1), with some evidence that IP3R activation can have an inhibitory effect on SOCE. 
(Lur et al. 2011) 
The process of SOCE is highly important in PAC, as it is the process through which the large 
sustained increases in cytoplasmic Ca2+ associated with pathological agents occurs through 
(Wen et al. 2015). Under physiological conditions SOCE results in refilling of the ER, 
causing STIM to rebind Ca2+ and terminate Ca2+ entry (Soboloff et al. 2012). In the case of  
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Fig. 6.1.1 The Effect of the CRAC channel blocker GSK-7975A on store-operated 
calcium entry in pancreatic acinar cells  
(A) Representative trace of SOCE in pancreatic acinar cells after depletion of ER calcium 
content by Tg in calcium free conditions (n = 5). (B) Representative trace of SOCE in 
pancreatic acinar cells in the presence of 10 µM GSK-7975A after depletion of ER calcium 
content by Tg in calcium free conditions (n = 5). (C) Representative trace of intracellular 
calcium responses to 100 µM POAEE in pancreatic acinar cells in the absence (n = 8) or 
presence of 10 µM GSK-7975A (n =12). (D) GSK-7975A reduced the amount of necrosis 
induced by 100 µM POAEE (Data represents mean ± SEM; n = 3 series of experiments with 
the number of tested cells in each group >350). Inhibition of necrosis was significant for 3 
μM GSK-7975A (**P < 0.02) and highly significant for 5 and 10 μM GSK-7975A (***P < 
0.003 and ****P < 0.001).  
Modified under terms of free use from J Gerasimenko et al.; PNAS; 2013 (Gerasimenko et al. 2013).    
  
194 
 
bile acids, it has been shown that these pathological agents disrupt this process by preventing 
refilling of the ER via inhibition of SERCA pumps; either through direct interaction (Kim et 
al. 2002) or indirectly by disrupting ATP production (Voronina et al. 2010). Due to the 
involvement of SOCE in the pathogenesis of pancreatitis it had previously been suggested 
that this refilling pathway might prove to be a potential therapeutic target (Li et al. 2014). 
Validation of this hypothesis was proven using the selective CRAC channel blocker GSK-
7975A; which blocks Ca2+ entry by inhibiting Orai1 channels (Derler et al. 2013; Rice et al. 
2013). Gerasimenko et al. found that this compound blocked Ca2+ entry in PAC induced by 
both Tg (Fig. 6.1.1A-B) and the pathological agent palmitoleic acid ethyl ester (POAEE) 
(Fig. 6.1.1C) in a dose-dependent manner (Gerasimenko et al. 2013). POAEE is a fatty acid 
ethyl ester; metabolite products of fatty acids and ethanol that have been shown to induce AP 
(Criddle et al. 2004). The inhibition of SOCE by GSK-7975A was enough to provide a 
protective effect against POAEE (Fig. 6.1.1D), with concentrations above 3 µM having a 
significant effect and 10 µM reducing the amount of necrosis observed to a level not 
significantly different from the control (Gerasimenko et al. 2013). Further confirmation was 
provided by Wen et al.; who used GSK-7975A and another CRAC channel blocker CM_128 
to show similar reductions in SOCE by both TLC-S and of supramaximal concentration of 
CCK (Wen et al. 2015). Additionally, they tested the effects of these compounds against 3 
different models of AP (Bile acid, ethanol metabolite and cerulean) and found a protective 
effect against all three models. 
 
6.2: The effect of the bile acid cholate on pancreatic acinar cells  
As the relationship between cholate and necrosis in PAC has not been characterised it is 
important to find the ideal concentration of cholate to characterise its effect in them. Bile  
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Fig. 6.2.1 Necrosis dose response to cholate by pancreatic acinar cells  
Compiled results of cell death assays performed on pancreatic acinar cells treated with a 
varying concentration of cholate for 1 hour with their corresponding controls. Purple bars 
represent the number of necrotic cells as a percentage of the total number of cells counted for 
untreated control samples, and orange bars represent the number of necrotic cells as a 
percentage of the total number of cells counted when treated with a specific concentration of 
cholate (Data represents mean ± SEM; n = 1054 cells for 10 mM, n = 846 cells for 7 mM, n = 
5305 cells for 5 mM, n = 2031 cells for 3 mM, n = 3771 cells for 2 mM, n = 4646 cells for 
1.5 mM and n = 1866 cells for 1 mM; *, P ≤ 0.05; n/s, not significant). 
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acids in biliary bile have been reported as reaching the low millimolar (Gerasimenko, 
Flowerdew, et al. 2006) range, a selection of cholate concentrations between 1  and 10 mM 
were tested (Fig. 6.2.1). The data displayed is the compiled results of multiple different 
experiments so each concentration of cholate is displayed with its corresponding control, 
which vary between 6.8 and 11.1 % necrotic cells. While the highest control value is slightly 
above the maximum desirable background level of 10 % necrotic cells, it is not enough to be 
concerned and there is no significant difference between any of the control sets of data. 
A clear pattern of an increase in the concentration of cholate resulting in an increase in the 
amount of necrosis can be observed. 1 mM induced a comparable level of necrosis to that in 
its untreated control cells, 10.2 % compared to 11.1 %, which was not deemed significant by 
ANOVA comparison (p > 0.999). While increasing the cholate concentration to 1.5 mM 
almost doubled the amount of necrosis observed to 18.0 %, this was not deemed significant 
compared to its control (p = 0.89). A large increase was seen when the concentration was 
increased by another 0.5 mM to 2 mM, with 44.3 % of cells labelled with PI, an amount 
deemed significant to its control (p < 0.0001). Increasing the cholate concentration above 2 
mM resulted in further increases in the amount of necrosis observed, however none of the 
increases were deemed as significant compared to the amount of necrosis in the previous 
concentration used.  
The ideal amount of necrotic cells for these experiments is between 30 and 40% of the total 
cells counted. A level of necrosis below this might mean any reduction caused by a 
pharmacological agent is not large enough to be deemed significant as the positive control is 
too similar to the negative control (as was seen in Fig. 4.2.4.B). Alternatively, an excessive 
amount of necrosis may produce in unspecific effects or occur too rapidly for a 
pharmacological agent to have a protective effect. The results for both 2 mM and 1.5 mM  
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Fig. 6.2.2 Effect of Ned-19 on cell death in acinar cells induced by 1.5 mM Cholate  
The results of cell death assays performed on pancreatic acinar cells treated with 2 mM 
cholate with and without 100 µM Ned-19 for 1 hour. Data represents the number of necrotic 
cells as a percentage of the total number of cells counted for that specific treatment (Data 
represents mean ± SEM, n = 6742 cells; *, P ≤ 0.05).  
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cholate are outside of this range, with the level of necrosis induced by 1.5 mM 12 % below 
the lower bound and 2 mM 4.3 % above the upper bound. As neither concentration was 
within the desired range the effect of 100 µM Ned-19 was tested against both of them. 
ANOVA comparison of the 1.5 mM cholate experiment (Fig. 6.2.2) deemed the response to 
the bile acid alone was significantly higher than the untreated control (p = 0.0013). When the 
effects of Ned-19 were tested against 1.5 mM cholate a significant reduction in necrosis was 
observed (p = 0.0117). However, when its effect was tested against 2 mM cholate (Fig. 6.2.3) 
a nonsignificant reduction was observed (p = 0.4368). It should be noted in these experiments 
the average amount of necrosis induced by 2 mM cholate was slightly lower than seen in the 
dose response experiments; down to 38.9 % of the total cells counted for that treatment, a 
value within the desired range of necrosis.  
As Ned-19 was unable to significantly reduce the amount of necrosis induced by the higher 
concentration of cholate the inhibitor of SOCE, GSK-7975A, was tested. SOCE is the process 
by which a pathological [Ca2+]c is sustained in PAC after store depletion, and inhibition of 
this process has been shown to have a protective effect against various models of AP  (Wen et 
al. 2015). When PAC were incubated with cholate and GSK-7975A (like with Ned-19) a 
reduction in necrosis was observed compared to cholate alone, however this reduction was 
also not deemed as significant (p = 0.2776). 
Despite GSK-7975A not showing an additive protective effect when used in combination 
with Ned-19 against necrosis induced by 200 µM of the bile acid TLC-S, a combination of 
the two compounds was tested against 2 mM cholate. When used in combination a lower 
level of necrosis was observed compared to either GSK-7975A or Ned-19 alone, down to 
18.62 ± 3.86 %. This reduction was deemed significant compared to cholate alone (p = 
0.0496) unlike when either of the compounds were used separately. Despite the amount of  
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Fig. 6.2.3 Effect of Ned-19 and GSK-7975A on cell death in acinar cells induced by 2 
mM Cholate 
The results of cell death assays performed on pancreatic acinar cells treated with 2 mM 
cholate, 100 µM Ned-19 and/or 10 µM GSK-7975A for 1 hour. Data represents the number 
of necrotic cells as a percentage of the total number of cells counted for that specific 
treatment (Data represents mean ± SEM, n = 7675 cells; *, P ≤ 0.05; n/s, not significant).  
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necrosis being about double that seen in the control of 9.77 ± 0.21 %, this difference was not 
deemed significant by ANOVA comparison (p = 0.6204). 
To visualise the protective effects of using a combination of Ned-19 and GSK-7975A, 
imaging experiments were performed with conditions similar to those in the necrosis 
experiments. PAC were either perfused with NaHEPES solution for 15 min and then 2 mM 
cholate for the same hour period of the necrosis experiments; or pre-treated for 15 min with 
100 µM Ned-19 and 10 µM GSK-7975A, then continued to be exposed to these compounds 
as well as 2 mM Cholate for an hour. Additionally, some control experiments were performed 
where cells were perfused with NaHEPES for 75 min. After some of the experiments 
Propidium Iodide was added to the cells and the number of necrotic and viable cells 
calculated.  
In all 18 of the recorded cells exposed to Cholate alone (Fig. 6.2.3A) there was a large 
increase in [Ca2+]c followed by a rapid decrease below the baseline (believed to be the result 
of the loss of plasmalemma integrity). The onset of this phenomenon differed between cells, 
varying between about 20 and 55 min after the addition of the bile acid. While it was also 
seen in the majority of the recorded cells also treated with Ned-19 and GSK-7975A (Fig. 
6.2.3B), it was not observed in a third of them (8 out of 25 cells). In the cells it did occur in, it 
was only observed in the final 10 minutes of the recording; suggesting that while the 
combination of compounds might not have prevented cell death in all of the cells observed, it 
may have delayed it in those cells. Of the 9 observed control cells, none displayed the rise 
and loss of fluorescence seen in all of the cells exposed to cholate alone, implying that it is 
caused by the bile acid and not the cells being exposed to the light source for that time period. 
After imaging, when the amount of necrosis was calculated by addition of Propidium Iodide 
(Fig. 6.2.3C), the bile acid alone was observed to induced a significantly higher amount of  
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Fig. 6.2.4 The effect of 2 mM cholate on pancreatic acinar cells 
(A) Representative trace of the effect of  2 mM cholate on cytoplasmic calcium in pancreatic 
acinar cells. (B) Representative trace of the effect of 2 mM cholate on cytoplasmic calcium in 
pancreatic acinar cells in the presence of 100 µM Ned-19 and 10 µM GSK-7975A. 
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Fig. 6.2.4 (continued) 
(C) The results of cell death assays performed on pancreatic acinar cells after imaging by the 
addition of 2 µM PI, during imaging cells were exposed to 2 mM Cholate in the presence or 
absence of 100 µM Ned-19 and 10 µM GSK-7975A for 1 hour. Data represents the number 
of necrotic cells as a percentage of the total number of cells counted for that specific 
treatment (Data represents mean ± SEM, n = 3562 cells; *, P ≤ 0.05; n/s, not significant).  
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necrosis than either the control or when also exposed to Ned-19 and GSK-7975A. While the 
amount of necrosis was higher in the cells treated with cholate, Ned-19 and GSK-7975A than 
the untreated control cells; there was no significant difference between the two sets of cells (p 
= 0.292).  
 
6.3 Discussion 
While various bile acids have been shown to induce increases in cytoplasmic Ca2+ in PAC 
and/or their death (Kim et al. 2002; Voronina et al. 2002), the effect of cholate on them has 
yet to be characterised. Like other bile acids, cholate was also found to induce necrosis in 
PAC. However, this required a concentration in the millimolar range rather than the 100 
micromolar range for the better characterised bile acid TLC-S. As TLC-S is a derivative of 
cholate it would suggest the chemical modifications that changes cholate’s structure into 
TLC-S’s increases the potency of its effect on PAC.  
The lowest concentration of cholate tested, 1 mM, showed no effect on the amount of 
necrosis compared to the untreated control. While increasing the cholate concentration to 1.5 
mM doubled the amount of necrosis, this was not deemed significant compared to its control. 
Another increase of 0.5 mM to 2 mM had a similar effect, roughly doubling the amount of 
necrosis; while further increases in the concentration of cholate increased the number of 
necrotic cells counted, none of these increases was as dramatic. This suggests that there is a 
narrow range between 1 and 2 mM of cholate where the bile acid becomes toxic to PAC. 
Based on the well characterised effects of another bile acid, TLC-S; it will be in this 
concentration range that cholate changes from inducing harmless transient changes in [Ca2+]c 
to a pathological sustained increase. 
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For experimental purposes a desired amount of necrosis is between 30 % and 40 % of the 
total cells when studying the effects of pharmacological agents. In the cholate concentration 
response results (Fig. 6.2.1) none of the concentrations tested produced an amount of necrosis 
within the desired range. With 1.5 and 2 mM cholate producing values either side of the 
desired range, Ned-19 was tested against both of them. While Ned-19 reduced the amount of 
necrosis induced by concentrations of cholate it was only deemed significant when used 
against the lower concentration (which in this incidence induced a significant increase in 
necrosis compared to its control). It is possible that while 100 µM Ned-19 is a high 
concentration of the compound, it might not be sufficient to significantly inhibit the effects of 
cholate at higher concentrations. Alternatively, at higher concentrations the NAADP-
independent effects of cholate could be enhanced, minimising the Ned-19’s ability to inhibit 
them. Therefore, it could be useful to test the effect of higher concentrations of Ned-19 
against 2 mM cholate to see if they have a significant protective effect.  
With Ned-19 showing no significant reduction against the necrotic effect of 2 mM cholate the 
effects of GSK-7975A were tested. Similar to Ned-19, GSK-7975A produced a 
nonsignificant reduction in cholate-induced necrosis. Like with Ned-19 it would be useful to 
test higher concentrations of GSK-7975A to discover if 10 µM is a sub-optimal concentration 
of the compound.  
While inhibiton of either NAADP-induced Ca2+ release or SOCE alone by Ned-19 or GSK-
7975A respectively did not produce a significant reduction in necrosis, applying both both 
compounds together did produce a significant protective effect. These results could suggest 
that when used alone, neither compound was applied at a sufficient concentration to prevent 
the [Ca2+]i from reaching cytotoxic levels in enough cells to significantly reduce the amount 
of necrosis observed. Alternatively, it could indicate that the inhibition of multiple elements 
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of the cell’s ‘Ca2+ signalling toolkit’ is required to sufficiently protect PAC against cholate-
induced necrosis. If use of increased concentrations of either Ned-19 or GSK-7975A alone 
has no increased inhibitory effect on cholate-induced necrosis it would suggest that a 
‘multidrug’ approach is required. Under such circumstance the response of either Ned-19 or 
GSK-7975A and inhibitors for other elements of Ca2+, e.g. caffeine to block IP3 sensitive 
Ca2+ release (Wakui et al. 1990), should be tested as may have greater protective effect than 
the combination of Ned-19 and GSK-7975A. 
When Ned-19 and GSK-7975A were used together against 200 µM TLC-S, they showed no 
additive protective effect against the amount of necrosis induced compared to either of them 
individually. However, the combination of Ned-19 and GSK-7975A did show an additive 
protective effect against 2 mM cholate. This could be due the lower level of necrosis seen in 
the positive controls (when the bile acids were used alone) for TLC-S compared to cholate. 
As Ned-19 alone was enough to significantly reduce the necrotic effect of TLC-S, it might 
reduce the amount of Ca2+ released in response to TLC-S below that required to trigger 
SOCE, which in turn would mean GSK-7975A would have no additional protective effect. 
This implies that either 100 µM Ned-19 is not a sufficient concentration to achieve a similar 
effect against 2mM cholate; or that at this concentration of bile acid there is NAADP-
independent Ca2+ release occurring, which is sufficient to initiate SOCE. Testing if higher 
concentrations of Ned-19 can significantly reduce the amount of necrosis induced by 2 mM 
cholate (like 100 µM Ned-19 did against 1.5 mM cholate) could help resolve which of these 
possibilities is true. It may also be interesting to see if 100 µM of Ned-19 still has a 
significant protective effect against a higher concentration of TLC-S that induces a 
comparable amount of necrosis to 2 mM cholate; and if not if addition of 10 µM GSK-7975A 
has an additive effect.  
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Fluorescent Ca2+ imaging was used to corroborate the findings of the initial necrosis 
experiments and give a greater idea of the pattern of cholate-induced cell death. The majority 
of cells recorded initially showed an oscillatory pattern in response to cholate reminiscent of 
physiological secretagogue- induced signalling. This signalling was not inhibited by the 
combination of Ned-19 and GSK-7975A, though did appear to be reduced in size. The pattern 
of this Ca2+ response suggests that it is the result of the release of Ca2+ from organelle stores 
via secondary messenger’s pathways and its, at least partial, insensitivity to Ned-19 suggests 
an NAADP-independent component to this release. As such characterising whether this 
component is either IP3 and/or cADPR sensitive would aid in identifying inhibitors that could 
be used in combination with Ned-19 and/or GSK-7975A to provide a more effective 
inhibition of cholate-induced necrosis of PAC.   
Within the hour exposure to 2 mM cholate alone, all of the cells whose Ca2+ responses were 
recorded showed a clear loss of plasma membrane integrity characteristic of a cell dying. 
This pattern was also observed in two thirds of the cells recorded when Ned-19 and GSK-
7975A were also present. As GSK-7975A has a protective effect against cholate it is likely 
that the death observed is the result of a sustained cytotoxic concentration of Ca2+ occurring 
via SOCE. This would have several pro-necrotic effects, such as the opening of the mPTP 
and disruption of ATP production via loss of the inner mitochondrial membrane’s potential. 
Addition of 6 µM PI post-imaging allowed for the number of necrotic cells to be counted. 
The same pattern as the initial necrosis experiments was observed, though with a roughly 15 
% higher average amount of necrosis for all treatments. This confirmed the previous necrosis 
results; but demonstrated one of the drawbacks of the preparation used, the time dependence 
of its use. From the time the PAC cells are isolated their quality declines, limiting its use to a 
few hours. As the number of necrotic cells in the imaging experiments were counted one to 
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two hours later than those in the initial necrosis experiments the extra necrosis observed was 
a result of this phenomenon.  
As TPC2 has been shown to affect SOCE in some cell types (López et al. 2012) it would be 
interesting to see if PAC isolated from TPCN2-/- mice show reduced levels of Ca2+ entry in 
response to store depletion compared to wild type cells. If this was the case these knockout 
cells might have an additional resistance to cholate induced necrosis, at least at lower 
concentrations of the bile acid due to the reduced amount of Ca2+ entry occurring in them. 
 Together with the results for the bile acid TLC-S this work demonstrates that inhibition of 
NAADP-sensitive Ca2+ release by the NAADP antagonist Ned-19 can have a protective 
effect in a cellular model of biliary AP. Testing its protective potential against the necrotic 
effects of other bile acids, especially those derived from the other initial bile 
chenodeoxycholic acid rather than from cholate, would help strengthen this conclusion. As 
would testing if it can inhibit other forms of necrosis, most notably ethanol and its 
metabolites like fatty acid ethyl esters. Additionally, progression from cellular models of the 
disease to animal models would demonstrate if Ned-19 has future clinical applications. 
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Chapter 7: The synthetic NAADP antagonist BZ194 shows no effect in pancreatic 
acinar cells 
 
7.1: Overview of BZ194 
The intracellular secondary signalling molecule NAADP has been shown to induce the 
release of Ca2+ from intracellular stores in a wide range of both mammalian (G. C. Brailoiu et 
al. 2009; Aley et al. 2010; Sánchez-Tusie et al. 2014) and non-mammalian cells (Galione et 
al. 2000; Navazio et al. 2000). It is structurally identical to its chemical precursor NADP 
other than the substitution of a nicotinic acid moiety for a nicotinamide one (Aarhus et al. 
1995), this exchanges an amide anion for a hydroxide anion (Fig. 7.1.1). This change reduces 
the molecule’s net charge by -1 down to -4 and confers the Ca2+ mobilising activity that 
NADP lacks; implying the nicotinic acid moiety is the key structural requirement for 
NAADP’s activity (Lee and Aarhus 1997). 
It is known that high concentrations of NAADP are auto inhibitory in mammalian cells, 
exhibiting a bell-shaped response curve (Berg et al. 2000). Additionally, coapplication of 
nicotinic acid with NAADP via microinjection into T cells, greatly reduces the increase in 
[Ca2+] observed; an effect lacking when nicotinamide instead is coapplied (Dammermann et 
al. 2009). Together these results imply that nicotinic acid, either as a molecule or as a moiety 
in NAADP, is producing this inhibitory effect. However due to their polar nature both 
NAADP and nicotinic acid have a low membrane permeability, limiting their use as 
pharmacological agents in research.  
Dammermann et al. decided to design a small molecule inhibitor of NAADP’s activity 
(Dammermann et al. 2009) using nicotinic acid as a lead compound rather than NAADP itself 
due to its lower net charge (-1 compared to -4). They performed a screen of a library of  
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Fig. 7.1.1 Structures of NAADP and NADP 
The skeletal formulas of the dinucleotides NAADP and NADP.  
 
 
 
 
Reproduced under terms of free use from W Dammermann et al.; PNAS; 2009 (Dammermann et al. 2009). 
  
211 
 
alkylated nicotinic acid derivatives, examining their ability to block T-cell proliferation (a 
measure of their activation, which is regulated by NAADP signalling). This identified a N-
alkylated 8-carbon side chain derivative of nicotinic acid as the most efficient antagonist of 
effector T cell proliferation. The compound (Fig. 7.1.2A), 3-carboxyl-1-
octylcarbamoylmethyl-pyridinium (BZ194), when coinjected with NAADP was able to 
reduce the increase in [Ca2+]c observed in a concentration-dependent manner (Fig. 7.1.2B), 
with an IC50 below 10 µM (Fig 7.1.2C). This effect was specific to NAADP’s activity; 
showing no significant effect on the Ca2+ mobilizing capacity of either IP3 or cADPR the 
other Ca2+ mobilizing secondary messengers (Fig. 7.1.2D).   
As well as reducing the Ca2+ response to NAADP directly; BZ194 was able to reduce the 
increase in [Ca2+]c observed in primary T cells activated by either the Myelin basic protein 
(MBP) antigen or by CD3 antibodies. Both the phases of the Ca2+ response, the initial peak 
and sustained plateau, were diminished when T cells were preincubated with BZ194. While 
only a partial reduction in the [Ca2+]c upon T cell activation is observed in the presence of 
BZ194 (likely a result of several secondary messengers being involved in such a response, as 
is the case of the response to CCK in PAC (Cancela 2001)), this reduction is enough to 
suppress several downstream events of Ca2+ signalling in T cells. Both nuclear translocation 
of nuclear factor of T cells” (NFAT) and antigen- induced production of interleukin-2 was 
significantly reduced when BZ194 was present, restimulation of cells after removal of the 
compound resulted in expression of the cytokine. A similar effect was observed on T cell 
proliferation; preincubation with BZ194 before stimulation suppressed proliferation, removal 
and reapplication of an antigen resulted in a normal response.  
Previously, the group had shown that NAADP increased binding of [3H]ryanodine to purified 
RyR1 receptors (the binding of which is proportional to channel opening). BZ194 showed no  
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Fig. 7.1.2 Structure of BZ194 and its effect on NAADP signalling  
(A) The skeletal formula of the shared structure used in Dammermann et al.’s screen of 
nicotinic acid analogues and variable groups for BZ194. (B) Inhibition of Ca2+ signals 
induced by coinjection of 100 nM NAADP in Jurkat T cells with a variable concentration of 
BZ194, traces represent the mean data of 5-13 experiments.  (C) Concentration-response 
curve of NAADP-induced [Ca2+]c with BZ194 (mean ± SEM, n = 5-13; *, P ≤ 0.05). (D) 
Effect of NAADP (100 nM), IP3 (4 µM) or cADPR (100 µM) microinjection on Jurkat T 
cells with or with coapplication of 1 mM BZ194 (Data represents mean ± SEM, n = 5-13; *, 
P ≤ 0.05; ns, not significant).  
Modified under terms of free from W Dammermann et al.; PNAS; 2009 (Dammermann et al. 2009). 
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ability to disrupt basal binding of [3H]ryanodine to the receptor, but did block the increased 
binding induced by NAADP. This effect is also concentration-dependent, with a comparable 
IC50 value to its ability to block NAADP induced Ca2+ release. As BZ194 was observed 
promoting the dissociation of NAADP, but not [3H]ryanodine from reactivated RyR1, it is 
most likely via allosteric regulation. 
Together this work showed that BZ194 is a cell permeable specific inhibitor of NAADP’s 
Ca2+ releasing activity via RyR1. Subsequently it has been used in several studies to examine 
NAADP’s role in cellular processes; including experimental autoimmune encephalomyelitis 
(Cordiglieri et al. 2010), isoproterenol-induced cardiac arrhythmias (Nebel et al. 2013), and T 
cell shape and migration (Nebel et al. 2015).  However, Ali et al. found BZ194 had no effect 
on the proliferation of naïve CD4 T Cells, but Ned-19 did (Ali et al. 2016); and suggested 
that BZ194 effect may be cell specific. 
Another study by Ali et. al showed that co-injection of 100 µM BZ194 with NAADP into 
SKBR3 cells diminished Ca2+ responses compared to NAADP alone (Ali et al. 2014), but had 
no effect on either NAADP-induced Ca2+ release or NAADP binding in sea urchin egg 
homogenate. They also found no effect of Ned-19 on NAADP’s activity and binding in the 
homogenate; directly contradicting previous findings in this model, showing Ned-19 
affecting both (Naylor et al. 2009). While Ali et al. concluded this shows a difference in 
specificity between human and urchin NAADP receptors for BZ194, the Ned-19 urchin 
results do raise doubts about the validity of this conclusion. 
As well as disrupting NAADP’s ability to release Ca2+ via RyR’s, BZ194 could have an 
additional effect on NAADP signalling by affecting its synthesis. NAADP is produced as part 
of an intracellular signalling cascade in response to a cell receiving an external stimulus 
(Cosker et al. 2010). It is synthesised from NADP and nicotinic acid via a base-exchange 
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catalysed by the enzyme CD38. As BZ194 is based on the structure of nicotinic acid, it could 
potentially compete with nicotinic acid in CD38’s binding site, blocking the base-exchange 
with NADP due to the extra acyl group present on BZ194. 
The ability of RyR’s to act as NAADP sensitive Ca2+ channels has been disputed, due to both 
their ER/SR subcellular location in most cells and some experimental evidence (Copello et al. 
2001; Wagner et al. 2014). However there is compelling evidence that it can do so both in 
isolation (Mojžišová et al. 2001; Hohenegger et al. 2002) and in whole cells (Gerasimenko et 
al. 2003; Mitchell et al. 2003; Steen et al. 2007).  
It was recently suggested in PAC that NAADP-induced Ca2+ release can occur by either TPC 
and RyR channels (Gerasimenko et al. 2015), with disruption to either type of channel 
resulting in a large reduction in the size of the Ca2+ response to NAADP. As PAC have been 
shown to mobilize Ca2+ (at least in part) via RyR’s, with RyR1 providing the bulk of this 
response, it is likely that BZ194 should have an inhibitory effect on NAADP signalling in 
PAC. 
 
7.2: The effect of BZ194 in pancreatic acinar cells 
5 pM CCK was applied to intact PAC to induce a typical oscillatory Ca2+ response and then a 
high inhibitory concentration of BZ194 (Dammermann et al. 2009) was applied acutely to the 
cells, as previously done with Ned-19 (Gerasimenko et al. 2015). After 300 s of CCK alone, 
BZ194 was added in the continued presence of CCK for 300 s. Addition of BZ194 appeared 
to cause a small reduction in the amplitude of the Ca2+ oscillations observed (Fig. 7.2.1A); 
but not a total inhibition, like that observed for Ned-19. The average area under the trace was 
calculated for the two 300 s periods that CCK was applied to the cells with and without  
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Fig. 7.2.1 The effect of BZ194 on CCK induced calcium oscillations in pancreatic acinar 
cells 
(A) Representative trace of the effect of 1 mM BZ194 on the CCK response in pancreatic 
acinar cells. (B) Bar Chart showing the average area under the trace for the cells sampled; 
either in the presence or absence BZ194. Together this data shows that BZ194 CCK between 
100 s and 400 s and CCK & BZ194 between 400 s and 700s (Data represents mean ± SEM, n 
= 11; n/s, not significant). 
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BZ194 (Fig. 7.2.1B). While a slight reduction in response was observed after the addition of 
BZ194, it was deemed not significant by use of a Student’s t-test, p = 0.63.   
While BZ194 showed no ability to block the CCK-induced Ca2+ response when applied 
acutely it may affect the activity of the bile acid TLC-S, which also contains an NAADP 
element (Gerasimenko, Flowerdew, et al. 2006). Therefore, it was decided to test its ability to 
reduce necrosis in a biliary model of pancreatitis. As preincubation was required in T cells to 
produce the best effects with BZ194, PAC were treated for 15min with 100 µM BZ194 and 
then exposed to 200 µM TLC-S for 1 hour.  
Compared to the untreated control cells, those exposed to TLC-S alone or TLC-S and BZ194 
both showed an increase in the number of necrotic cells counted. These increases were 
deemed significant by ANOVA comparison, p = 0.0025 and p = 0.0028 respectively. 
Interestingly cells treated with 100 µM BZ194 alone for 75 min also showed an increase in 
necrosis above that observed in the control, however this increase was not deemed to be 
significant (p = 0.1913). Importantly there was no significant difference in the amount of 
necrosis between cells exposed to TLC-S either in the presence or absence of BZ194, p = 
0.9998.  
 
7.3 Discussion 
Our understanding of secondary messenger Ca2+ signalling has been greatly aided by 
pharmacological agents that inhibit specific individual elements of signalling pathways, 
allowing their roles to be discerned. One such agent is the NAADP specific antagonist Ned-
19, discovered based on its similarity to the 3D electrostatic structure of NAADP (Naylor et 
al. 2009). Due to its autofluorescence Ned-19 is known to stain lysosomes in murine 
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Fig. 7.2.2 Effect of BZ194 on TLC-S-induced cell death in acinar cells  
The results of cell death assays performed on pancreatic acinar cells preincubated for 15 min 
with or without 100 µM BZ194 and subsequently treated with 200 µM TLC-S for 1 hour 
where applicable. Data represents the number of necrotic cells as a percentage of the total 
number of cells counted for that specific treatment (Data represents mean ± SEM, n = 3168 
cells; *, P ≤ 0.05; n/s, not significant). 
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pancreatic beta cells (Naylor et al. 2009) and colocalize with TPC1 staining on acrosomes in 
murine sperm (Arndt et al. 2014). It has also been used to study the gating of TPC2 channels 
in lipid bilayers by patch clamping (Pitt et al. 2014), displaying the ability to induce channel 
opening at low concentrations and inhibit opening at higher concentrations. Ned-19’s ability 
to inhibit NAADP-induced Ca2+ release via RyR is unknown as no data on the matter has 
been published. With Ned-19 localising to organelles that do not contain RyR in their 
membranes and only a 67.8% inhibition of NAADP-induced Ca2+ release in PAC 
(Gerasimenko et al. 2015) (where NAADP has also been shown to mobilise Ca2+ via RyR 
(Gerasimenko et al. 2003; Gerasimenko, Sherwood, et al. 2006)) it is possible that NAADP-
induced Ca2+ release via RyRs is insensitive to Ned-19. This possibility is supported by the 
crystal structure of AtTPC1, which showed a binding site on the channel for Ned-19 (Guo et 
al. 2016; Kintzer and Stroud 2016). Which agrees with the finding that Ned-19 is a non-
competitive antagonist (Naylor et al. 2009) of NAADP, and so may act by directly inhibiting 
TPC channels rather than NAADP’s action on them. An alternative theory would be that as 
NAADP acts via binding proteins (Lin-Moshier et al. 2012; Walseth et al. 2012), it is 
possible that Ned-19 only affects the binding protein/proteins that are responsible for 
NAADP activity via TPC channels. 
With 32.2% of NAADP-induced Ca2+ release in PAC being insensitive to Ned-19 it is 
important that there is a larger range of pharmacological agents capable of disrupting 
NAADP signalling to investigate this phenomenon. As such BZ194 might have proved an 
invaluable tool to investigate this and NAADP-induced Ca2+ release via RyR in these cells, 
however the experimental data shows a lack of effect in them. Unlike Ned-19, which showed 
the ability to cause a complete cessation of oscillations when applied acutely (Gerasimenko et 
al. 2015), BZ194 showed no effect on CCK-induced Ca2+ oscillations (Fig. 2.2.1). Previous 
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reports using BZ194 in Ca2+ imaging experiments either used preincubation of the compound 
or coapplication of it with NAADP rather than an acute application on top of a response 
(Dammermann et al. 2009; Nebel et al. 2013). These types of application were not tested in 
PAC as only its effect compared to that of Ned-19 were of interest. Preincubation of PAC 
with BZ194 before application of CCK might reduce or inhibit any Ca2+ oscillations; but 
would mean the compound would be of little use to treat acute pancreatitis, where it would 
need to have an acute effect. 
Indeed, even with a 15 min preincubation BZ194 had no significant effect on the level of 
TLC-S-induced necrosis observed (Fig. 2.2.2). A longer incubation may yield a protective 
effect against TLC-S experimentally, e.g. a 48 h preincubation was used to suppress antigen-
induced T cell proliferation (though half the concentration of the compound was applied 
(Dammermann et al. 2009)). However, as previously mentioned this would not be 
therapeutically useful as any treatment for acute pancreatitis would have to be applied to 
patients already experiencing an incident of the disease. Additionally, due to the steady 
deterioration of the preparation of PAC used, any extension of experiment time would 
increase the basal level of necrosis seen, which could reduce any protective effects of a 
longer preincubation of BZ194.  
In the cell death experiments BZ194 also appeared to have a toxic effect; however, the 
increase in necrosis in the cells treated with BZ194 alone for 75 min compared to the 
untreated control was not deemed significant. Previous experiments injecting rats with 
concentrations of BZ194 up to 1mM for 7 days of 0.5 mM for 14 days showed no evidence of 
the compound being toxic (Cordiglieri et al. 2010). Preincubation with BZ194 was able to 
reduce the proliferation of stimulated T cells (Dammermann et al. 2009), though this effect 
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was attributed to it preventing their activation rather than any toxic effect (which was not 
tested for).  
Together this work shows that BZ194 has no effect on physiological or pathological NAADP 
related Ca2+ signalling in PAC when applied acutely or after a short incubation respectively, 
and therefore would have little therapeutic use for acute pancreatitis. Its effect as a research 
tool however cannot be discounted, as further work into its effect after a longer preincubation 
period would be required.  
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Chapter 8: Concluding remarks 
8.1 Summary  
The main aim of this study was to provide further insight into the role that NAADP-induced 
Ca2+ release plays in both pathological and physiological signalling in PAC. Of the three 
known intracellular secondary Ca2+ signalling molecules NAADP is the most recently 
identified (Lee and Aarhus 1995) and therefore the least well characterised. However, it has 
been shown to mobilise Ca2+ in mammalian and non-mammalian cells (Galione et al. 2000; 
Navazio et al. 2000), and has been shown to have a role in a diverse range of cellular 
processes (Barceló-Torns et al. 2011; Coxon et al. 2012; Arndt et al. 2014). 
PAC were the first mammalian cell type that NAADP was shown to have Ca2+ mobilising 
activity (Cancela et al. 1999), which also linked the secondary messenger to physiological 
signalling by the secretory hormone CCK. Since this initial report, NAADP has been shown 
to mobilise Ca2+ in these cells from both acidic and ER stores (Gerasimenko, Sherwood, et al. 
2006) as well as the nucleus (Gerasimenko et al. 2003); indicating a role for the messenger 
beyond just secretion of digestive enzymes. NAADP-induced Ca2+ release has also been 
shown to play a role in pathological Ca2+ signalling in PAC, with inhibition of this process 
reducing the amount of Ca2+ mobilized in response to the bile acid TLC-S (Gerasimenko, 
Flowerdew, et al. 2006). 
Since these initial discoveries in PAC, two significant discoveries in the field of NAADP 
signalling have been made. The first was the in silico identification of the membrane 
permeable NAADP-specific antagonist Ned-19 (Naylor et al. 2009). This compound has 
greatly increased the ease in which the role of NAADP can be highlighted in physiological 
processes by blocking its activity (Esposito et al. 2011; Aley et al. 2013; Favia et al. 2016). 
Since the discovery of Ned-19 a second membrane permeable NAADP-specific antagonist 
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has been identified called BZ194 (Dammermann et al. 2009), however its effectiveness 
compared to Ned-19 has been questioned (Ali et al. 2016). 
The second key discovery was that members of the TPC family of proteins can form 
NAADP-sensitive ion channels (E. Brailoiu et al. 2009; Calcraft et al. 2009; Zong et al. 
2009). While both TRP-ML1 and RyR channels had previously been suggested as fulfilling a 
similar role (Hohenegger et al. 2002; Zhang et al. 2009), both types of channel suitability had 
been questioned (Copello et al. 2001; Pryor et al. 2006). A similar challenge was issued 
against TPC’s candidacy (Wang et al. 2012; Cang et al. 2013), which instead suggested that 
these channels are NAADP insensitive and are instead PI(3,5)P2 gated Na+ channels 
regulated by mTOR. These finding have since been reconciled with TPC channels being 
NAADP sensitive cation channels that are also regulated by a range of factors including 
PI(3,5)P2, cytoplasmic Mg2+, their phosphorylation state, luminal pH and [Ca2+]l (Pitt et al. 
2010; Jha et al. 2014). Importantly it was shown that the ‘TPC1/2-/- double knockout mice’ 
used in the conflicting studies still expressed approximately 90% of the protein’s sequence 
and therefore were not true TPC nulls (Ruas et al. 2015). Creation of a true TPC1/2-/- double 
knockout mouse model was used to confirm the channels’ sensitivity to NAADP, which has 
generally been accepted since (Pereira et al. 2011; Davis et al. 2015; Sakurai et al. 2015; 
Nguyen et al. 2017). 
As such, it was intended to use these recent developments in the field of NAAPD signalling 
to further characterise the role that this messenger plays in PAC. This was done by first 
characterising the mechanism by which it mobilized Ca2+ from intracellular stores in this cell 
type; which was shown to involve the activity of both TPC and RyR channels, with a variable 
dependence of the different isoforms of both types of channel. Next the key role it plays in 
both initiating and sustaining intracellular Ca2+ responses to the physiological secretagogue 
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CCK was demonstrate by inhibiting such responses with Ned-19. The importance of 
NAADP-sensitive Ca2+ release in pathological signalling induced by the bile acids TLC-S 
then highlighted, again using Ned-19. The NAADP-antagonist was able to significantly 
inhibit both increases in [Ca2+]c and necrosis induced by TLC-S; suggesting a potential 
therapeutic role for the compound against AP, a condition that currently does not have a 
specific treatment (Johnson 2005). Unlike Ned-19, the alternative NAADP-antagonist BZ194 
showed no ability to inhibit either the intracellular response to CCK or TLC-S induced 
necrosis. Use of Ned-19 alone was not enough to significantly reduce the amount of necrosis 
observed in response to another bile acid, cholate. Neither was use of the CRAC channel 
blocker GSK-7975A; which had previously shown to have a protective effect against several 
models of AP, including one induced by TLC-S (Gerasimenko et al. 2013; Wen et al. 2015). 
However, a combination of both Ned-19 and GSK-7975A was able to cause a significant 
reduction in cholate-induced necrosis, suggesting a multi-targeted therapeutic approach 
inhibiting several elements of the cells ‘Ca2+ signalling toolkit’ (Berridge et al. 2000) may be 
the best solution for the treatment of AP. 
 
8.2 NAADP-induced calcium release from organelle stores in pancreatic acinar cells 
requires the involvement of both TPC and RyR channels  
Since its initial discovery as a distinct intracellular secondary Ca2+ messenger in its own right  
(Lee and Aarhus 1995), NAADP has been shown to mobilise Ca2+ from a unique source. This 
was first identified when the messenger was found to mobilize some Ca2+ independently of 
the activity of Tg (Genazzani and Galione 1996). However NAADP-induced release was 
diminished in the presence of Tg; and similarly by inhibitors of IP3 and cADPR induced 
released, while inhibitors of both completely abolished NAADP responses (Churchill and 
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Galione 2001). This led to the creation of the ‘trigger hypothesis’, where NAADP acts on a 
distinct Tg insensitive Ca2+ store to mobilize a small amount of ‘trigger Ca2+’ which then acts 
via CICR on IP3R and RyR in the ER to mobilize more Ca2+ from the Tg sensitive ER store, 
which both amplifies the overall response to NAADP and creates the Ca2+ oscillations 
consistently observed in response to the secondary messenger. This hypothesis, created using 
results from sea urchin eggs, was strengthened by similar findings in mammalian cells 
(Cancela et al. 1999) and the discovery that in sea urchin eggs NAADP mobilizes calcium 
from reserve granules (Churchill et al. 2002), a type of acidic organelle related to lysosomes 
in mammalian cells. 
Since these early discoveries there has been the desire to identify the ‘NAADP receptor’; 
hoped by many in the field to be a single Ca2+ channel (or family of channels) directly gated 
by NAADP, located on lysosomal membranes. This assumption (that NAADP only acts 
directly on lysosomal Ca2+ stores) was the key reason many rule out the possibility of RyR 
playing a direct role in NAADP-induced Ca2+ release, despite evidence supporting this 
(Hohenegger et al. 2002; Gerasimenko et al. 2003; Dammermann and Guse 2005; 
Dammermann et al. 2009; Wolf et al. 2015). Meaning that the possibility for NAADP to act 
directly on both lysosomal (via an unidentified Ca2+ channel) and ER stores (via RyR) was 
not considered as a possibility. However, with the discovery of TPC channels as NAADP 
sensitive ion channels (E. Brailoiu et al. 2009; Calcraft et al. 2009; Zong et al. 2009) the 
possibility of this has been strengthened as NAADP has been shown to act on these channels 
via a separate binding protein rather than directly (Lin-Moshier et al. 2012; Walseth et al. 
2012). This creates the possibility of there being multiple such NAADP binding proteins, 
which may be expressed in a cell type dependent manner. Such a possibility would certainly 
support the fact the NAADP-dependent activation of RyR has so far only been observed in 
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PAC (Gerasimenko et al. 2003) and T-cells (Dammermann and Guse 2005; Dammermann et 
al. 2009; Wolf et al. 2015), as well as membrane preparations from myocytes (Mojžišová et 
al. 2001; Hohenegger et al. 2002). 
Unlike most other cell types, in addition to their traditional sites of action PAC show the 
ability for IP3 and cADPR-induced Ca2+ release to occur from acidic stores (Gerasimenko, 
Sherwood, et al. 2006). Due to their secretory function these cells contain a large number of 
acidic secretory granules, which (due to other acid organelle Ca2+ stores being ruled out by 
pharmacological disruption) is the likely source of unique activity. While IP3R and RyR are 
not normally found on acidic organelles it is probable that the high rate of ER turnover 
required to produce and sustain such a large number of secretory vesicles is the cause of their 
non-traditional location in this cell type. As well as providing unique sensitivity to secondary 
messengers these zymogen granules also create an acidic Ca2+ store much larger than that 
found in others cells, increasing the importance of release from such stores. In addition to 
these findings NAADP was shown to be able to mobilize Ca2+ directly from the ER after 
depletion of acidic Ca2+ stores (Gerasimenko, Sherwood, et al. 2006). Based on experimental 
data produced using the related nuclear envelope (Gerasimenko et al. 2003), this release from 
the ER is believed to occur via RyR.  
The results presented in Chapter 3 expand on these previous reports using PAC to show that 
NAADP-induced Ca2+ release requires the involvement of both TPC and RyR channels 
(Gerasimenko et al. 2015). Based on the weight of evidence supporting TPC channels ’ 
sensitivity to NAADP (E. Brailoiu et al. 2009; Calcraft et al. 2009; Zong et al. 2009; Pitt et 
al. 2010; Jha et al. 2014; Ruas et al. 2015) it is believed that in PAC they are also directly 
activated by NAADP. Inhibition of both TPC isoforms activity was not found to completely 
abolish NAADP-induced Ca2+ release, suggesting a component of NAADP’s activity is TPC 
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independent. While no direct evidence was found to confirm that this TPC-independent 
component was the result of NAADP acting directly on RyR, based on their requirement for 
NAADP-induced Ca2+ and previous findings in PAC (Gerasimenko et al. 2003; 
Gerasimenko, Sherwood, et al. 2006) it can be assumed that this is probably the case.  
The dependence on the different RyR isoforms was found to be different for NAADP and 
cADPR, which is known to act directly on these channels (Lee 2001). It is possible that the 
variable dependence observed is the result of each messenger acting directly on only one or 
two of the 3 RyR isoforms and then indirectly on the others by CICR. Like NAADP-induced 
Ca2+ release, cADPR-induced release is known to require cADPR binding proteins (Walseth 
et al. 1993; Noguchi et al. 1997; Zhang et al. 2017). These binding proteins could provide the 
different isoform involvement observed, as they could provide the specificity by only 
interacting with specific RyR isoforms.   
 
8.3 The activity of NAADP is essential for the physiological response to CCK in 
pancreatic acinar cells 
When NAADP was first shown to play a role in intracellular Ca2+ release in mammalian cells 
using PAC it was found to be required for the initiation of responses to the secretagogue CCK 
(Cancela et al. 1999). The results in presented in Chapter 4 also show that the secondary 
messenger is required to sustain the response to CCK, as the acute application of Ned-19 on 
top of such responses terminated them. It is probable that as NAADP is likely to act directly 
on both TPC and RyR in PAC that Ned-19 inhibits both types of channel in these cells. 
However, this inhibition must occur in a similar isoform specific manner as NAADP-induced 
release, as Ned-19 had no significant effect on cADPR induced Ca2+ release in permeabilized 
PAC. Therefore, the inhibition of NAADP-induced release is enough to terminate responses 
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to CCK despite PAC producing both cADPR and NAADP when stimulated by the hormone 
(Yamasaki et al. 2005).  
The 100 µM concentration of Ned-19 used was unable to provide a complete inhibition 
against 100 nM NAADP in permeabilized PAC but did prove a complete inhibition of CCK 
responses. This suggests that the amount of NAADP produced by PAC upon stimulation with 
5 pM CCK is lower than the 100 nM concentration used in the permeabilized cell 
experiments, and that the Ned-19 insensitive component of the NAADP response observed in 
them not physiologically relevant.  
Unlike Ned-19, the alternative NAADP antagonist BZ194 showed no effect on CCK-induced 
Ca2+ oscillations in PAC. This correlates with the findings of Ali et al.; who found the similar 
results against the proliferation of naïve CD4 and CD8 T cells by anti-CD3/CD28 stimulation 
(Ali et al. 2016), with Ned-19 suppressing proliferation and BZ194 having no effect. While 
BZ194 has been shown to antagonise NAADP responses in several studies (Dammermann et 
al. 2009; Cordiglieri et al. 2010; Nebel et al. 2013; Nebel et al. 2015), it has been utilized a 
lot less as a research tool than Ned-19 due to its lack of commercial availability. Because of 
this it is hard to draw definitive conclusions on its effectiveness compared to Ned-19; though 
with its proven antagonistic effect (Naylor et al. 2009; Esposito et al. 2011; Pereira et al. 
2011; Favia et al. 2016; Kelu et al. 2017), lack of toxic effect (Coxon et al. 2012; Favia et al. 
2016) and ready availability; it is likely that Ned-19 will remain the NAADP antagonist of 
choice for most researchers. 
Despite permeabilized PAC isolated from TPCN2-/- mice showing a significantly reduced 
response to NAADP, intact cells from these knockout animals showed no loss of sensitivity 
to CCK. While the size of the response was not calculated to see if it was diminished 
compared to that in wild type PAC, it does suggest that the activity of the remaining 
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NAADP-sensitive ion channels in TPCN2-/- cells is enough to produce a response to the 
secretagogue. The knockout cells also showed the same sensitivity to Ned-19 as wild type 
PAC, with the compound completely inhibiting responses to CCK. This means even with 
their reduced sensitivity to NAADP, the secondary messenger is still integral to CCK effect 
on the knockout cells. As the different isoforms of TPC and RyR were found to contribute to 
the NAADP response in PAC to different extents, it could be of interest to do the same for 
CCK, and see if the isoform requirements for physiological signalling differs from direct 
application of secondary messengers.  
 
8.4 Inhibition of NAADP-induced calcium release by Ned-19 is a potential therapeutic 
solution to acute pancreatitis 
Gallstones are the most common cause of AP, contributing to just under 30% of all 
incidences of the disease in western countries (Joergensen et al. 2010). It is believed that 
these condensates of bile components create a physical blockage in the common bile duct 
(Lammert et al. 2016), which results in the reflux of bile into the pancreas, where components 
of the bile such as bile acids have a toxic effect resulting in an incident of AP (Arendt et al. 
1999).  
To recreate an experimental model of this biliary form of AP the bile acid TLC-S is often 
used as a ‘model bile acid’ (Perides et al. 2010; Muili, Jin, et al. 2013; Orabi et al. 2013; Wen 
et al. 2015; Huang et al. 2017). This bile acid has been found to instigate increases in the 
[Ca2+]c of PAC which can reach cytotoxic levels and result in uncontrolled necrosis typical of 
AP (Voronina et al. 2002). Such increases in Ca2+ are the result of TLC-S inducing the 
release of Ca2+ from organelle stores (Gerasimenko, Flowerdew, et al. 2006) and is dependent 
on the activity of CD38 (Orabi et al. 2013). 
  
230 
 
As TLC-S-induced Ca2+ release had previously been found to be reduced in the presence of a 
high autoinhibitory concentration of NAADP (Gerasimenko, Flowerdew, et al. 2006), it was 
predicted that Ned-19 would have a similar effect. The results in Chapter 5 confirm that Ned-
19 is not just capable of reducing the amount of Ca2+ mobilized in response to TLC-S, but 
also has a protective effect against the necrosis induced by this bile acid. While Ned-19 was 
found to be capable of significantly reducing the amount of necrosis observed in response to 
TLC-S, it was never able to reduce it to the level of the control. Because of this, it was used 
in combination with either caffeine or GSK-7975A, which have also both been shown to 
significantly inhibit  TLC-S-induced necrosis (Wen et al. 2015; Huang et al. 2017). Unlike 
GSK-7975A, caffeine showed an additive protective effect when used in combination with 
Ned-19, reducing the amount of necrosis observed to a level identical to the control.  
The alternative NAADP antagonist BZ194 was found to exhibit no effect against TLC-S-
induced necrosis, as this matched the finding against CCK-induced Ca2+ release it strengthens 
the argument that this compound has no effect in PAC. Similarly, TPCN2-/- showed no 
reduction in sensitivity to the necrotic effects of TLC-S or the protective effect of Ned-19 
against it. This suggests that, like for the response to CCK, PAC contain enough NAADP 
sensitive Ca2+ channels to compensated for the loss of TPC2 in the knockout cells; and that 
any reduction in Ca2+ response to TLC-S compared to wild types ones is insignificant, as it 
has no effect on the bile acid’s necrotic effects.  
In chapter 6 the primary bile acid cholate was shown to induce Ca2+ responses in PAC, which 
ultimately resulted in the death and loss of membrane integrity of the cell. When used alone 
either Ned-19 or GSK-7975A was found reduce the amount of necrosis observed in response 
to cholate, though neither’s effect was deemed significant. Unlike when used against TLC-S, 
a combination of the two compounds had an additive protective effect and reduced the 
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amount of necrosis significantly. This suggests that different bile acids have different 
toxicities, and so the protective effect of a compound seen against one bile acid might not be 
sufficient to significantly inhibit the effect of another. Therefore, under true pathological 
conditions (where PAC will be exposed to a mixture of bile acids) an optimised treatment, 
targeting multiple elements of the cells ‘Ca2+ signalling toolkit’ (Berridge et al. 2000) may be 
required to treat AP. 
TLC-S’s effect in PAC has been shown to be CD38 dependent (Orabi et al. 2013 p.38), 
presumably the bile acid stimulates the activity of this enzyme resulting in the production of 
the secondary messengers NAADP and cADPR. The mechanism by which it does this is 
unknown; as is if it has a similar effect on PLC to induce the production of IP3. Potentially it 
could occur extracellularly via the stimulation of the same plasma membrane receptors used 
for physiological signalling, or directly by the uptake of bile acids by their transporters, 
which PAC are known to express (Kim et al. 2002). Identifying which process TLC-S 
utilises, and if other bile acids share this, could provide several alternative targets for 
pharmacological inhibition of AP than the ion channels that this report focused on. 
Due to its membrane permeability (Naylor et al. 2009), proven lack of toxicity in vivo (Favia 
et al. 2016) and the results presented in this report, Ned-19 offers a potential treatment for 
AP. Confirmation of this requires further study of its effect against other models of the 
diseases and progression from cellular models to in vivo ones.  
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